Page last updated: 2024-10-21

n-methyl-3,4-methylenedioxyamphetamine and Chemical Dependence

n-methyl-3,4-methylenedioxyamphetamine has been researched along with Chemical Dependence in 878 studies

N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.

Research Excerpts

ExcerptRelevanceReference
"Stimulant use, including cocaine, methamphetamines, ecstasy, and prescription stimulants, in pregnancy is increasingly common."5.01Stimulant Use in Pregnancy: An Under-recognized Epidemic Among Pregnant Women. ( Gordon, AJ; Metz, TD; Smid, MC, 2019)
"We report the case of a 27-year-old woman hospitalized with edema, ascites and severe liver failure (prothrombin rate 33%), following the use of ecstasy and cocaine over the previous 9 months."3.79Severe chronic hepatitis secondary to prolonged use of ecstasy and cocaine. ( Bacq, Y; de Muret, A; Payancé, A; Perarnau, JM; Scotto, B, 2013)
"Thromboaspiration was performed in a young adult in a coma because of acute basilar artery occlusion associated with cocaine and ecstasy abuse 30 hours after symptom onset."3.72Acute basilar artery occlusion treated by thromboaspiration in a cocaine and ecstasy abuser. ( Barragan-Campos, HM; Chiras, J; Crozier, S; Guillevin, R; Lo, D; Obadia, M; Samson, Y; Vallée, JN, 2003)
"Post-traumatic stress disorder (PTSD) is commonly associated with alcohol and substance use disorders (ASUD)."3.11The effects of MDMA-assisted therapy on alcohol and substance use in a phase 3 trial for treatment of severe PTSD. ( Brown, RT; Coker, A; Doblin, R; Emerson, A; Klaire, SS; Mitchell, JM; Nicholas, CR; Wang, JB; Yazar-Klosinski, B, 2022)
"The rationale for the use of MDMA in PTSD and SUD is being extended to a broader beneficial "psychedelic effect," which is supporting further clinical investigations, in spite of the lack of mechanistic hypothesis."2.58Psychedelics and reconsolidation of traumatic and appetitive maladaptive memories: focus on cannabinoids and ketamine. ( Chiamulera, C; Fattore, L; Fumagalli, G; Piva, A; Zanda, MT, 2018)
" The principal sources of pharmacodynamic variability are reviewed, with special emphasis on sex-gender, race-ethnicity, genetic differences, interactions, and MDMA acute toxicity, as well as possible therapeutic use."2.58Key interindividual determinants in MDMA pharmacodynamics. ( Farré, M; Muga, R; Papaseit, E; Pérez-Mañá, C; Torrens, M, 2018)
" These desirable and adverse effects of MDMA are extensions of its fascinating pharmacologic and pharmacokinetic profile."2.50How MDMA's pharmacology and pharmacokinetics drive desired effects and harms. ( Michael White, C, 2014)
"MDMA may also help treat substance abuse based on shared features with psychedelic compounds and recent reports indicating that MDMAassisted psychotherapy can reduce symptoms of PTSD."2.49Can MDMA play a role in the treatment of substance abuse? ( Jerome, L; Schuster, S; Yazar-Klosinski, BB, 2013)
" Many people (ab)use BZP-based party pills usually without any significant toxic effects."2.48Nephrotoxicity of recreational party drugs. ( Berney-Meyer, L; Putt, T; Schollum, J; Walker, R, 2012)
"Oxytocin therefore has fascinating potential to reverse the corrosive effects of long-term drugs abuse on social behavior and to perhaps inoculate against future vulnerability to addictive disorders."2.48Breaking the loop: oxytocin as a potential treatment for drug addiction. ( Bowen, MT; McGregor, IS, 2012)
" Both Lifetime Total Ecstasy Consumption (LTEC) and the effect sizes for alcohol, nicotine, amphetamine, cocaine and lysergic acid diethylamide (LSD) were regressed on the mean effect sizes (mES) of the WM subcomponents in order to study dose-response relationships."2.46Deterioration of executive functioning in chronic ecstasy users; evidence for multiple drugs effects. ( Verbaten, MN, 2010)
"Oral effects include xerostomia, bruxism, and an increased risk of developing dental erosion."2.44Ecstasy (MDMA) and oral health. ( Brand, HS; Dun, SN; Nieuw Amerongen, AV, 2008)
"This review of chronic tolerance to MDMA (3,4-methylenedioxymetamphetamine) covers the empirical data on dosage escalation, reduced subjective efficacy and bingeing in recreational Ecstasy users."2.43Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy. ( Parrott, AC, 2005)
"The number of registered drug abusers increased from 70,000 in 1990 to more than one million by the end of 2004."2.43Recent trends in drug abuse in China. ( Fang, YX; Liu, ZM; Lu, L; Shi, J; Wang, YB, 2006)
" A mistaken belief that it is a safe drug of low toxicity and a long duration of action has led to its widespread popularity among teenagers and young adults in recent years."2.43[Ecstasy toxicity]. ( Reingardiene, D, 2006)
" Some studies have found a dose-response relationship, so that increasing levels of abuse are associated with greater risk of hemorrhage."2.42Cerebrovascular complications of alcohol and sympathomimetic drug abuse. ( Bruno, A, 2003)
"Drug abuse is a global problem of considerable concern to health."2.42Methylenedioxymethamphetamine (MDMA, 'Ecstasy'): a stressor on the immune system. ( Connor, TJ, 2004)
"Conventional wisdom, and even well-reasoned theoretical mechanisms, suggests that the chronic use of psychoactive substances would impair cognitive functioning of individuals."2.42Cognitive impairment in substance abuse. ( Cellucci, T; Hedt, J; Jarchow, A; Vik, PW, 2004)
"Drug abuse affects a significant number of individuals of all ages."2.42Common drugs of abuse--Part II. ( Cuddy, ML, 2004)
"This article summarizes the short-term physiological toxicity and the adverse behavioral effects of four substances (GHB, ketamine, MDMA, and Rohypnol) that have been used at latenight dance clubs."2.42Acute toxic effects of club drugs. ( Gable, RS, 2004)
"The greatest challenge facing the drug abuse prevention field is to get information out to practitioners and communities about the best prevention programs, approaches, and principles of effectiveness."2.41Prevention of alcohol and drug abuse: what works? ( Kumpfer, KL, 2002)
"Besides smoking, alcohol abuse has also been implicated as a renal risk factor."2.41[Adverse renal effects of legal and illicit drugs]. ( Orth, SR, 2002)
"Flunitrazepam is a potent benzodiazepine."2.41Club drugs: methylenedioxymethamphetamine, flunitrazepam, ketamine hydrochloride, and gamma-hydroxybutyrate. ( Larive, LL; Romanelli, F; Smith, KM, 2002)
"Convulsive seizures are among the most common problems involving the central nervous system."2.40[MDMA ("Ecstasy") use--an overview of psychiatric and medical sequelae]. ( Kraus, D; Schmolke, M; Thomasius, R, 1997)
" Up to now, no death could be attributed to MDMA intoxication only because our analyses always revealed the additional presence of toxic amounts of other psychoactive drugs (e."2.40[Ecstasy--the status in French-speaking Switzerland. Composition of seized drugs, analysis of biological specimens and short review of its pharmacological action and toxicity]. ( Augsburger, M; Giroud, C; Rivier, L; Sadeghipour, F; Varesio, E; Veuthey, JL, 1997)
"Consume of XTC as a typical drug abuse of the techno scene represents a new challenge for the classical drug aid system."2.39[Ecstasy, a new designer drug in the techno-scene]. ( Kuhlmann, T, 1996)
" MDMA was either equally toxic or slightly to moderately less toxic than its close congener, MDA, (+/-)-3,4-methylenedioxyamphetamine."2.37Toxicity of MDA (3,4-methylenedioxyamphetamine) considered for relevance to hazards of MDMA (Ecstasy) abuse. ( Davis, WM; Hatoum, HT; Waters, IW, 1987)
"Illicit substance use has constantly evolved over the years, particularly in the party scene."1.91First results of the French OCTOPUS survey among festival attendees: a latent class analysis. ( Babonnaud, L; Bresdin, V; Eudeline, V; Grall-Bronnec, M; Guillet, JE; Guillo, M; Istvan, M; Jolliet, P; Laigo, P; Mainguy, M; Schreck, B; Victorri-Vigneau, C, 2023)
"Locomotor activity and conditioned place preference dose-response curves were generated at 20±2°C for two amphetamine analogues (MDMA and methamphetamine [METH]) and two cathinone analogues (MDPV and α-pyrrolidinopentiophenone [αPVP]) in mice."1.91Effects of ambient temperature on locomotor activity and place conditioning elicited by abused psychostimulants in mice: Role of 3,4-methylenedioxy moiety. ( Fantegrossi, WE; Fitzgerald, LR; Gannon, BM; Godwin, CO; Hughes-Meredith, HD; Rice, KC, 2023)
"He had a family history of Parkinson's disease, though the onset of his symptoms was significantly earlier than those of his family members."1.91Early onset Parkinson's disease in the cycle of 3,4-methylenedioxymethamphetamine and substance use: a case report. ( Guo, S; Hui, T, 2023)
"Substance use has been extensively linked to sexual behavior and HIV/STI risk among men who have sex with men (MSM) and transgender women (TW)."1.91Substance use and variation in sexual partnership rates among young MSM and young transgender women: Disaggregating between and within-person associations. ( Birkett, M; Janulis, P; Jenness, SM; Mustanski, B; Phillips, G; Risher, K, 2023)
"Multiple illicit substance users were more likely to use methamphetamine (p = 0."1.72Survey of substance use among adolescent drug offenders referred from juvenile courts in Taiwan: Clinical epidemiology of single versus multiple illicit substance use. ( Chen, LY; Chen, MH; Chen, YH; Wei, HT, 2022)
"Efforts to intervene on substance use in connection with sex remain critical for health promotion."1.72Changes in substance use among HIV-negative MSM: A longitudinal analysis, 1995-2019. ( Coyer, L; Davidovich, U; Kelly, BC; Mustillo, SA; Prins, M, 2022)
"Heroin biomarkers were not detected at any locations, and fentanyl was detected around or below the limit of reporting."1.72Illicit drug consumption estimated using wastewater analysis and compared by settlement size in New Zealand. ( Armstrong, B; Chappell, A; Grigg, S; Jay, E; McCormick, S; Phung, K; Waite, B, 2022)
"In this study, we aimed to test whether substance use in this population is related to an attempt to self-medicate PTSD-related symptoms."1.72Coping motives mediate the relationship between PTSD and MDMA use in adolescents with substance use disorders. ( Basedow, LA; Golub, Y; Kuitunen-Paul, S; Roessner, V; Wiedmann, MF, 2022)
"Reducing substance use harm in young people is a major public health priority, however, health promotion messages often struggle to achieve meaningful engagement."1.72Neuroscience literacy and substance use prevention: How well do young people understand their brain? ( Birrell, L; Champion, K; Debenham, J; Lawler, S; Lees, B; Newton, N; Stapinski, L; Teesson, M, 2022)
"Adolescent patients with a substance use disorder (SUD) often fulfil the criteria for a co-occurring post-traumatic stress disorder (PTSD)."1.62Self-reported PTSD is associated with increased use of MDMA in adolescents with substance use disorders. ( Basedow, LA; Golub, Y; Kuitunen-Paul, S; Roessner, V; Wiedmann, MF, 2021)
"Ketamine is a dissociative anesthetic used in medical practice, used recreationally since the mid-1960s."1.62Ketamine Use Among People Who Regularly Use Ecstasy and Other Illicit Stimulants in Australia: Trends and Characteristics of Use, 2009-2019. ( Cossar, R; Dietze, P; Djordjevic, F; Lenton, S; Peacock, A; Salom, C; Stewart, AC, 2021)
"All cases of drug abuse identified by hair analysis were from the public security organs in Shanghai, China."1.56A Retrospective of Prevalence of Drugs of Abuse by Hair Analysis in Shanghai using LC-MS-MS. ( Cui, J; Liu, W; Shen, B; Shen, M; Wang, X; Xiang, P; Zhang, S; Zhuo, Y, 2020)
"Methylenedioxymethamphetamine (MDMA) and methcathinone (MCAT) are abused psychostimulant drugs that produce adverse effects in human users that include hepatotoxicity and death."1.56High ambient temperature increases the toxicity and lethality of 3,4-methylenedioxymethamphetamine and methcathinone. ( Chen, Y; Hall, FS; Saber, YH; Tran, HTN, 2020)
"To explore how synthetic substance use relates to other forms of use, this paper presents an analysis of polysubstance use among a sample of 676 people who use illicit substances in the United States."1.51Polysubstance use patterns and novel synthetics: A cluster analysis from three U.S. cities. ( Benoit, E; Campos, S; Elliott, L; Haddock, CK, 2019)
"Illegal substance use at music festivals is less documented than it is in nightlife and electronic dance music settings."1.51Illegal substance use among 1,309 music festival attendees: An investigation using oral fluid sample drug tests, breathalysers and questionnaires. ( Bretteville-Jensen, AL; Furuhaugen, H; Gjerde, H; Gjersing, L, 2019)
"Twenty-five had complaints related to substance use including ethanol (n = 18), "molly" or "ecstasy" (n = 13), and marijuana (n = 8)."1.48Emergency Department Patient Burden from an Electronic Dance Music Festival. ( Chhabra, N; Gimbar, RP; Thompson, TM; Walla, LM, 2018)
"Depressed level of consciousness was the most common physical sign (33."1.48Street drug use among emergency patients in a Public Hospital in Turkey. ( Caliskan, FT; Karcioglu, O; Temizyurek, Z; Toker, I; Toktas, R; Unek, O; Zirek, B, 2018)
"We report one case of spontaneous subarachnoid hemorrhage and small acute cerebellar infarction in an otherwise healthy patient after ingestion of molly."1.43Intracranial Vascular Complications of "Molly" Usage: Case Report and Review of the Literature. ( Afshani, M; Wong, S, 2016)
"Examine the severity of club drug dependence and perceived need for treatment, and further identify their determinants among a sample of club drug users in Shanghai, China."1.40Severity of club drug dependence and perceived need for treatment among a sample of adult club drug users in Shanghai, China. ( Detels, R; Ding, Y; Gao, M; He, N; Shoptaw, S, 2014)
"Tramadol hydrochloride is a common prescription pain reliever that is structurally similar to morphine and codeine with its analgesic effects identified as a mu-receptor agonist."1.40The association between tramadol hydrochloride misuse and other substances use in an adolescent population: Phase I of a prospective survey. ( Bidel, Z; Carson, KV; Nazarzadeh, M, 2014)
"This paper reports on changes in substance use and substance dependence symptoms-without intervention-among young adult multidrug users in the club scene, ages 18-29, (N = 444) who participated in a natural history study."1.39Interview as intervention: the case of young adult multidrug users in the club scene. ( Buttram, ME; Chen, M; Kurtz, SP; Levi-Minzi, MA; Surratt, HL, 2013)
"Lifetime and recent substance use and SPU at last recalled use was described by structured interviews."1.38Simultaneous polysubstance use among Danish 3,4-methylenedioxymethamphetamine and hallucinogen users: combination patterns and proposed biological bases. ( Christoffersen, M; Damgaard, L; Erritzoe, D; Fink-Jensen, A; Knudsen, GM; Licht, CL; Okholm, M, 2012)
"Our sample consisted of 49 polysubstance users enrolled in residential treatment."1.38Neural correlates of the severity of cocaine, heroin, alcohol, MDMA and cannabis use in polysubstance abusers: a resting-PET brain metabolism study. ( Fernández-Serrano, MJ; Gómez-Río, M; Moreno-López, L; Pérez-García, M; Rodríguez-Fernández, A; Stamatakis, EA; Verdejo-García, A, 2012)
"Ecstasy and cocaine abusers exhibited higher TAS-20 and BDI-13 scores and lower levels of emotional awareness than non-drug users."1.38[Emotion regulation among psychostimulants drug users at techno parties]. ( Lillaz, C; Varescon, I, 2012)
"One of the most common drug abused by pregnant women is methamphetamine (MA), which is also the most frequently abused illicit drug in the Czech Republic."1.38Do prenatally methamphetamine-exposed adult male rats display general predisposition to drug abuse in the conditioned place preference test? ( Hrubá, L; Macúchová, E; Nová, E; Pometlová, M; Rokyta, R; Schutová, B; Šlamberová, R, 2012)
"With rates of drug abuse and misuse on the rise, clinicians must remain especially attentive to drug abusers' verbal and nonverbal cues, and be familiar with treating perioperative complications if they arise."1.37Drug abuse in plastic surgery patients: optimizing detection and minimizing complications. ( Cone, JD; Harrington, MA; Kelley, SS; Payne, WG; Prince, MD; Smith, DJ, 2011)
"Phentermine (PT) has been widely used as an anti-obesity drug."1.37Detection of phentermine in hair samples from drug suspects. ( Choi, H; Chung, H; Chung, KH; In, S; Kim, J; Lee, S, 2011)
"The dependent variable was the number of reported ecstasy-related adverse effects."1.37Modelling the adverse effects associated with ecstasy use. ( Fisk, JE; Hadjiefthyvoulou, F; Montgomery, C; Murphy, PN, 2011)
"The annual death rate from drug abuse for teenagers increased from 1."1.37Trends and pattern of drug abuse deaths in Maryland teenagers. ( Fowler, DR; Levine, B; Li, G; Li, L; Zhang, X; Zielke, HR, 2011)
"Information on adolescent substance use, suicidal behaviors, and related sociodemographic, family, and individual factors was obtained in the survey."1.37Ecstasy use and suicidal behavior among adolescents: findings from a national survey. ( Fan, B; Kerner, N; Kim, J; Liu, X; Wu, P, 2011)
"Implications for designing substance use prevention/intervention programs for this minority group are discussed."1.37Ecstasy use and associated risk factors among Asian-American youth: findings from a national survey. ( Fan, B; Kim, J; Liu, X; Wu, P, 2011)
"Bruxism is a recognized side effect of several licit and illicit drugs."1.36Bruxism after 3,4-methylenedioxymethamphetamine (ecstasy) abuse. ( Caldas, I; Carvalho, F; Dinis-Oliveira, RJ; Magalhães, T, 2010)
"Methamphetamine use was highest in the largest city and cocaine use was lowest in the smallest city."1.36Illicit drugs in Canadian municipal wastewater and estimates of community drug use. ( Li, H; Metcalfe, C; Rodayan, A; Tindale, K; Yargeau, V, 2010)
"A method of hollow fiber (HF) liquid phase microextraction (LPME) combined with gas chromatography (GC)-flame ionization detection (FID) was developed for the simultaneous quantification of trace amphetamine (AP), methamphetamine (MA), methylenedioxyamphetamine (MDA), methylenedioxymethamphetamine (MDMA), caffeine and ketamine (KT) in drug abuser urine samples."1.36Simultaneous quantification of amphetamines, caffeine and ketamine in urine by hollow fiber liquid phase microextraction combined with gas chromatography-flame ionization detector. ( Chen, J; He, M; Hu, B; Xiong, J, 2010)
"Polydrug use in pregnancy is harmful."1.36[Maternal and obstetrical data in a retrospective cohort of 170 newborns from polydrug using mothers, in the Paris area, 1999-2008]. ( Crenn-Hebert, C; Genest, L; Lejeune, C; Miossec, E; Simmat-Durand, L; Simonpoli, AM; Toutain, S; Vellut, N, 2010)
"Humans with genetic predisposition for the slow metabolism of MDMA, the so-called "poor metabolizers" of debrisoquin are at higher risk."1.36Long-term neuronal damage and recovery after a single dose of MDMA: expression and distribution of serotonin transporter in the rat brain. ( Kirilly, E, 2010)
"5-h intervals) 12 h prior to the MDMA dosing regimen (20 mg/kg x 3 at 2-h intervals) aggravated the MDMA-induced dopaminergic toxicity."1.35Ketamine pretreatment exacerbated 3,4-methylenedioxymethamphetamine-induced central dopamine toxicity. ( Cherng, CG; Ho, MC; Ke, JJ; Tsai, CW; Tsai, YP; Yu, L, 2008)
" However, such dosing regimens do not adequately mimic the intermittent use patterns commonly seen in adolescent recreational ecstasy users."1.35Development and characterization of a novel animal model of intermittent MDMA ("Ecstasy") exposure during adolescence. ( Meyer, JS; Piper, BJ; Vancollie, VE, 2008)
" However, findings on the presence of a dose-response relation are inconsistent, possibly due to individual differences in genetic vulnerability."1.35The effect of Ecstasy on memory is moderated by a functional polymorphism in the cathechol-O-methyltransferase (COMT) gene. ( de Win, MM; den Brink, Wv; Koeter, MW; Schilt, T; Schmand, B; van Amelsvoort, TA; Zinkstok, JR, 2009)
"Self-reported STDs and substance use were assessed by the audio computer-assisted self-interviewing method."1.35Association of MDMA/ecstasy and other substance use with self-reported sexually transmitted diseases among college-aged adults: a national study. ( Blazer, DG; Hubbard, RL; Patkar, AA; Ringwalt, CL; Wu, LT, 2009)
"The computerized Substance Abuse Module for Club Drug (CD-SAM) was used to assess MDMA abuse and dependence."1.35Test-re-test reliability of DSM-IV adopted criteria for 3,4-methylenedioxymethamphetamine (MDMA) abuse and dependence: a cross-national study. ( Abdallah, AB; Cottler, LB; Leung, KS, 2009)
"Ketamine was found in 28 of these cases, signifying the popularity of this drug in Taiwan."1.35Methylenedioxymethamphetamine-related deaths in Taiwan: 2001-2008. ( Lin, DL; Liu, HC; Liu, RH, 2009)
"During sleep deprivation, MDMA users, but not controls, became increasingly impulsive, performing more rapidly at the expense of accuracy on tasks of working and short-term memory."1.35Sleep deprivation differentially impairs cognitive performance in abstinent methylenedioxymethamphetamine ("Ecstasy") users. ( McCann, UD; Ricaurte, GA; Sgambati, FP; Wilson, MJ, 2009)
"Obstructive sleep apnea (OSA) is a common form of sleep-disordered breathing in which brain serotonin dysfunction may play a role."1.35Sleep apnea in young abstinent recreational MDMA ("ecstasy") consumers. ( McCann, UD; Ricaurte, GA; Schwartz, AR; Sgambati, FP, 2009)
"Illicit drug abusers in a Drug Abstention and Treatment Center were recruited to complete the questionnaires and their data were compared with an age-matched control."1.35Sexual dysfunction in men who abuse illicit drugs: a preliminary report. ( Bang-Ping, J, 2009)
"Data ascertained in a study of club drug use among 450 gay and bisexual men indicate that at least one class of PDE-5 (phosphodiesterase type 5 inhibitor, sildenafil [Viagra]) is used frequently in combination with club drugs such as methamphetamine, MDMA (3,4 methylenedioxymethamphetamine [ecstasy]), ketamine, cocaine, and GHB (gamma hydroxy butyrate)."1.34Sildenafil (Viagra) and club drug use in gay and bisexual men: the role of drug combinations and context. ( Green, KA; Halkitis, PN, 2007)
"Behavioural economic models of substance use describe the relationship between changes in unit price and consumption."1.34The effects of price and perceived quality on the behavioural economics of alcohol, amphetamine, cannabis, cocaine, and ecstasy purchases. ( Clayton, H; Cole, JC; Field, M; Goudie, AJ; Sumnall, HR, 2007)
"The correlates of polysubstance use were examined using the two-step procedure of variable selection."1.34Polysubstance use and its correlates in adolescent ecstasy users in Taiwan. ( Cheng, CP; Hsu, SY; Yen, CF, 2007)
"Time to HIV seroconversion was the outcome of interest."1.34The relationship between methamphetamine and popper use and risk of HIV seroconversion in the multicenter AIDS cohort study. ( Cox, C; Jacobson, LP; Li, X; Ostrow, DG; Peck, JA; Plankey, MW; Stall, R, 2007)
"Further research is needed to study substance use and related problem behavior among immigrant youth controlling for the impact of acculturation and other factors."1.34Former Soviet Union immigrant and native-born adolescents in Israel: substance use and related problem behavior. ( Isralowitz, RE; Reznik, A, 2007)
" Mean MDMA dosage of tablets decreased from 1999 to 2003 and dosage for tablets bearing the same logo appeared to be highly variable."1.34Monitoring ecstasy content in France: results from the National Surveillance System 1999-2004. ( Bello, PY; Giraudon, I, 2007)
"Recent publications claim that the recreational drug ecstasy is considered to be safe by many or most ecstasy users, or by young people or the general public."1.33Is ecstasy perceived to be safe? A critical survey. ( Gamma, A; Jerome, L; Liechti, ME; Sumnall, HR, 2005)
"All (119) subjects were poly-drug abusers (abused one or more illicit drugs in the past)."1.33Oral health sensations associated with illicit drug abuse. ( Chan, B; McGrath, C, 2005)
"All participants were polysubstance users, consuming a number of other substances simultaneously and concurrently with ecstasy."1.33An in-depth qualitative examination of the ecstasy experience: results of a focus group with ecstasy-using college students. ( Arria, AM; Levy, KB; O'Grady, KE; Wish, ED, 2005)
"In 5 cases death was caused by airway obstruction by swallowed packages."1.33Concealment of drugs by police detainees: lessons learned from adverse incidents and from 'routine' clinical practice. ( Best, D; Carter, J; Havis, S, 2005)
"Prescription drug abuse was reported by 87%; alprazolam (57%), oxycodone (36%), hydrocodone (32%) and diazepam (30%) were cited most often."1.33Prescription drug abuse among ecstasy users in Miami. ( Cottler, L; Inciardi, JA; Kurtz, SP; Surratt, HL, 2005)
" Previous studies suggest that ecstasy (3,4 methylene-dioxymethamphetamine, MDMA, XTC) is toxic toward brain serotonin axons, but most of these studies have serious methodological limitations."1.33The Netherlands XTC Toxicity (NeXT) study: objectives and methods of a study investigating causality, course, and clinical relevance. ( Booij, J; De Win, MM; Den Heeten, GJ; Jager, G; Korf, DJ; Ramsey, NF; Reneman, L; Schilt, T; Van den Brink, W; Verhulst, FC; Vervaeke, HK, 2005)
"Ketamine users were primarily employed youths."1.33Concurrent use of methamphetamine, MDMA, LSD, ketamine, GHB, and flunitrazepam among American youths. ( Galvin, DM; Schlenger, WE; Wu, LT, 2006)
"Simultaneous polysubstance use (SPU) is a common phenomenon, yet little is known about how various substances are used with one another."1.33Patterns of simultaneous polysubstance use in drug using university students. ( Barrett, SP; Darredeau, C; Pihl, RO, 2006)
"Amphetamine was more frequent in the west of Denmark, while heroin hydrochloride was more frequent in central Denmark."1.32Narcotics at street level in Denmark. A prospective investigation from 1995 to 2000. ( Kaa, E; Nielsen, E; Rollmann, D; Simonsen, KW, 2003)
"It was found that i."1.32Intravenous drug injection habits: drug users' self-reports versus researchers' perception. ( Giacomuzzi, S; Riemer, Y; Saria, A; Sturm, K; Wakonigg, G; Zernig, G, 2003)
"Here, we report the patterns of drug abuse by the participants in a metropolitan city disco-dancing club and the general public in Taiwan."1.32Profiles of urine samples from participants at rave party in Taiwan: prevalence of ketamine and MDMA abuse. ( Hu, AR; Lin, HR; Lua, AC; Tseng, YT; Yeh, PC, 2003)
"It measures changes in substance use at both locations between 1999 and 2002 and examines the role of dance resorts in recruiting individuals into using new substances."1.32The role of an international nightlife resort in the proliferation of recreational drugs. ( Bellis, MA; Bennett, A; Hughes, K; Thomson, R, 2003)
"Additionally, users that met DSM-IV substance use disorder criteria for lifetime MDMA abuse or dependence exhibited a number of additional deficits relative to those who did not meet these criteria."1.32Neurocognitive function in users of MDMA: the importance of clinically significant patterns of use. ( Hanson, KL; Luciana, M, 2004)
"In the current study, data from the Drug Abuse Warning Network (DAWN), Monitoring the Future (MTF), and National Household Survey on Drug Abuse (NHSDA) are used to explore ecstasy use trends in the United States during the 1990s."1.32Tracking ecstasy trends in the United States with data from three national drug surveillance systems. ( Yacoubian, GS, 2003)
"Friends, drug abuse treatment programs, and physicians were perceived to be the most accurate sources of information about ecstasy by 45."1.32Sources of information about MDMA (3,4-methylenedioxymethamphetamine): perceived accuracy, importance, and implications for prevention among young adult users. ( Carlson, RG; Falck, RS; Siegal, HA; Wang, J, 2004)
"Odds ratios (ORs) for association of substance use and UAI during the previous year were adjusted for age and calendar year."1.32Unprotected anal intercourse associated with recreational drug use among young men who have sex with men depends on partner type and intercourse role. ( Hogg, RS; Lampinen, TM; Rusch, M; Schilder, A, 2004)
"Amphetamine was a substitute for alcohol, cocaine was a compliment drug and ecstasy was independent."1.32A behavioural economic analysis of alcohol, amphetamine, cocaine and ecstasy purchases by polysubstance misusers. ( Cole, JC; Sumnall, HR; Tyler, E; Wagstaff, GF, 2004)
"Chest x-ray revealed acute pulmonary edema."1.32Subarachnoid hemorrhage and death following coingestion of MDMA with other drugs. ( Ho, MP; Tsai, JL; Wong, YK, 2004)
"Within 10 days the patient developed acute liver failure."1.31[Acute liver failure following the use of ecstasy (MDMA)]. ( Berg, T; Fliege, H; Klapp, BF; Lange-Brock, N; Mönnikes, H; Müller, AR; Neuhaus, P; Wiedenmann, B, 2002)
"Examination showed bilateral sixth nerve palsy."1.31Bilateral sixth nerve palsy associated with MDMA ("ecstasy") abuse. ( Brieden, S; Schroeder, B, 2000)
"Intracranial aneurysms were demonstrated in six patients and arteriovenous malformations in three patients."1.31Intracerebral haemorrhage and drug abuse in young adults. ( Kitchen, ND; McEvoy, AW; Thomas, DG, 2000)
"The long-term use of the serotonin-releaser and uptake-inhibitor 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") has been associated with memory impairments and increased liability to depressive mood and anxiety attacks."1.31No difference in brain activation during cognitive performance between ecstasy (3,4-methylenedioxymethamphetamine) users and control subjects: a [H2(15)O]-positron emission tomography study. ( Berthold, T; Buck, A; Gamma, A; Vollenweider, FX, 2001)
"She died of water intoxication and cerebral edema approximately 24 hours after ingestion of one tablet of "ecstasy" at a rave club in Amsterdam."1.31[Young woman dies of water intoxication after taking one tablet of ecstasy. Today's drug panorama calls for increased vigilance in health care]. ( Bråbäck, L; Humble, M, 2001)
"On several variables, college substance users differed more sharply from nonusers in 1999 than in previous decades."1.31Drug use and life style among college undergraduates: a 30-year longitudinal study. ( Ionescu-Pioggia, M; Pope, HG; Pope, KW, 2001)
"A 26-year-old woman suffered disseminated intravascular coagulation (DIC) and a brief respiratory arrest following recreational use of 3,4-methylene-dioxymethamphetamine (MDMA; 'ecstasy'), together with amyl nitrate, lysergic acid (LSD), cannabis and alcohol."1.31Amnesic syndrome and severe ataxia following the recreational use of 3,4-methylene-dioxymethamphetamine (MDMA, 'ecstasy') and other substances. ( Isaac, C; Jaldow, E; Kopelman, MD; Laing, H; Marsden, P; Mayes, AR; Reed, LJ, 2001)
"A sample of drug users (n = 158) were contacted and interviewed in non-clinical community settings about their use of Ecstasy, cocaine powder, and amphetamines and the adverse effects of these drugs."1.30Adverse effects of stimulant drugs in a community sample of drug users. ( Fountain, J; Gossop, M; Griffiths, P; Powis, B; Strang, J; Williamson, S, 1997)
" Longer-term, larger dosage (acute or cumulative) MDMA consumers were found to be at high risk of developing psychopathological disturbances."1.30MDMA ('ecstasy') consumption in the context of polydrug abuse: a report on 150 patients. ( Bricolo, R; Di Furia, L; Forza, G; Minicuci, N; Schifano, F, 1998)
"We report two cases of aplastic anaemia following exposure to 'Ecstasy' (MDMA, 3,4-methylenedioxymethamphetamine)."1.29Aplastic anaemia following exposure to 3,4-methylenedioxymethamphetamine ('Ecstasy'). ( Abboudi, ZH; Baughan, AS; Daly, S; Gibson, FM; Gordon-Smith, EC; Marsh, JC; O'Shaunnessy, DF; Scopes, J, 1994)
"Four patients presented with acute liver failure without hyperthermia."1.29Acute liver damage and ecstasy ingestion. ( Ellis, AJ; Portmann, B; Wendon, JA; Williams, R, 1996)
" Side effects, insight gained, pleasure, and intensity of the MDMA experience were evaluated as were the influence of set and setting at the time the MDMA was taken and the dosage utilized."1.28Phenomenology and sequelae of 3,4-methylenedioxymethamphetamine use. ( Bravo, GL; Grob, CS; Liester, MB; Walsh, RN, 1992)
"The risk of adverse reactions to 3,4-methylenedioxymethamphetamine (MDMA), more commonly known as "ecstasy", is now widely known in both the USA and UK, but the patterns of illness remain varied."1.28Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy") ( Dawling, S; Henry, JA; Jeffreys, KJ, 1992)

Research

Studies (878)

TimeframeStudies, this research(%)All Research%
pre-199013 (1.48)18.7374
1990's145 (16.51)18.2507
2000's420 (47.84)29.6817
2010's223 (25.40)24.3611
2020's77 (8.77)2.80

Authors

AuthorsStudies
Ivers, JH1
Killeen, N1
Keenan, E1
Basedow, LA2
Kuitunen-Paul, S2
Wiedmann, MF2
Roessner, V2
Golub, Y2
Salas-Wright, CP1
Hodges, JC1
Hai, AH1
Alsolami, A1
Vaughn, MG1
Weatherburn, D1
Alexeev, S1
Livingston, M1
Jones, GM2
Nock, MK2
Wong, GF1
Lee, WM1
Li, CK1
Stilmant, AC1
Zhu, L1
Gorur, Y1
Cardos, B1
Yerna, M1
Ali, D1
Hase, A1
Erdmann, M1
Limbach, V1
Hasler, G1
Palamar, JJ18
Rutherford, C1
Cleland, CM4
Keyes, KM3
Sönmez, İ1
Levent, A1
Davelaar, EJ1
Casey, LE1
Pourmarzi, D1
Wessel, EL1
Kemp, R2
Smirnov, A2
Mellos, E1
Paparrigopoulos, T1
Nicholas, CR1
Wang, JB1
Coker, A1
Mitchell, JM1
Klaire, SS1
Yazar-Klosinski, B2
Emerson, A1
Brown, RT1
Doblin, R3
Chen, YH1
Chen, MH1
Wei, HT1
Chen, LY1
Estévez-Danta, A1
Bijlsma, L2
Capela, R1
Cela, R1
Celma, A1
Hernández, F3
Lertxundi, U1
Matias, J2
Montes, R1
Orive, G1
Prieto, A1
Santos, MM1
Rodil, R2
Quintana, JB2
Hahn, RZ1
Bastiani, MF1
Lizot, LLF1
Schneider, A2
da Silva Moreira, IC1
Meireles, YF1
Viana, MF1
do Nascimento, CA1
Linden, R1
Kelly, BC4
Coyer, L1
Mustillo, SA1
Prins, M1
Davidovich, U1
Íncera-Fernández, D1
Román, FJ1
Gámez-Guadix, M1
Chappell, A1
Armstrong, B1
Jay, E1
Phung, K1
McCormick, S1
Grigg, S1
Waite, B1
Hermansen, SK1
Christoffersen, DJ1
Akhoundzadeh, D1
Kamali, P1
van den Bogaard, B1
Gresnigt, FMJ1
Livne, O1
Shmulewitz, D1
Walsh, C1
Hasin, DS2
Reddi, S1
Friedman, MS1
Psichoudaki, M1
Mina, T1
Savvidou, M1
Mina, C1
Michael, C1
Fatta-Kassinos, D2
Geuens, M1
Van Hoofstadt, K1
Hoogmartens, O1
Van den Eede, N1
Sabbe, M1
Ter Laak, TL1
Emke, E3
Benschop, A4
Nabben, T2
Béen, F1
Jones, G1
Ricard, JA1
Hendricks, P1
Simonsson, O1
Manke, HN1
Nelson, KH1
Huang, S1
Bailey, JM1
Bowman, SK1
Jones, RA1
Cerveny, SE1
Rice, KC3
Riley, AL1
Guerras, JM4
Hoyos, J4
Donat, M4
de la Fuente, L3
Palma Díaz, D3
Ayerdi, O3
García-Pérez, JN3
García de Olalla, P3
Belza, MJ4
Gibbs, D1
Peacock, A4
Hughes, C1
Grigg, J2
Chandrasena, U1
Sutherland, R3
Van Dyck, E1
Ponnet, K1
Van Havere, T2
Hauspie, B2
Dirkx, N2
Schrooten, J2
Waldron, J3
Grabski, M3
Freeman, TP2
Curran, HV8
De Neve, J1
Luo, J1
Bello, D1
Pagsuyoin, S1
Istvan, M1
Bresdin, V1
Mainguy, M1
Laigo, P1
Grall-Bronnec, M1
Eudeline, V1
Guillet, JE1
Guillo, M1
Babonnaud, L1
Jolliet, P1
Schreck, B1
Victorri-Vigneau, C1
Pérez-Romero, C1
Barrio, G1
Regidor, E1
Politi, J1
Pulido, J1
Kreim, S1
Marchand, K1
Mallia, E1
Dubras, R1
McMaster, WR1
Tee, K1
Mathias, S1
Barbic, S1
Senta, I2
Krizman-Matasic, I1
Kostanjevecki, P1
Gonzalez-Mariño, I2
Mikac, I1
Terzic, S2
Ahel, M1
de Jonge, MC1
Bukman, AJ1
Ter Bogt, T2
Onrust, SA1
Kleinjan, M1
Perrone, D1
Fischer, R1
Florek, J1
Rousis, N1
Bade, R4
Romero-Sánchez, I1
Mueller, JF4
Thomaidis, NS1
Thomas, KV3
Gracia-Lor, E3
Tschudi, L1
Fischer, SKM1
Perlov, E1
Baumgartner, MR1
Soyka, M1
Müller, TJ1
Seifritz, E1
Mutschler, J1
Bonny-Noach, H1
Shapira, B1
Baumol, P1
Tadmor, N1
Rosca, P1
Shoshan, S1
Harel-Fisch, Y1
Caduri, A1
Gannon, BM1
Fitzgerald, LR1
Godwin, CO1
Hughes-Meredith, HD1
Fantegrossi, WE1
Hui, T1
Guo, S1
Willeman, T1
Bartolli, M1
Jourdil, JF1
Vial, S1
Eysseric-Guérin, H1
Stanke-Labesque, F1
Janulis, P1
Jenness, SM1
Risher, K1
Phillips, G1
Mustanski, B1
Birkett, M1
Mendoza-Valencia, CY1
Mariño Gaviria, DJ1
Patiño Reyes, N1
Lopez-Vallejo, F1
Sarmiento Gutiérrez, ÁE1
Trespalacios Rodríguez, D1
Lin, C1
Wong, BY1
Lo, MT1
Chiu, YC1
Lin, YH1
Burgueño, MJ1
Sánchez, S1
Castro, MÁ1
Mateos-Campos, R1
Elliott, L1
Haddock, CK1
Campos, S1
Benoit, E1
van Amsterdam, J2
Pennings, E2
van den Brink, W11
Wang, X1
Cui, J1
Zhuo, Y1
Shen, B1
Zhang, S1
Liu, W1
Shen, M1
Xiang, P1
Chen, Y1
Tran, HTN1
Saber, YH1
Hall, FS1
Abbott, KL1
Gill, KS1
Flannery, PC1
Boothe, DM1
Dhanasekaran, M2
Pondugula, SR1
Vreeker, A1
Brunt, TM3
Treur, JL1
Willemsen, G1
Boomsma, DI1
Verweij, KJH1
Vink, JM1
Rigg, KK2
Mills, A1
Mokrysz, C1
Hindocha, C1
Measham, F1
van Beek, R1
van der Pol, P1
Elgán, TH2
Feltmann, K2
Benedetti, E1
Tomba, GS1
Fabi, F1
Molinaro, S1
Gripenberg, J2
van Laar, M1
Southey, M1
Kathirgamalingam, A1
Crawford, B1
Kaul, R1
McNamara, J1
John-Leader, F1
Heslop, J1
Pit, SW1
Salomone, A5
Acosta, P2
White, JM7
Nguyen, L1
Pandopulos, AJ1
Gerber, C2
Bazin, B1
Duroy, D1
Lejoyeux, M1
Bates, MLS1
Trujillo, KA1
Peters, GY1
Blickman, T1
Hollemans, K1
Breeksema, JJJ1
Ramaekers, JG3
Maris, C1
van Bakkum, F1
Scholten, W1
Reitsma, T1
Noijen, J2
Koning, R1
Schenk, S3
Highgate, Q1
Stewart, AC1
Djordjevic, F1
Cossar, R1
Salom, C1
Lenton, S1
Dietze, P2
Young, AH1
Strandberg, AK1
Kvillemo, P1
Jayaram-Lindström, N1
Freeman, T1
Koning, RPJ1
Wijffels, C1
Debenham, J1
Newton, N1
Champion, K1
Lawler, S1
Lees, B1
Stapinski, L2
Teesson, M4
Birrell, L1
Cox, DJ1
Johnson, MW1
Davey, CG1
Gerace, E2
Di Corcia, D2
Vincenti, M3
Downey, LA3
Tysse, B1
Ford, TC1
Samuels, AC1
Wilson, RP1
Parrott, AC21
Montgomery, C22
Fisk, JE19
Roberts, CA5
Castillo-Carniglia, A1
Pizarro, E1
Marín, JD1
Rodríguez, N1
Casas-Cordero, C1
Cerdá, M1
Zuccato, E1
Rousis, NI2
Parabiaghi, A1
Riva, F1
Castiglioni, S3
Weng, S1
Dong, R1
Zhu, Z1
Zhang, D1
Zhao, J1
Huang, L1
Liang, D1
Hoegberg, LCG1
Christiansen, C1
Soe, J1
Telving, R1
Andreasen, MF1
Staerk, D1
Christrup, LL1
Kongstad, KT1
Mauro, PM1
Han, BH1
Martins, SS6
Mobaraki, F1
Seghatoleslam, M1
Fazel, A1
Ebrahimzadeh-Bideskan, A1
Chhabra, N1
Gimbar, RP1
Walla, LM1
Thompson, TM1
Garcia-Pardo, MP2
de la Rubia, JE1
Aguilar, MA3
Mounteney, J1
Griffiths, P3
Bo, A1
Cunningham, A1
Pirona, A3
Fattore, L1
Piva, A1
Zanda, MT1
Fumagalli, G1
Chiamulera, C1
Sharp, A1
Papaseit, E2
Torrens, M2
Pérez-Mañá, C1
Muga, R1
Farré, M9
Chambers, SA1
DeSousa, JM1
Huseman, ED1
Townsend, SD1
Dolan, SB1
Chen, Z1
Huang, R1
Gatch, MB1
Caliskan, FT1
Toker, I1
Toktas, R1
Temizyurek, Z1
Unek, O1
Zirek, B1
Karcioglu, O1
Chapman, S1
Ashack, K1
Bell, E1
Sendelweck, MA1
Dellavalle, R1
Heinsbroek, E1
Glass, R1
Edmundson, C1
Hope, V1
Desai, M1
Foppe, KS1
Hammond-Weinberger, DR1
Subedi, B1
Tscharke, BJ1
Longo, M1
Cooke, R1
He, L1
Pan, X1
Wang, N1
Yang, J1
Jiang, J1
Luo, Y1
Zhang, X2
Li, X2
Szigeti, B1
Winstock, AR4
Erritzoe, D2
Maier, LJ1
Roxburgh, A2
Barratt, MJ1
Burns, L5
Bruno, R18
Wong, S1
Afshani, M1
Kaplan, K1
Kurtz, F1
Serafini, K1
Kostick, KM1
Schensul, JJ1
Wilkins, C4
Lai, FY3
O'Brien, J1
Thai, P1
Armitage, MC1
Bryant, RJ1
Page, CB1
Salathe, C1
Blanc, AL1
Tagan, D1
Wilcockson, TDW1
Pothos, EM1
Gaddis, A1
Lake, S1
Tupper, K1
Nosova, E1
Blommaert, K1
Wood, E1
DeBeck, K1
Oliver, CF1
Simmons, SJ1
Philogene-Khalid, HL1
Stokes-McCloskey, N1
Rawls, SM1
Romeo, JS1
Rychert, M1
Prasad, J1
Graydon-Guy, T1
Champion, KE3
Newton, NC3
Wang, LJ1
Chen, MY1
Lin, CY1
Chong, MY1
Chou, WJ1
You, YH1
Tsai, CP1
Chen, YS1
Lu, SF1
Smid, MC1
Metz, TD1
Gordon, AJ1
Gjersing, L1
Bretteville-Jensen, AL1
Furuhaugen, H1
Gjerde, H1
Platt, B1
O'Driscoll, C1
Curran, VH1
Rendell, PG2
Kamboj, SK1
Anderson, K1
Reavey, P1
Boden, Z1
Pagoulatos, DD1
Makri, OE1
Kapsala, ZG1
Georgakopoulos, CD1
van de Wetering, R1
Le, A1
Ogeil, RP2
Rajaratnam, SM2
Broadbear, JH2
Ciudad-Roberts, A1
Camarasa, J1
Pubill, D1
Escubedo, E1
O'Sullivan, EM1
Fairclough, SH2
Tames, F1
Kumpfer, KL1
Burch, HJ1
Clarke, EJ1
Hubbard, AM1
Scott-Ham, M1
Jerome, L6
Schuster, S1
Yazar-Klosinski, BB1
Najman, JM2
Hayatbakhsh, R1
Wells, H1
Legosz, M1
George, AM1
Olesen, S1
Tait, RJ1
Ding, Y2
He, N2
Shoptaw, S1
Gao, M1
Detels, R2
Scott, RM2
Hides, L4
Allen, JS2
Lubman, DI3
Fairclough, S1
Tames, FT1
Payancé, A1
Scotto, B1
Perarnau, JM1
de Muret, A1
Bacq, Y1
Rodríguez-Arias, M2
Valverde, O1
Daza-Losada, M1
Blanco-Gandía, MC1
Miñarro, J2
McGlone, FP1
Nazarzadeh, M1
Bidel, Z1
Carson, KV1
Taurah, L1
Chandler, C1
Sanders, G1
Wetherell, MA3
Evans, S1
Kasprzyk-Hordern, B5
de Voogt, P3
Chalmers, J1
Matthew-Simmons, F1
Hughes, CE1
Leung, HW1
Thai, PK2
Ort, C4
Carter, S2
Thompson, K1
Lam, PK1
Sands, HR1
Jones, L1
Clow, A1
Evans, P1
Stalder, T1
Michael White, C1
Gallagher, DT2
Hadjiefthyvoulou, F5
Talbert, JJ1
Bedi, G5
Cecchi, GA1
Slezak, DF1
Carrillo, F1
Sigman, M1
de Wit, H2
McKetin, R2
Copeland, J8
Norberg, MM2
Khawar, L2
Theodore, PS1
Durán, RE1
Antoni, MH1
van Nuijs, AL2
Berset, JD1
Covaci, A2
Grabic, R1
Mastroianni, N1
Meierjohann, A1
Nefau, T1
Ostman, M1
Pico, Y1
Racamonde, I1
Reid, M2
Slobodnik, J1
Thomaidis, N1
Kamboukos, D1
Kuypers, KP2
de la Torre, R5
Yubero-Lahoz, S2
Dziobek, I1
Van den Bos, W1
Johnson, J1
Patel, S1
Saraf-Lavi, E1
Aziz-Sultan, MA1
Yavagal, DR1
Stough, C2
Scholey, AB7
Booij, L1
Soucy, JP1
Young, SN1
Regoli, M1
Gravel, P1
Diksic, M1
Leyton, M1
Pihl, RO3
Benkelfat, C1
Uosukainen, H1
Tacke, U1
Cumming, P1
Matthews, AJ3
Butler, K1
Olivier, J1
Ridpath, A1
Driver, CR1
Nolan, ML1
Karpati, A1
Kass, D1
Paone, D1
Jakubowski, A1
Hoffman, RS1
Nelson, LS1
Kunins, HV1
Langohr, K4
Maloney, WJ1
Raymond, G1
Bearn, J1
O'Brien, M1
May, AL1
Su, MK1
Ompad, DC2
Salvatore, S3
Bramness, JG2
Reid, MJ1
Harman, C1
Røislien, J2
Sindicich, N2
Dunn, M7
Whittaker, E1
Entwistle, G1
Chan, WL1
Wood, DM2
Dargan, PI2
Xu, C1
Loh, HH1
Law, PY1
Szabó, A1
Kazai, A1
Frecska, E1
Brys, Z1
Aguilar-Raab, C1
Heene, M1
Grevenstein, D1
Weinhold, J1
Roger-Sánchez, C1
Bershad, AK1
Weafer, JJ1
Kirkpatrick, MG1
Wardle, MC1
Miller, MA3
Todd, G2
Pearson-Dennett, V1
Flavel, SC2
Haberfield, M1
Edwards, H1
Stapinski, LA1
Nagy, C1
Bücheli, A1
Martins, D1
Ugarte, M1
Beduwe, C1
Ventura Vilamala, M1
Jones, A1
Brüggemann, N1
Heldmann, M1
Sprenger, A1
Repenthin, J1
Münte, TF1
Naidoo, M1
Govind, M1
Katz, DP1
Deruiter, J1
Bhattacharya, D1
Ahuja, M1
Bhattacharya, S1
Clark, CR1
Suppiramaniam, V1
Watson, R1
Eggleston, W1
Stork, C1
Keyes, K1
Davis, AK1
Rosenberg, H1
O'Brien, JW1
Hall, W2
Chan, G1
Prichard, J1
Anuj, S1
Kirkbride, KP1
Gartner, C1
Humphries, M1
Negus, SS1
Banks, ML1
Baz-Lomba, JA1
Castrignanò, E1
Causanilles, A1
Kinyua, J1
McCall, AK1
van Nuijs, A1
Plósz, BG1
Ramin, P1
Ryu, Y1
Bramness, J1
Thomas, K1
Aarde, SM1
Taffe, MA1
Clark, L1
Roiser, JP4
Robbins, TW2
Sahakian, BJ5
Sweetsur, P2
Halkitis, PN2
Soar, K2
Parrott, A3
Turner, J1
Indlekofer, F2
Piechatzek, M2
Daamen, M2
Glasmacher, C2
Lieb, R6
Pfister, H4
Tucha, O2
Lange, KW2
Wittchen, HU5
Schütz, CG3
Ke, JJ1
Ho, MC1
Cherng, CG1
Tsai, YP1
Tsai, CW1
Yu, L1
Scheier, LM2
Ben Abdallah, A2
Inciardi, JA4
Cottler, LB6
Vervaeke, HK4
Korf, DJ5
Craig, L1
Murphy, PN7
Wareing, M6
Van Dam, NT1
Redman, J5
Green, JA1
de Win, MM6
Jager, G5
Booij, J3
Reneman, L6
Schilt, T7
Lavini, C1
Olabarriaga, SD1
den Heeten, GJ4
Peters, GJ2
Kok, G3
Schaalma, HP1
Meyer, JS1
Piper, BJ1
Vancollie, VE1
Sterk, CE4
Klein, H2
Elifson, KW4
Matthews, A3
Johnston, J3
Black, E1
Degenhardt, L12
Gritti, P1
Agostinis, C1
Bortolotti, GM1
Zilio, A1
Button, J1
Lidder, S1
Ramsey, J1
Holt, DW1
Cowan, RL7
Joers, JM1
Dietrich, MS5
Koeter, MW2
Zinkstok, JR1
van Amelsvoort, TA1
Schmand, B4
den Brink, Wv1
Horowitz, A1
Galanter, M2
Dermatis, H2
Franklin, J1
Wu, ZH2
Baillargeon, JG1
Berenson, AB2
Holzer, CE1
Leung, KS4
Li, JH1
Tsay, WI1
Callahan, C1
Liu, SF1
Hsu, J1
Hoffer, L1
Taéron, C1
Chen, WJ2
Fu, TC1
Ting, TT1
Huang, WL1
Tang, GM1
Hsiao, CK1
Chen, CY3
Krebs, TS1
Johansen, PØ1
Halpern, JH2
Whittingham, JR1
Ruiter, RA1
Bolier, L1
Lemmers, L1
Van Hasselt, N1
Pompili, M1
Lester, D1
Girardi, P1
Tatarelli, R1
Raj, V1
Liang, HC1
Woodward, ND1
Bauernfeind, AL1
Lee, J1
Park, S1
Joya, X1
Civit, E1
Pellegrini, M2
Vall, O2
Garcia-Algar, O2
Scaravelli, G1
Pichini, S2
Morgan, MJ3
Wu, LT4
Ringwalt, CL3
Patkar, AA2
Mannelli, P1
Blazer, DG3
Black, DL1
Cawthon, B1
Robert, T1
Moser, F1
Caplan, YH1
Cone, EJ1
Frederick, AL1
Stanwood, GD1
Lin, KM1
Daniulaityte, R1
Falck, RS7
Wang, J5
Carlson, RG7
Nguyen-Oghalai, TU1
Shokar, NK1
Cottler, L2
Argo, V1
Brillant, E1
Fulgencio, JP1
Bonnet, F1
Green, KA1
Weiss, RD2
Jovanović, P1
Hentova-Senćanić, P1
Zorić, L1
Petrović, M1
Bozinović, MT1
Carhart-Harris, RL1
Nutt, DJ1
Munafo, MR1
Christmas, DM1
Wilson, SJ1
Banta-Green, CJ1
Field, JA1
Chiaia, AC1
Sudakin, DL1
Power, L1
de Montigny, L1
Barr, MS1
Fitzgerald, PB1
Farzan, F1
George, TP1
Daskalakis, ZJ1
Hubbard, RL1
Abdallah, AB2
Wan, L1
Baldridge, RM1
Colby, AM1
Stanford, MS1
Daveluy, A1
Miremont-Salamé, G1
Rahis, AC1
Delile, JM1
Bégaud, B1
Gachie, JP1
Haramburu, F1
Day, C1
Campbell, G1
Lin, DL2
Liu, HC2
Liu, RH2
Sano, R1
Hasuike, T1
Nakano, M1
Kominato, Y1
Itoh, H1
Topp, L4
Gouzoulis-Mayfrank, E14
Daumann, J10
McCann, UD9
Wilson, MJ1
Sgambati, FP2
Ricaurte, GA14
Ramo, DE1
Grov, C1
Delucchi, K1
Parsons, JT2
Moore, DG1
Turner, JD2
Goodwin, JE1
Fulton, SE1
Min, MO1
Fox, HC5
Braddick, FM1
Axelsson, EL1
Lynch, S1
Ribeiro, H1
Frostick, CJ1
Singer, LT2
Chamberlin, NL1
Saper, CB1
Schwartz, AR1
de Almeida, SP3
Garcia-Mijares, M1
Silva, MT4
Silins, E2
Dillon, P4
Ayala, ME1
Fernández-Serrano, MJ2
Lozano, O1
Pérez-García, M4
Verdejo-García, A5
Fagundo, AB2
Cuyàs, E2
Khymenets, O2
Martín-Santos, R2
Burke, R1
Bridges, N3
Miller, PG2
Fry, CL1
Nulsen, CE1
Fox, AM1
Hammond, GR1
Scott, R1
Gee, P1
Jerram, T1
Bowie, D1
Yamamoto, BK2
Moszczynska, A1
Gudelsky, GA1
Yen, CF4
Huang, YS1
Chang, YP1
Cheng, CP3
Hanson, KL3
Luciana, M3
Roberts, GM1
Garavan, H1
Angelucci, F1
Ricci, V1
Martinotti, G2
Palladino, I1
Spalletta, G1
Caltagirone, C1
Bria, P1
Halpern, P1
Moskovich, J1
Avrahami, B1
Bentur, Y1
Soffer, D1
Peleg, K1
Dinis-Oliveira, RJ1
Caldas, I1
Carvalho, F1
Magalhães, T1
George, J1
Kinner, SA4
Du Mont, J1
Macdonald, S2
Rotbard, N1
Bainbridge, D1
Asllani, E1
Smith, N1
Cohen, MM1
Metcalfe, C1
Tindale, K1
Li, H1
Rodayan, A1
Yargeau, V1
Xiong, J1
Chen, J1
He, M1
Hu, B1
Knudsen, K1
Jonsson, U1
Abrahamsson, J1
Simmat-Durand, L1
Toutain, S1
Vellut, N1
Genest, L1
Crenn-Hebert, C1
Simonpoli, AM1
Miossec, E1
Lejeune, C1
Chen, YT1
Buchanan, T5
Heffernan, TM2
Ling, J5
Rodgers, J7
Baghianimoghadam, MH1
Mazloomy Mahmoodabad, SS1
Mohammadi, S1
Baghianimoghadam, B1
Seger, D1
Cone, JD1
Harrington, MA1
Kelley, SS1
Prince, MD1
Payne, WG1
Smith, DJ1
Kirilly, E1
Arendt, M1
Munk-Jørgensen, P1
Sher, L1
Jensen, SO1
Verbaten, MN1
Logan, BK1
Costantino, AG1
Rieders, EF1
Sanders, D1
Adamaszek, M1
Khaw, AV1
Buck, U1
Andresen, B2
Thomasius, R10
Lee, S1
Kim, J3
In, S1
Choi, H1
Chung, H1
Chung, KH1
Tai, YF1
Hoshi, R3
Brignell, CM1
Cohen, L1
Brooks, DJ1
Piccini, P2
Steinkellner, T1
Freissmuth, M1
Sitte, HH1
Montgomery, T1
Sherwood, AR1
Hudson, JI2
Gruber, S1
Kozin, D1
Pope, HG3
Nichols, D1
Claffey, C1
Mougel, JF1
Tarcomnicu, I1
Bervoets, L1
Blust, R1
Jorens, PG1
Neels, H1
Irvine, RJ4
Kostakis, C2
Felgate, PD2
Jaehne, EJ1
Chen, C2
Li, L1
Levine, B1
Li, G1
Zielke, HR1
Fowler, DR1
den Hollander, B1
Schouw, M1
Groot, P1
Huisman, H1
Caan, M1
Barkhof, F1
van Holst, RJ1
Pilgrim, JL1
Gerostamoulos, D1
Drummer, OH1
Griffiths, R1
Galicia, M1
Nogue, S1
Miró, O1
Fan, B2
Liu, X2
Kerner, N1
Wu, P2
Heffernan, T3
Scholey, A1
St Onge, G1
Ziel, R1
Khan, U1
Nicell, JA1
Chakraborty, K1
Neogi, R1
Basu, D1
Niesink, RJ3
Mohamed, WM1
Ben Hamida, S1
Cassel, JC1
de Vasconcelos, AP1
Jones, BC1
Salomon, RM2
Karageorgiou, J1
McLellan, JY1
Charboneau, EJ1
Blackford, JU2
Becoña Iglesias, E1
López-Durán, A1
Fernández Del Río, E1
Martínez Pradeda, Ú1
Osorio López, J1
Fraga Ares, J1
Arrojo Romero, M1
López Crecente, F1
Domínguez González, MN1
Smerdon, MJ1
Francis, AJ1
Harpas, P1
Nulsen, C2
Fox, A1
Hammond, G1
Phillips, JG1
Redman, JR1
Karila, L1
Reynaud, M1
Weinborn, M1
Woods, SP1
Park, K1
Berney-Meyer, L1
Putt, T1
Schollum, J1
Walker, R1
Rodríguez, J2
Cuenca, A1
de Sola Llopis, S2
Peña-Casanova, J2
Di Iorio, CR1
Watkins, TJ1
Cao, A1
Rogers, B1
Ansari, MS1
Baldwin, RM1
Li, R1
Kessler, RM1
Benningfield, M1
McGregor, IS4
Bowen, MT1
Alati, R3
McIlwraith, F2
Hickey, S2
Judge, J1
Robinson, SJ1
Taylor, PJ1
Ryland, I1
Hilton, J1
Atherton, K1
Grainger, J1
Brosnan, R1
Murray, E1
Brown, J1
Baker, DR2
Hittner, JB1
Schachne, ER1
Ritter, A1
Lancaster, K1
Licht, CL1
Christoffersen, M1
Okholm, M1
Damgaard, L1
Fink-Jensen, A1
Knudsen, GM1
Carmona-Perera, M1
Young, L1
Molina-Fernández, A1
Moreno-López, L1
Stamatakis, EA1
Gómez-Río, M1
Rodríguez-Fernández, A1
Očenášková, V1
Kvicalova, M1
Kurtz, SP3
Surratt, HL3
Buttram, ME1
Levi-Minzi, MA1
Chen, M1
Loeffler, G1
Hurst, D1
Penn, A1
Yung, K1
Lillaz, C1
Varescon, I2
Krul, J1
Girbes, AR1
Sanou, BT1
Šlamberová, R1
Pometlová, M1
Schutová, B1
Hrubá, L1
Macúchová, E1
Nová, E1
Rokyta, R1
Mithoefer, MC1
Wagner, MT1
Mithoefer, AT1
Martin, SF1
Michel, Y1
Brewerton, TD1
Burucker, J1
Kropp, S1
Font-Mayolas, S1
Gras, ME1
Cebrián, N1
Salamó, A1
Planes, M1
Sullman, MJ1
Lock, J1
Adnum, L1
Thome, J1
Wolff, K2
Aitchison, K1
Potter, A1
Downey, L1
Chow, C1
Vallance, K1
Stockwell, T1
Martin, G1
Ivsins, A1
Marsh, DC1
Michelow, W1
Roth, E1
Duff, C1
Platteborze, PL1
Martin, TM1
Cole, JC10
Sumnall, HR11
Wagstaff, GF3
McLean, A1
Turner, JJ4
Rogers, R1
Nixon, PJ1
Youngson, CC1
Beese, A1
McKenna, C1
Badon, LA1
Hicks, A1
Lord, K1
Ogden, BA1
Meleg-Smith, S1
Varner, KJ1
Gowing, LR1
Henry-Edwards, SM1
Ali, RL1
Gerra, G3
Zaimovic, A3
Moi, G2
Giusti, F1
Gardini, S1
Delsignore, R2
Laviola, G1
Macchia, T1
Brambilla, F3
Gross, SR1
Barrett, SP2
Shestowsky, JS1
Zakzanis, KK2
Young, DA1
Radkhoshnoud, NF1
Freese, TE1
Miotto, K1
Reback, CJ1
Schuetz, CG1
von Sydow, K2
Wittchen, H1
MacInnes, N2
Handley, SL2
Harding, GF2
Goorney, BP1
Scholes, P1
Tellier, PP1
Lange-Brock, N1
Berg, T1
Müller, AR1
Fliege, H1
Neuhaus, P1
Wiedenmann, B1
Klapp, BF1
Mönnikes, H1
Badaoui, R1
El Kettani, C1
Fikri, M1
Ouendo, M1
Canova-Bartoli, P1
Ossart, M1
Ochoa Mangado, E1
Yacoubian, GS5
Gijsman, HJ1
van Gerven, JM1
Verkes, RJ1
Schoemaker, RC1
Pieters, MS1
Pennings, EJ1
Hessing, TJ1
Cohen, AF1
Jamieson, MA1
Weir, E2
Rickert, VI1
Coupey, SM1
Bruno, A1
Schifano, F6
Oyefeso, A2
Webb, L1
Pollard, M1
Corkery, J1
Ghodse, AH1
Rokach, A1
Auer, J1
Berent, R1
Weber, T1
Lassnig, E1
Eber, B1
Lingford-Hughes, A1
Nutt, D1
Gamma, A3
Simonsen, KW1
Kaa, E1
Nielsen, E1
Rollmann, D1
Satsumi, YN1
Buchert, R5
Nebeling, B4
Petersen, K6
Obrocki, J5
Jenicke, L2
Wilke, F3
Wartberg, L5
Zapletalova, P5
Clausen, M4
Schmoldt, A3
Walters, ST1
Foy, BD1
Castro, RJ1
Zernig, G1
Giacomuzzi, S1
Riemer, Y1
Wakonigg, G1
Sturm, K1
Saria, A1
Forrest, AR3
Boulu, R1
Caudevilla Gálligo, F1
Bosman, IJ1
Lusthof, KJ1
Abanades, S2
Oliveri, M1
Calvo, G1
Saarijärvi, S1
Lopperi, M1
Budisavljevic, MN1
Stewart, L1
Sahn, SA1
Ploth, DW1
Thimm, B2
Rezk, M2
Hensen, G2
Lua, AC1
Lin, HR1
Tseng, YT1
Hu, AR1
Yeh, PC1
Bond, AJ1
Verheyden, SL1
Wingrove, J1
Vallée, JN1
Crozier, S1
Guillevin, R1
Obadia, M1
Lo, D1
Barragan-Campos, HM1
Samson, Y1
Chiras, J1
Leoni, M1
Rawaf, S1
Rovetto, F1
Bassignana, S1
Bussandri, M1
Caccavari, R1
Molina, E1
Schnitker, R1
Weidemann, J1
Schnell, K1
Thron, A4
Tancer, M2
Johanson, CE3
Soto, O1
Hedley-Whyte, ET1
Madhok, A1
Boxer, R1
Chowdhury, D1
O'Suilleabhain, P1
Giller, C1
Lyoo, IK1
Sung, SM1
Ahn, KH1
Kim, MJ1
Hwang, J1
Haga, E3
Vimal, RL2
Lukas, SE4
Renshaw, PF4
Stuerenburg, HJ1
Buhmann, C1
Rosenkranz, M1
Baeumer, T1
Fendrich, M1
Wislar, JS1
Johnson, TP1
Hubbell, A1
Bellis, MA1
Hughes, K1
Bennett, A1
Thomson, R1
Corapçioğlu, A1
Ogel, K1
Barker, B2
Kuczkowski, KM1
Lee, SJ1
McDowell, D1
Patel, MM2
Wright, DW1
Ratcliff, JJ1
Quednow, BB1
Kühn, KU1
Hoenig, K1
Maier, W1
Wagner, M1
Laure, P1
Lecerf, T1
Friser, A1
Binsinger, C1
Plüddemann, A1
Parry, CD1
Myers, B1
Bhana, A1
Ng, RS1
Darko, DA1
Hillson, RM1
Royo-Isach, J2
Magrané, M2
Blancafort, F1
Ferrer, J1
von Geusau, NA1
Stalenhoef, P1
Huizinga, M1
Snel, J1
Ridderinkhof, KR1
Lora-Tamayo, C1
Tena, T1
Rodríguez, A1
Moreno, D1
Sancho, JR1
Enseñat, P1
Muela, F1
Connor, TJ1
Vik, PW1
Cellucci, T1
Jarchow, A1
Hedt, J1
Siegal, HA6
Kojima, H1
Miyazawa, M1
Ishikawa, T1
Takayanagi, H1
Aasatani, H1
Doi, K1
Klein, M2
Kramer, F1
Kela, N1
Kela, P1
Cuddy, ML1
Fischermann, T4
Pilatus, U1
Moeller-Hartmann, W1
Linares, TJ1
Ntiri, S1
Henry, R1
Minnes, S1
Gahlinger, PM1
Marchioro, L1
Bassetto, F1
Dall'Olio, G1
Tedeschi, L2
Castagna, F2
Plebani, M1
Moeller, FG2
Steinberg, JL2
Dougherty, DM2
Narayana, PA2
Kramer, LA2
Schulze, O1
Schmidt, U1
Galliot-Guilley, M1
Brazda, MT1
Rusch, M1
Lampinen, TM2
Schilder, A1
Hogg, RS1
Bartlett, T1
Heekeren, K2
Engels, RC1
McCaughan, JA2
Agar, M1
Reisinger, HS1
Henke, K1
Butler, GK1
Montgomery, AM1
Tyler, E1
Miller, S1
Pianim, S1
Kunz, M1
Orrick, E1
Link, T1
Palacios, WR1
Peters, RJ1
Gesi, M2
Ferrucci, M2
Giusiani, M1
Lenzi, P2
Lazzeri, G1
Alessandrì, MG1
Salvadorini, A1
Fulceri, F1
Pellegrini, A1
Fornai, F2
Paparelli, A2
Baumann, MH2
Clark, RD1
Budzynski, AG1
Partilla, JS2
Blough, BE1
Rothman, RB2
Morley, KC1
Cornish, JL2
Li, KM1
Murphy, P2
Parks, KA1
Kennedy, CL1
Gable, RS1
Verdejo-García, AJ1
López-Torrecillas, F1
Aguilar de Arcos, F1
Bisla, J1
Karus, C1
Wiedenmann, H1
Hermle, L6
Sack, PM1
Zeichner, D2
Küstner, U1
Schindler, A1
Krüger, A1
Uhlmann, S1
Petersen, KU2
Schulte-Markwort, M1
Heinz, A1
Gouzoulis-Meyfrank, E1
Solowij, N4
Velilla, A1
Ruiz, L1
Salzmann, J1
Marie-Claire, C1
Noble, F1
Muñoz, P1
Drobinska, A1
Bianchi, L1
Züger, Ch1
Pirovino, M1
Liechti, ME2
Mortelmans, LJ1
Bogaerts, PJ1
Hellemans, S1
Volders, W1
Van Rossom, P1
McGrath, C1
Chan, B1
Cook, LJ2
Cooper, JD1
Rubinsztein, DC1
Ho, MP1
Tsai, JL2
Wong, YK1
Milani, RM2
White, B1
Breen, C2
Newman, J2
Proudfoot, P1
Zimmermann, P1
Waszak, F1
Nocon, A1
Höfler, M2
Puig, C1
Zuccaro, P2
Marchei, E1
Murillo, J1
Pacifici, R2
Newman, RG1
Newcombe, R1
Diamond, GM1
Izzard, MC1
Kedar, T1
Hutlzer, A1
Mell, H1
McCambridge, J2
Mitcheson, L2
Winstock, A4
Hunt, N3
Britt, GC1
McCance-Katz, EF1
Joe Laidler, KA1
Soellner, R1
Clatts, MC1
Goldsamt, LA1
Yi, H1
Levy, KB1
O'Grady, KE1
Wish, ED2
Arria, AM2
Hendrickson, JC2
Gerstein, DR1
Held, J1
Manser, T1
Michailidou, K1
Novoa, RA1
Wu, Y1
Vlahov, D1
Galea, S1
Herning, RI1
Better, W1
Tate, K1
Cadet, JL1
Trittibach, P1
Frueh, BE1
Goldblum, D1
Williams, P1
Havis, S1
Best, D1
Carter, J1
Allott, K1
Uys, JD1
Belson, MG1
Longwater, AB1
Olson, KR1
Medina, KL2
Shear, PK2
Corcoran, K1
Cybulska, B1
Impallomeni, LC1
Rogers, RD3
Dafters, RI2
Bossong, MG1
Van Dijk, JP1
Trigo, JM1
Panayi, F1
Soria, G1
Maldonado, R1
Robledo, P1
Kunz, I1
Kupferschmidt, H2
Verhulst, FC2
Ramsey, NF3
Fang, YX1
Wang, YB1
Shi, J1
Liu, ZM1
Lu, L1
Danger, Y1
Gadjou, C1
Devys, A1
Galons, H1
Blanchard, D1
Folléa, G1
Theall, KP2
Guillot, C1
Schlenger, WE1
Galvin, DM1
Huizink, AC1
Ferdinand, RF1
van der Ende, J1
Campbell, Z1
McGhee, D1
Martin, I1
Reay, JL1
Hamilton, C1
Kennedy, DO1
Tsapakis, EM1
Hartley, D1
Holt, D1
Forsling, ML1
Aitchison, KJ1
Yu, RL1
Ko, HC1
Poikolainen, K1
Wells, BE1
Battisti, MC1
Noto, AR1
Nappo, S1
Carlini, Ede A1
Hopper, JW1
Su, Z1
Looby, AR1
Ryan, ET1
Penetar, DM1
Palmer, CM1
Marsden, J1
Stillwell, G1
Barlow, H1
Boys, A1
Taylor, C1
Farrell, M1
deB Frederick, B1
Darredeau, C1
Quinton, MS1
Kinner, S1
Jenkinson, R1
Reinhard, C1
Wolffgramm, J1
Reingardiene, D1
Gunter, TD1
Arndt, S1
Wenman, G1
Laurindo da Silva, L1
Valdes, IH1
Swann, AC1
Barratt, ES1
Freudenmann, RW2
Schönfeldt-Lecuona, C1
Spitzer, M1
Grön, G1
Mazzotti, G1
Chilcoat, HD3
Stone, AL1
O'Brien, MS1
De La Torre, A1
Anthony, JC1
Warren, MW1
Kobeissy, FH1
Liu, MC1
Hayes, RL1
Gold, MS1
Wang, KK1
Jurgaitiene, D1
Targamadze, V1
Klitzman, R1
Bernschneider-Reif, S1
Oxler, F1
Brotto, V1
Lee, G1
Hastings, A1
Ghandour, LA1
Goudie, AJ2
Field, M3
Clayton, H1
Chandler, MD1
Cicero, TJ1
Hsu, SY3
Kłys, M1
Rojek, S1
Woźniak, K1
Rzepecka-Woźniak, E1
Plankey, MW1
Ostrow, DG1
Stall, R1
Cox, C1
Peck, JA1
Jacobson, LP1
Sessa, B1
Durdle, H1
Lundahl, LH1
Clemens, KJ1
Hunt, GE2
Lenné, MG1
McElwee, PR1
Noble, R1
Isralowitz, RE1
Reznik, A1
Kumar, RS1
Farinelli, AC1
van der Tweel, I1
Kahn, RS1
van Ree, JM1
Koeter, M1
Hernández, E1
Fernández, A1
Bolo, NR1
Dietrich, M1
Ball, KT1
Walsh, KM1
Rebec, GV1
Mullins, K1
Boundy, C1
Brignell, C1
Gray, TJ1
Henry, JD1
Tolan, A1
Laws, KR1
Kokkalis, J1
Hayatbakhsh, MR1
Mamun, AA1
Williams, GM1
Witters, JG1
Kestelyn, P1
Van Slycken, S1
Verstraete, A1
Van Aken, EH1
Giraudon, I1
Bello, PY1
Greenwald, MK1
Droogmans, S1
Cosyns, B1
D'haenen, H1
Creeten, E1
Weytjens, C1
Franken, PR1
Scott, B1
Schoors, D1
Kemdem, A1
Close, L1
Vandenbossche, JL1
Bechet, S1
Van Camp, G1
Gardner, TJ1
Kosten, TR1
Yücel, M1
Brewer, WJ1
Karlsen, SN1
Spigset, O1
Slørdal, L1
Storr, CL1
Alexandre, PK1
Bang-Ping, J1
Nakagawa, T1
Kaneko, S1
Loverseed, AC1
Charlton, S1
Miguelez-Pan, M1
Poudevida, S1
Böhm, P1
Verdejo García, A1
Loxton, NJ1
Wan, VL1
Ho, AM1
Cheung, BK1
Tam, N1
Leung, FY1
Stadlin, A1
Brand, HS1
Dun, SN1
Nieuw Amerongen, AV1
Almeida, SP1
Bizeto, J1
Mendes, FJ1
Lomba, L1
Schierenbeck, T1
Riemann, D1
Berger, M1
Hornyak, M1
Kuwahara, T1
Nakakura, T1
Oda, S1
Mori, M1
Uehira, T1
Okamoto, G1
Yoshino, M1
Sasakawa, A1
Yajima, K1
Umemoto, A1
Takada, K1
Makie, T1
Yamamoto, Y1
Hill, S1
Thomas, SH1
Sullwold, K1
van Deursen, L1
Ozkardesler, S1
Gurpinar, T1
Akan, M1
Koca, U1
Sarikaya, H1
Olmez, T1
Elar, Z1
Hashimoto, K1
Callaghan, PD1
Kintz, P1
Cirimele, V1
Tracqui, A1
Mangin, P1
von Wilmsdorff, M1
Gastpar, M1
Steidle, B1
McConn, UD1
Squier, MV1
Jalloh, S1
Hilton-Jones, D1
Series, H1
Hanyu, S1
Ikeguchi, K1
Imai, H1
Imai, N1
Yoshida, M1
Skopp, G1
Aderjan, R1
Koster, J1
Nielsen, JC1
Nicholson, K1
Pitzner-Jørgensen, BL1
Undén, M1
Selmi, F1
Davies, KG1
Sharma, RR1
Neal, JW1
Marsh, JC1
Abboudi, ZH1
Gibson, FM1
Scopes, J1
Daly, S1
O'Shaunnessy, DF1
Baughan, AS1
Gordon-Smith, EC1
Szukaj, M1
Magni, G1
Bryden, AA1
Rothwell, PJ1
O'Reilly, PH1
Renton, RJ1
Cowie, JS1
Oon, MC1
Allen, RP1
Watson, JD1
Ferguson, C1
Hinds, CJ1
Skinner, R1
Coakley, JH1
Manchanda, S1
Connolly, MJ1
Galloway, JH1
Marsh, ID1
Strachan, GA1
Clark, JC2
Kramer, K1
Azmitia, EC1
Whitaker-Azmitia, PM1
Cuomo, MJ1
Dyment, PG1
Gammino, VM1
de Man, RA1
Hooft, PJ1
van de Voorde, HP1
Mannaerts, GH1
Luitse, JS1
Zandstra, DF1
Hoitsma, HF1
Gouzoulis, E1
Borchardt, D1
Frison, G1
Giorgetti, R1
Ferrara, SD1
Levine, AJ1
Drew, S1
Rees, GM1
Barrett, PJ1
Taylor, GT1
Cadier, MA1
Clarke, JA1
Schwartz, RH1
Cox, DE1
Galloway, G1
Shulgin, AT1
Kornfeld, H1
Frederick, SL1
Keup, W1
Milroy, CM3
Ellis, AJ1
Wendon, JA1
Portmann, B1
Williams, R1
Brown, ER1
Jarvie, DR1
Simpson, D1
Coore, JR1
Robson, P1
Cohen, RS1
Demirkiran, M1
Jankovic, J1
Dean, JM1
Camí, J2
Bodenham, AR2
Mallick, A2
Slate, SO1
Kronstrand, R1
Onwudike, M1
White, SR1
Obradovic, T1
Imel, KM1
Wheaton, MJ1
Schechter, MD1
Prada, C1
Alvarez, FJ1
Kovar, KA3
Sass, H4
Kuhlmann, T1
Box, SA1
Prescott, LF1
Freestone, S1
Kikura, R2
Nakahara, Y2
Mieczkowski, T1
Tagliaro, F3
Bochner, F1
de la Fuente de Hoz, L2
Rodríguez Arenas, MA2
Vicente Orta, J1
Sánchez Payá, J1
Barrio Anta, G2
Elk, C1
Williamson, S1
Gossop, M1
Powis, B1
Fountain, J1
Strang, J1
Rutty, GN1
Schmolke, M1
Kraus, D1
Giroud, C1
Augsburger, M1
Sadeghipour, F1
Varesio, E1
Veuthey, JL1
Rivier, L1
Towers, S1
Möller-Nehring, E1
Luderer, HJ1
Tretter, F1
Durst, R1
Rebaudengo-Rosca, P1
Murthy, BV1
Roberts, NB1
Wilkes, RG1
Kua, EH1
Gerada, C1
Ashworth, M1
Morgan, AE1
Horan, B1
Dewey, SL1
Ashby, CR1
Travill, RA1
Rothe, M1
Pragst, F1
Spiegel, K1
Harrach, T1
Fischer, K1
Kunkel, J1
Pittman, JA1
Pounsford, JC1
Rees, C1
Lehane, M1
Caan, W1
Banjeri, T1
Royuela, L1
Holler, A1
Huether, G1
Lapostolle, F1
Eliez, CA1
el Massioui, Y1
Adnet, F1
Leclerc, G1
Efthymiou, ML1
Baud, F1
Avila de Tomás, JF2
Salas Dueñas, R1
García Martín, P1
Mendive, JM1
Giner Durán, R1
Flors, H1
Millán, M1
Manzanera, R1
Manetto, G2
Crivellente, F2
Scarcella, D1
Marigo, M2
Keller, T1
Miki, A1
Regenscheit, P1
Dirnhofer, R1
Tsuchihashi, H1
Redfearn, PJ1
Agrawal, N2
Mair, LH1
Ajaelo, I1
Koenig, K1
Snoey, E1
Mueller, PD1
Korey, WS1
Schuster, P1
Lamertz, C1
Roques, V1
Perney, P1
Beaufort, P1
Hanslik, B1
Ramos, J1
Durand, L1
Le Bricquir, Y1
Blanc, F1
Williams, H1
Dratcu, L1
Taylor, R1
Roberts, M1
Di Furia, L1
Forza, G1
Minicuci, N1
Bricolo, R1
Nitschke, S1
Mas, M1
Roset, PN1
Keppel Hesselink, JM1
Ferigolo, M1
Medeiros, FB1
Barros, HM1
Jansen, KL1
van Tonningen-van Driel, MM1
Garbis-Berkvens, JM1
Reuvers-Lodewijks, WE1
Reed, LJ2
Cleare, AJ1
McGuire, P3
Hamilton, J1
Balint, P1
Sturrock, RD1
Hando, J1
Roche, A1
Milosevic, A1
Redfearn, P1
Mair, L1
Scearce-Levie, K1
Chen, JP1
Gardner, E1
Hen, R1
Felgenhauer, N1
Zilker, T1
Duffy, F1
O'Donnell, PJ1
Bouquet, C1
Stein, DJ1
Rink, J1
Krishnan, A1
Brown, R1
Quin, GI1
McCarthy, GM1
Harries, DK1
Chang, L1
Ernst, T1
Grob, CS3
Poland, RE1
Gore, SM1
Christensen, HR1
Dersch, CM1
Carroll, FI1
Ferri, M1
Zambelli, U1
Timpano, M1
Neri, E1
Marzocchi, GF1
Valentini, R1
Carli, G1
Allen, DL2
Oliver, JS2
Schroeder, B1
Brieden, S1
Cooper, GA1
Scott, KS1
Ditton, J1
Smith, ID1
Kelly, PA1
Tuchtenhagen, F1
Pelz, S1
Becker, S1
Kunert, HJ1
Fimm, B1
Ghuran, A1
Nolan, J1
Sisk, E1
Klitzman, RL2
Ferrie, R1
Loveland, RC1
Pedersen, W1
Skrondal, A1
Rieder, MJ1
Kent, H1
Kish, SJ2
Furukawa, Y1
Ang, L1
Vorce, SP1
Kalasinsky, KS1
Henry, JA3
Cloud, J1
Ege, PP1
Vollenweider-Scherpenhuyzen, MF1
Vollenweider, FX2
Baggott, M1
Heifets, B1
Jones, RT1
Mendelson, J1
Sferios, E1
Zehnder, J1
Cambronero, JA1
Nevado, E1
Trascasa, M1
DubinN, N1
Razack, AH1
Graeme, KA1
McEvoy, AW1
Kitchen, ND1
Thomas, DG1
Buck, A1
Berthold, T1
Ragavan, C1
Wood, R1
Synovitz, LB1
Bråbäck, L1
Humble, M1
McElrath, K1
McEvoy, K1
Spruit, IP1
Tossmann, P1
Boldt, S1
Tensil, MD1
Goss, J1
Kelley, D1
Mayerhofer, A1
Schmidt, WJ1
Elliott, SP1
Väterlein, O1
Bohuslavizki, KH1
Vastag, B1
Balmelli, C1
Rentsch, K1
Schneemann, M1
Ali, L1
Gerhard, H1
Ionescu-Pioggia, M1
Pope, KW1
Lavalaye, J1
de Wolff, FA1
Molliver, ME1
Croft, RJ1
Klugman, A1
Baldeweg, T1
Gruzelier, JH1
Franceschini, E1
Baronti, R1
Siliquini, R1
Faggiano, F1
Geninatti, S1
Versino, E1
Mitola, B1
Ippolito, R1
Shibolet, O1
Kalish, Y1
Gillis, S1
Ilan, Y1
Obergriesser, T1
Ende, G1
Braus, DF1
Henn, FA1
O'Leary, G1
Nargiso, J1
Tancer, ME1
Kopelman, MD1
Marsden, P1
Mayes, AR1
Jaldow, E1
Laing, H1
Isaac, C1
Strote, J1
Lee, JE1
Wechsler, H1
Parmar, R1
Harris, LS1
Birnbach, DJ1
Feldman, N1
Croquette-Krokar, M1
Majoie, CB1
Flick, H1
Cole, J1
Fost, E1
Greenberg, JD1
Pollack, LM1
Dolezal, C1
Hill, A1
Orth, SR1
Hurley, RA1
Taber, KH1
Soldani, P1
Giusiani, A1
Koesters, SC1
Rogers, PD1
Rajasingham, CR1
Diaz, V1
Wyckoff, MM1
Smith, KM1
Larive, LL1
Romanelli, F1
Bobes, J1
Sáiz, PA1
González, MP1
Bascarán, MT1
Bousoño, M1
Smith, M1
Kaskey, GB1
Fahy, T2
Campkin, NT1
Davies, UM1
Liester, MB2
Bravo, GL2
Walsh, RN2
Fahal, IH1
Sallomi, DF1
Yaqoob, M1
Bell, GM1
Jeffreys, KJ1
Dawling, S1
Lee, N1
Singarajah, C1
Lavies, NG1
Rittoo, DB2
Rittoo, D3
Ellis, SJ1
Larner, AJ1
Gorard, DA1
Davies, SE1
Clark, ML1
Shearman, JD1
Chapman, RW1
Satsangi, J1
Ryley, NG1
Weatherhead, S1
De Silva, RN1
Harries, DP1
Sawyer, J1
Stephens, WP1
Lyttle, T1
Montagne, M1
Krystal, JH3
Price, LH3
Opsahl, C1
Heninger, GR3
Prat, A1
Montero, M1
Reig, R1
Sanz, P1
Chadwick, IS1
Curry, PD1
Linsley, A1
Freemont, AJ1
Doran, B1
Kaminer, Y1
Zemishlany, Z1
Finnegan, KT1
Irwin, I1
Langston, JW1
Grob, C1
Bravo, G1
Walsh, R1
Peroutka, SJ3
Edwards, G1
Laverty, R1
Logan, BJ1
Mack, RB1
Davis, WM1
Hatoum, HT1
Waters, IW1
Frith, CH1
Chang, LW1
Lattin, DL1
Walls, RC1
Hamm, J1
Barnes, DM2
Jacobson, AE1
Newman, H1
Harris, H1

Clinical Trials (11)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Consumption of New Psychoactive Substances in Intoxicated Patients During the Winter Activities[NCT04155281]87 participants (Actual)Observational2020-01-23Completed
Impact of a Novel HIV Peer Navigation and Overdose Prevention Intervention on Engagement in the HIV Prevention and Treatment Cascade[NCT05977881]600 participants (Anticipated)Interventional2023-07-28Recruiting
Effect of Transcranial Direct Current Stimulation (tDCS) on Tobacco Consumption.[NCT01930422]34 participants (Actual)Interventional2013-07-31Completed
Theta Burst TMS as a Tool to Change Smoking Behavior[NCT02939339]Early Phase 115 participants (Actual)Interventional2015-10-31Completed
Pilot Study of an Intervention Involving Cognitive Training and Transcranial Direct-current Stimulation (tDCS) in Morbidly Obese Subjects[NCT03943979]Phase 218 participants (Actual)Interventional2016-02-25Completed
Charleston ARC Clinical Project 4 Cortical rTMS as a Tool to Change Craving and Brain Reactivity to Alcohol Cues[NCT02939313]Early Phase 171 participants (Actual)Interventional2016-01-31Completed
Oxytocin in Alcohol Use Disorder: A Novel and Translational Approach[NCT02711189]Phase 10 participants (Actual)Interventional2016-03-08Withdrawn
Phase II Clinical Trial Testing the Safety and Efficacy of 3,4-Methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy in Subjects With Chronic Posttraumatic Stress Disorder[NCT00090064]Phase 223 participants (Actual)Interventional2004-03-12Completed
The Effects of MDMA on Prefrontal and Amygdala Activation in Posttraumatic Stress Disorder[NCT03752918]Phase 120 participants (Anticipated)Interventional2024-01-31Not yet recruiting
Stimulation of Parieto-hippocampal Connectivity in Patients With Major Depressive Disorder[NCT04081519]53 participants (Actual)Interventional2016-08-02Completed
Neurotoxicity of Ecstasy: Causality, Course and Clinical Relevance[NCT00235768]225 participants Observational2002-04-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Change in Clinician-Administered PTSD Scale (CAPS-IV) From Baseline to 2-month Follow-up

The Clinician-Administered PTSD Scale for DSM-IV (CAPS-IV) is a clinician administered and scored assessment of PTSD symptoms via structured interview based upon PTSD diagnosis in DSM-IV. The total severity score is a sum of symptom frequency and intensity scores for the subscales B (re-experiencing), C (avoidance) and D (hypervigilance) and ranges from 0 to 136, with higher scores indicating greater severity of PTSD symptoms. (NCT00090064)
Timeframe: Baseline to 2 months post second experimental session

Interventionscore on a scale (Mean)
MDMA-assisted Therapy-55.2
Placebo With Therapy-20.5

Change in Impact of Events Scale Revised (IES-R) From Baseline to 2-month Follow-up

"The Impact of Events Scale Revised (IES-R) is a 22-item self-report measure (for DSM-IV) designed to measure the extent to which a given stressful life event produces subjective distress. Each item corresponds directly to 14 of the 17 DSM-IV symptoms of PTSD and is rated on a 5-point scale ranging from 0 (not at all) to 4 (extremely) for the extent to which the item was true for the participant during the past seven days. The IES-R yields a total score ranging from 0 to 88 with higher scores indicated greater distress." (NCT00090064)
Timeframe: Baseline to 2 months post second experimental session

Interventionscore on a scale (Mean)
MDMA-assisted Therapy-29.7
Placebo With Therapy-12.9

Reviews

130 reviews available for n-methyl-3,4-methylenedioxyamphetamine and Chemical Dependence

ArticleYear
Substance use during the COVID-19 pandemic: What is really happening?
    Psychiatrike = Psychiatriki, 2022, Mar-28, Volume: 33, Issue:1

    Topics: Adult; Benzodiazepines; Cocaine; Communicable Disease Control; COVID-19; Cross-Sectional Studies; Hu

2022
Fatal and non-fatal health incidents related to recreational ecstasy use.
    Journal of psychopharmacology (Oxford, England), 2020, Volume: 34, Issue:6

    Topics: Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Risk Assessment; Severity of Illness

2020
Use and abuse of dissociative and psychedelic drugs in adolescence.
    Pharmacology, biochemistry, and behavior, 2021, Volume: 203

    Topics: Adolescent; Adult; Age Factors; Animals; Dextromethorphan; Female; Hallucinogens; Humans; Ketamine;

2021
Methylenedioxymethamphetamine (MDMA): Serotonergic and dopaminergic mechanisms related to its use and misuse.
    Journal of neurochemistry, 2021, Volume: 157, Issue:5

    Topics: Animals; Dopamine; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Net; Serotonin; Serotonin A

2021
[The influence of social stress on the reinforcing effect of ecstasy under the conditioned place preference paradigm: the role played by age, dose and type of stress].
    Revista de neurologia, 2017, 11-16, Volume: 65, Issue:10

    Topics: Age Factors; Conditioning, Psychological; Humans; Models, Psychological; N-Methyl-3,4-methylenedioxy

2017
Psychedelics and reconsolidation of traumatic and appetitive maladaptive memories: focus on cannabinoids and ketamine.
    Psychopharmacology, 2018, Volume: 235, Issue:2

    Topics: Anesthetics, Dissociative; Animals; Appetitive Behavior; Cannabinoids; Emotions; Hallucinogens; Huma

2018
Key interindividual determinants in MDMA pharmacodynamics.
    Expert opinion on drug metabolism & toxicology, 2018, Volume: 14, Issue:2

    Topics: Animals; Drug Interactions; Ethnicity; Female; Hallucinogens; Humans; Male; N-Methyl-3,4-methylenedi

2018
The DARK Side of Total Synthesis: Strategies and Tactics in Psychoactive Drug Production.
    ACS chemical neuroscience, 2018, 10-17, Volume: 9, Issue:10

    Topics: Amphetamines; Benzodiazepines; Central Nervous System Stimulants; Cocaine; Crack Cocaine; Drug Indus

2018
Are ecstasy induced serotonergic alterations overestimated for the majority of users?
    Journal of psychopharmacology (Oxford, England), 2018, Volume: 32, Issue:7

    Topics: Brain; Dose-Response Relationship, Drug; Drug Users; Hallucinogens; Humans; N-Methyl-3,4-methylenedi

2018
Synthetic cathinone adulteration of illegal drugs.
    Psychopharmacology, 2019, Volume: 236, Issue:3

    Topics: Alkaloids; Central Nervous System Stimulants; Drug Contamination; Humans; Illicit Drugs; N-Methyl-3,

2019
Stimulant Use in Pregnancy: An Under-recognized Epidemic Among Pregnant Women.
    Clinical obstetrics and gynecology, 2019, Volume: 62, Issue:1

    Topics: Alkaloids; Central Nervous System Stimulants; Cocaine; Female; Humans; Methamphetamine; N-Methyl-3,4

2019
The effects of licit and illicit recreational drugs on prospective memory: a meta-analytic review.
    Psychopharmacology, 2019, Volume: 236, Issue:4

    Topics: Alcohol Drinking; Cannabis; Hallucinogens; Humans; Illicit Drugs; Memory Disorders; Memory, Episodic

2019
Prevention of alcohol and drug abuse: what works?
    Substance abuse, 2002, Volume: 23, Issue:3 Suppl

    Topics: Adolescent; Alcoholism; Amphetamine-Related Disorders; Binge Drinking; Cocaine-Related Disorders; Co

2002
Can MDMA play a role in the treatment of substance abuse?
    Current drug abuse reviews, 2013, Volume: 6, Issue:1

    Topics: Animals; Brain; Combined Modality Therapy; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyampheta

2013
How MDMA's pharmacology and pharmacokinetics drive desired effects and harms.
    Journal of clinical pharmacology, 2014, Volume: 54, Issue:3

    Topics: Drug Interactions; Europe; Hallucinogens; Humans; Illicit Drugs; N-Methyl-3,4-methylenedioxyamphetam

2014
MDMA, cortisol, and heightened stress in recreational ecstasy users.
    Behavioural pharmacology, 2014, Volume: 25, Issue:5-6

    Topics: Animals; Hallucinogens; Humans; Hydrocortisone; Illicit Drugs; N-Methyl-3,4-methylenedioxyamphetamin

2014
"Addicted to Euphoria": The History, Clinical Presentation, and Management of Party Drug Misuse.
    International review of neurobiology, 2015, Volume: 120

    Topics: Euphoria; History, 20th Century; Humans; Hydroxybutyrates; Illicit Drugs; Ketamine; N-Methyl-3,4-met

2015
Effects of addictive drugs on adult neural stem/progenitor cells.
    Cellular and molecular life sciences : CMLS, 2016, Volume: 73, Issue:2

    Topics: Adult Stem Cells; Amphetamine; Analgesics, Opioid; Animals; Cannabinoids; Cell Proliferation; Centra

2016
[Psychedelics and quasi-psychedelics in the light of contemporary research: medical cannabis, MDMA, salvinorin A, ibogaine and ayahuasca].
    Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology, 2015, Volume: 17, Issue:3

    Topics: Banisteriopsis; Controlled Substances; Diterpenes, Clerodane; Hallucinogens; Humans; Hungary; Ibogai

2015
Neurochemical substrates of the rewarding effects of MDMA: implications for the development of pharmacotherapies to MDMA dependence.
    Behavioural pharmacology, 2016, Volume: 27, Issue:2-3 Spec I

    Topics: Animals; Brain; Conditioning, Psychological; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphe

2016
Meta-analysis of executive functioning in ecstasy/polydrug users.
    Psychological medicine, 2016, Volume: 46, Issue:8

    Topics: Case-Control Studies; Drug Users; Executive Function; Humans; Inhibition, Psychological; Memory, Lon

2016
Benzylpiperazine: "A messy drug".
    Drug and alcohol dependence, 2016, Jul-01, Volume: 164

    Topics: Contraindications; Designer Drugs; Dopamine; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphe

2016
Generation Z: Adolescent Xenobiotic Abuse in the 21st Century.
    Adolescent medicine: state of the art reviews, 2015, Volume: 26, Issue:3

    Topics: Adolescent; Amphetamine-Related Disorders; Cannabinoids; Central Nervous System Stimulants; Designer

2015
Predicting the Abuse Liability of Entactogen-Class, New and Emerging Psychoactive Substances via Preclinical Models of Drug Self-administration.
    Current topics in behavioral neurosciences, 2017, Volume: 32

    Topics: Animals; Behavior, Animal; Methamphetamine; Models, Animal; N-Methyl-3,4-methylenedioxyamphetamine;

2017
Drugs, biogenic amine targets and the developing brain.
    Developmental neuroscience, 2009, Volume: 31, Issue:1-2

    Topics: Adult; Amphetamine-Related Disorders; Animals; Behavior; Biogenic Amines; Brain; Brain Chemistry; Ch

2009
Health consequences of illegal drug use.
    Current opinion in psychiatry, 2009, Volume: 22, Issue:3

    Topics: Amphetamine; Depressive Disorder; Health Status; Hepatitis C; Humans; Illicit Drugs; Marijuana Abuse

2009
A structured review of reasons for ecstasy use and related behaviours: pointers for future research.
    BMC public health, 2009, Jul-13, Volume: 9

    Topics: Humans; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related Disorders

2009
Transcranial magnetic stimulation to understand the pathophysiology and treatment of substance use disorders.
    Current drug abuse reviews, 2008, Volume: 1, Issue:3

    Topics: Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Cerebral Cortex; Cocaine-

2008
Transcranial magnetic stimulation to understand the pathophysiology and treatment of substance use disorders.
    Current drug abuse reviews, 2008, Volume: 1, Issue:3

    Topics: Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Cerebral Cortex; Cocaine-

2008
Transcranial magnetic stimulation to understand the pathophysiology and treatment of substance use disorders.
    Current drug abuse reviews, 2008, Volume: 1, Issue:3

    Topics: Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Cerebral Cortex; Cocaine-

2008
Transcranial magnetic stimulation to understand the pathophysiology and treatment of substance use disorders.
    Current drug abuse reviews, 2008, Volume: 1, Issue:3

    Topics: Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Cerebral Cortex; Cocaine-

2008
Transcranial magnetic stimulation to understand the pathophysiology and treatment of substance use disorders.
    Current drug abuse reviews, 2008, Volume: 1, Issue:3

    Topics: Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Cerebral Cortex; Cocaine-

2008
Transcranial magnetic stimulation to understand the pathophysiology and treatment of substance use disorders.
    Current drug abuse reviews, 2008, Volume: 1, Issue:3

    Topics: Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Cerebral Cortex; Cocaine-

2008
Transcranial magnetic stimulation to understand the pathophysiology and treatment of substance use disorders.
    Current drug abuse reviews, 2008, Volume: 1, Issue:3

    Topics: Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Cerebral Cortex; Cocaine-

2008
Transcranial magnetic stimulation to understand the pathophysiology and treatment of substance use disorders.
    Current drug abuse reviews, 2008, Volume: 1, Issue:3

    Topics: Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Cerebral Cortex; Cocaine-

2008
Transcranial magnetic stimulation to understand the pathophysiology and treatment of substance use disorders.
    Current drug abuse reviews, 2008, Volume: 1, Issue:3

    Topics: Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Cerebral Cortex; Cocaine-

2008
Transcranial magnetic stimulation to understand the pathophysiology and treatment of substance use disorders.
    Current drug abuse reviews, 2008, Volume: 1, Issue:3

    Topics: Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Cerebral Cortex; Cocaine-

2008
Transcranial magnetic stimulation to understand the pathophysiology and treatment of substance use disorders.
    Current drug abuse reviews, 2008, Volume: 1, Issue:3

    Topics: Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Cerebral Cortex; Cocaine-

2008
Transcranial magnetic stimulation to understand the pathophysiology and treatment of substance use disorders.
    Current drug abuse reviews, 2008, Volume: 1, Issue:3

    Topics: Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Cerebral Cortex; Cocaine-

2008
Transcranial magnetic stimulation to understand the pathophysiology and treatment of substance use disorders.
    Current drug abuse reviews, 2008, Volume: 1, Issue:3

    Topics: Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Cerebral Cortex; Cocaine-

2008
Transcranial magnetic stimulation to understand the pathophysiology and treatment of substance use disorders.
    Current drug abuse reviews, 2008, Volume: 1, Issue:3

    Topics: Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Cerebral Cortex; Cocaine-

2008
Transcranial magnetic stimulation to understand the pathophysiology and treatment of substance use disorders.
    Current drug abuse reviews, 2008, Volume: 1, Issue:3

    Topics: Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Cerebral Cortex; Cocaine-

2008
Transcranial magnetic stimulation to understand the pathophysiology and treatment of substance use disorders.
    Current drug abuse reviews, 2008, Volume: 1, Issue:3

    Topics: Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Cerebral Cortex; Cocaine-

2008
Is ecstasy a drug of dependence?
    Drug and alcohol dependence, 2010, Feb-01, Volume: 107, Issue:1

    Topics: Animals; Behavior, Animal; Hallucinogens; Humans; Models, Neurological; Models, Psychological; N-Met

2010
Neurotoxicity of drugs of abuse--the case of methylenedioxyamphetamines (MDMA, ecstasy), and amphetamines.
    Dialogues in clinical neuroscience, 2009, Volume: 11, Issue:3

    Topics: Amphetamines; Animals; Brain; Disease Models, Animal; Humans; N-Methyl-3,4-methylenedioxyamphetamine

2009
Differential effects of ecstasy on short-term and working memory: a meta-analysis.
    Neuropsychology review, 2010, Volume: 20, Issue:1

    Topics: Hallucinogens; Humans; Memory, Short-Term; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related

2010
Amphetamine toxicities: classical and emerging mechanisms.
    Annals of the New York Academy of Sciences, 2010, Volume: 1187

    Topics: Amphetamines; Animals; Blood-Brain Barrier; Brain; Central Nervous System Stimulants; HIV Infections

2010
Cocaine, metamfetamine, and MDMA abuse: the role and clinical importance of neuroadaptation.
    Clinical toxicology (Philadelphia, Pa.), 2010, Volume: 48, Issue:7

    Topics: Adaptation, Physiological; Brain; Central Nervous System Stimulants; Cocaine; Dopamine; Humans; Meth

2010
Deterioration of executive functioning in chronic ecstasy users; evidence for multiple drugs effects.
    Current drug abuse reviews, 2010, Volume: 3, Issue:3

    Topics: Animals; Attention; Dose-Response Relationship, Drug; Executive Function; Hallucinogens; Humans; Mem

2010
MDMA ("ecstasy") abuse as an example of dopamine neuroplasticity.
    Neuroscience and biobehavioral reviews, 2011, Volume: 35, Issue:5

    Topics: Animals; Central Nervous System Stimulants; Discrimination, Psychological; Disease Models, Animal; D

2011
The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'), methamphetamine and D-amphetamine.
    Biological chemistry, 2011, Volume: 392, Issue:1-2

    Topics: Amphetamines; Animals; Dextroamphetamine; Humans; Methamphetamine; Mitochondria; Molecular Structure

2011
Drug-related decrease in neuropsychological functions of abstinent drug users.
    Current drug abuse reviews, 2011, Volume: 4, Issue:1

    Topics: Alcoholism; Amphetamine-Related Disorders; Cannabis; Central Nervous System Stimulants; Cocaine; Coc

2011
Club drugs: review of the 'rave' with a note of concern for the Indian scenario.
    The Indian journal of medical research, 2011, Volume: 133

    Topics: Anesthetics, Dissociative; Anti-Anxiety Agents; Designer Drugs; Flunitrazepam; Hallucinogens; Humans

2011
MDMA: interactions with other psychoactive drugs.
    Pharmacology, biochemistry, and behavior, 2011, Volume: 99, Issue:4

    Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Caffeine; Cannabis; Central Nervous System Depr

2011
GHB and synthetic cathinones: clinical effects and potential consequences.
    Drug testing and analysis, 2011, Volume: 3, Issue:9

    Topics: Alkaloids; Animals; Designer Drugs; Humans; Illicit Drugs; Indans; Methamphetamine; N-Methyl-3,4-met

2011
Nephrotoxicity of recreational party drugs.
    Nephrology (Carlton, Vic.), 2012, Volume: 17, Issue:2

    Topics: Acute Kidney Injury; Adult; Animals; Drug Overdose; Humans; Illicit Drugs; Kidney; Male; N-Methyl-3,

2012
Breaking the loop: oxytocin as a potential treatment for drug addiction.
    Hormones and behavior, 2012, Volume: 61, Issue:3

    Topics: Adaptation, Psychological; Alcoholism; Animals; Drug Tolerance; Hallucinogens; Humans; N-Methyl-3,4-

2012
The effects of 'ecstasy' (MDMA) on visuospatial memory performance: findings from a systematic review with meta-analyses.
    Human psychopharmacology, 2012, Volume: 27, Issue:2

    Topics: Animals; Executive Function; Hallucinogens; Humans; Memory Disorders; Memory, Short-Term; Mental Rec

2012
Meta-analysis of the association between ecstasy use and risky sexual behavior.
    Addictive behaviors, 2012, Volume: 37, Issue:7

    Topics: Hallucinogens; Humans; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Risk-Taking; Sexual Beha

2012
Spice, bath salts, and the U.S. military: the emergence of synthetic cannabinoid receptor agonists and cathinones in the U.S. Armed Forces.
    Military medicine, 2012, Volume: 177, Issue:9

    Topics: Alkaloids; Cannabinoid Receptor Agonists; Cannabinoids; Designer Drugs; Humans; Illicit Drugs; Milit

2012
[Levels of evidence in drug therapy for alcohol use disorders and illicit drug use].
    Fortschritte der Neurologie-Psychiatrie, 2012, Volume: 80, Issue:12

    Topics: Alcohol Deterrents; Alcoholism; Amphetamine-Related Disorders; Cocaine-Related Disorders; Combined M

2012
The health effects of ecstasy: a literature review.
    Drug and alcohol review, 2002, Volume: 21, Issue:1

    Topics: Animals; Fever; Humans; Illicit Drugs; N-Methyl-3,4-methylenedioxyamphetamine; Seizures; Substance-R

2002
The effects and consequences of selected club drugs.
    Journal of substance abuse treatment, 2002, Volume: 23, Issue:2

    Topics: Central Nervous System Stimulants; Humans; Ketamine; Methamphetamine; N-Methyl-3,4-methylenedioxyamp

2002
Club drugs: is it all ecstasy?
    Pediatric annals, 2002, Volume: 31, Issue:9

    Topics: Adolescent; Adolescent Behavior; Anxiety Disorders; Humans; Illicit Drugs; Ketamine; Methamphetamine

2002
Cerebrovascular complications of alcohol and sympathomimetic drug abuse.
    Current neurology and neuroscience reports, 2003, Volume: 3, Issue:1

    Topics: Alcohol Drinking; Alcoholism; Catecholamines; Cocaine; Humans; N-Methyl-3,4-methylenedioxyamphetamin

2003
Neurobiology of addiction and implications for treatment.
    The British journal of psychiatry : the journal of mental science, 2003, Volume: 182

    Topics: Behavior, Addictive; Dopamine; Heroin Dependence; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Ne

2003
[Recent abuse of 3,4-methylenedioxymethamphetamine ("yaoto-wang", "ecstasy")].
    Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica, 2002, Volume: 104, Issue:10

    Topics: Adolescent; Adult; Age Factors; Animals; Central Nervous System; Humans; Japan; N-Methyl-3,4-methyle

2002
Altered states: the clinical effects of Ecstasy.
    Pharmacology & therapeutics, 2003, Volume: 98, Issue:1

    Topics: 3,4-Methylenedioxyamphetamine; Brain; Clinical Trials as Topic; Cognition Disorders; Hallucinogens;

2003
[Ecstasy: a review of scientific literature about MDMA].
    Medicina clinica, 2003, Apr-12, Volume: 120, Issue:13

    Topics: Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related Disorders

2003
[Effects of ecstasy on the body].
    Duodecim; laaketieteellinen aikakauskirja, 2003, Volume: 119, Issue:13

    Topics: Brain; Hallucinogens; Humans; Mental Disorders; N-Methyl-3,4-methylenedioxyamphetamine; Serotonin; S

2003
Hyponatremia associated with 3,4-methylenedioxymethylamphetamine ("Ecstasy") abuse.
    The American journal of the medical sciences, 2003, Volume: 326, Issue:2

    Topics: Adolescent; Female; Humans; Hyponatremia; N-Methyl-3,4-methylenedioxyamphetamine; Sodium Chloride; S

2003
[Psychological aspects of MDMA (ecstasy) users].
    Annales de medecine interne, 2003, Volume: 154 Spec No 2

    Topics: Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Personality; Substance-Related Disord

2003
Methylenedioxymethamphetamine (MDMA, 'Ecstasy'): a stressor on the immune system.
    Immunology, 2004, Volume: 111, Issue:4

    Topics: Animals; Disease Models, Animal; Hallucinogens; Humans; Immune System; Immune Tolerance; N-Methyl-3,

2004
Cognitive impairment in substance abuse.
    The Psychiatric clinics of North America, 2004, Volume: 27, Issue:1

    Topics: Alcohol Amnestic Disorder; Amphetamines; Central Nervous System Stimulants; Cognition Disorders; Eth

2004
Rave drugs: pharmacological considerations.
    AANA journal, 2004, Volume: 72, Issue:1

    Topics: Adolescent; Adult; Anesthesia; Dancing; Designer Drugs; Emergency Treatment; Flunitrazepam; Hallucin

2004
Common drugs of abuse--Part II.
    The Journal of practical nursing, 2004,Spring, Volume: 54, Issue:1

    Topics: 4-Butyrolactone; Catha; Designer Drugs; Dibenzothiazepines; Diterpenes; Diterpenes, Clerodane; DOM 2

2004
Club drugs: MDMA, gamma-hydroxybutyrate (GHB), Rohypnol, and ketamine.
    American family physician, 2004, Jun-01, Volume: 69, Issue:11

    Topics: Anesthetics, Dissociative; Drug Overdose; Flunitrazepam; Hallucinogens; Humans; Ketamine; Leisure Ac

2004
Ecstasy: commodity or disease?
    Journal of psychoactive drugs, 2004, Volume: 36, Issue:2

    Topics: Humans; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related Disorders

2004
Acute toxic effects of club drugs.
    Journal of psychoactive drugs, 2004, Volume: 36, Issue:3

    Topics: Alcohol Drinking; Animals; Behavior; Drug Interactions; Flunitrazepam; Hallucinogens; Humans; Illici

2004
[AWMF-guideline: cocaine-, amphetamine-, ecstasy- and hallucinogen-related disorders].
    Fortschritte der Neurologie-Psychiatrie, 2004, Volume: 72, Issue:12

    Topics: Adult; Amphetamine-Related Disorders; Cocaine-Related Disorders; Comorbidity; Evidence-Based Medicin

2004
[Acute and long-term effects of ecstasy].
    Presse medicale (Paris, France : 1983), 2004, Oct-23, Volume: 33, Issue:18 Suppl

    Topics: Animals; Brain Diseases; Chemical and Drug Induced Liver Injury; Fever; Hallucinogens; Humans; N-Met

2004
Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy.
    Journal of psychopharmacology (Oxford, England), 2005, Volume: 19, Issue:1

    Topics: Drug Tolerance; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Neurotoxicity Syndromes; Serotonin;

2005
Self-reported depressive symptomatology in community samples of polysubstance misusers who report Ecstasy use: a meta-analysis.
    Journal of psychopharmacology (Oxford, England), 2005, Volume: 19, Issue:1

    Topics: Depressive Disorder; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Population Surveillance; Psychi

2005
A brief overview of the clinical pharmacology of "club drugs".
    Substance use & misuse, 2005, Volume: 40, Issue:9-10

    Topics: Adjuvants, Anesthesia; Anesthetics, Dissociative; Dancing; Flunitrazepam; GABA Modulators; Hallucino

2005
Recent trends in the use of "club drugs": an Australian review.
    Substance use & misuse, 2005, Volume: 40, Issue:9-10

    Topics: Adjuvants, Anesthesia; Adolescent; Adult; Anesthetics, Dissociative; Australia; Cognition Disorders;

2005
Pharmacological aspects of the combined use of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and gamma-hydroxybutyric acid (GHB): a review of the literature.
    Drug and alcohol review, 2005, Volume: 24, Issue:4

    Topics: Anxiety; Body Temperature; Depression; Dopamine; Hallucinogens; Humans; Hydroxybutyrates; N-Methyl-3

2005
Recent trends in drug abuse in China.
    Acta pharmacologica Sinica, 2006, Volume: 27, Issue:2

    Topics: China; Drug and Narcotic Control; HIV Infections; Ketamine; N-Methyl-3,4-methylenedioxyamphetamine;

2006
A clinical crossroads for MDMA.
    Journal of psychoactive drugs, 2005, Volume: 37, Issue:4

    Topics: Animals; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Neurotoxicity Syndromes; Ser

2005
Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?
    Addiction (Abingdon, England), 2006, Volume: 101, Issue:3

    Topics: Animals; Brain Diseases; Cognition Disorders; Hallucinogens; Humans; Memory Disorders; Mental Disord

2006
Causes and consequences of methamphetamine and MDMA toxicity.
    The AAPS journal, 2006, May-12, Volume: 8, Issue:2

    Topics: Blood-Brain Barrier; Dopamine; Humans; Methamphetamine; Mitochondria; N-Methyl-3,4-methylenedioxyamp

2006
[Ecstasy toxicity].
    Medicina (Kaunas, Lithuania), 2006, Volume: 42, Issue:6

    Topics: Adolescent; Adult; Age Factors; Cardiovascular Diseases; Emergencies; Hallucinogens; Hospitalization

2006
Reflections on the development and implementation of an early warning system for ecstasy and related drug markets in Australia.
    Drug and alcohol review, 2006, Volume: 25, Issue:5

    Topics: Australia; Commerce; Humans; Incidence; Mandatory Reporting; N-Methyl-3,4-methylenedioxyamphetamine;

2006
The origin of MDMA ("ecstasy")--separating the facts from the myth.
    Die Pharmazie, 2006, Volume: 61, Issue:11

    Topics: Germany; Hallucinogens; History, 19th Century; History, 20th Century; Humans; N-Methyl-3,4-methylene

2006
Substance use and its implications for the critical care nurses: a literature review.
    Intensive & critical care nursing, 2007, Volume: 23, Issue:2

    Topics: Adrenergic Uptake Inhibitors; Amphetamines; Cocaine; Critical Care; Humans; N-Methyl-3,4-methylenedi

2007
MDMA, methamphetamine and their combination: possible lessons for party drug users from recent preclinical research.
    Drug and alcohol review, 2007, Volume: 26, Issue:1

    Topics: Amphetamine-Related Disorders; Animals; Behavior, Animal; Brain; Disease Models, Animal; Drug Evalua

2007
Qualitative review of serotonin syndrome, ecstasy (MDMA) and the use of other serotonergic substances: hierarchy of risk.
    The Australian and New Zealand journal of psychiatry, 2007, Volume: 41, Issue:8

    Topics: Humans; N-Methyl-3,4-methylenedioxyamphetamine; Risk Factors; Serotonin Agents; Serotonin Syndrome;

2007
Ecstasy (MDMA) and memory function: a meta-analytic update.
    Human psychopharmacology, 2007, Volume: 22, Issue:6

    Topics: Cannabis; Databases, Factual; Hallucinogens; Humans; Illicit Drugs; Memory Disorders; Memory, Short-

2007
Effects of (+/-) 3,4-methylenedioxymethamphetamine (MDMA) on sleep and circadian rhythms.
    TheScientificWorldJournal, 2007, Nov-02, Volume: 7

    Topics: Animals; Circadian Rhythm; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Neurons; Serotonin; Sleep

2007
Understanding drug addiction: a neuropsychological perspective.
    The Australian and New Zealand journal of psychiatry, 2007, Volume: 41, Issue:12

    Topics: Adolescent; Adult; Age Factors; Alcoholism; Analgesics, Opioid; Behavior, Addictive; Central Nervous

2007
The dark side of ecstasy: neuropsychiatric symptoms after exposure to 3,4-methylenedioxymethamphetamine.
    Basic & clinical pharmacology & toxicology, 2008, Volume: 102, Issue:1

    Topics: Animals; Cognition Disorders; Dose-Response Relationship, Drug; Half-Life; Hallucinogens; Humans; Il

2008
Neuropsychotoxicity of abused drugs: molecular and neural mechanisms of neuropsychotoxicity induced by methamphetamine, 3,4-methylenedioxymethamphetamine (ecstasy), and 5-methoxy-N,N-diisopropyltryptamine (foxy).
    Journal of pharmacological sciences, 2008, Volume: 106, Issue:1

    Topics: 5-Methoxytryptamine; Animals; Brain; Central Nervous System Stimulants; Dopamine; Dopamine Plasma Me

2008
Ecstasy (MDMA) and oral health.
    British dental journal, 2008, Jan-26, Volume: 204, Issue:2

    Topics: Adult; Animals; Bruxism; Dental Care for Chronically Ill; Hallucinogens; Humans; N-Methyl-3,4-methyl

2008
Effect of illicit recreational drugs upon sleep: cocaine, ecstasy and marijuana.
    Sleep medicine reviews, 2008, Volume: 12, Issue:5

    Topics: Animals; Brain; Cocaine; Disease Models, Animal; Dronabinol; Humans; Illicit Drugs; N-Methyl-3,4-met

2008
Ecstasy and other club drugs: a review of recent epidemiologic studies.
    Current opinion in psychiatry, 2008, Volume: 21, Issue:3

    Topics: Australia; Costa Rica; Guatemala; Hong Kong; Humans; Illicit Drugs; Israel; Italy; N-Methyl-3,4-meth

2008
[Minocycline as a therapeutic drug for methamphetamine use disorders].
    Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology, 2008, Volume: 28, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Brain; Disease Models, Animal; Humans; Methamphetamine; Minocycline;

2008
From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long-term adverse consequences of drug use?
    British journal of pharmacology, 2008, Volume: 154, Issue:2

    Topics: Adaptation, Physiological; Adaptation, Psychological; Amphetamine-Related Disorders; Animals; Behavi

2008
[Computed tomography in acute rhabdomyolysis].
    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1995, Volume: 163, Issue:4

    Topics: Acute Disease; Adult; Cocaine; Diagnosis, Differential; Diphenhydramine; Heroin Dependence; Humans;

1995
[Abuse of Ecstasy (3,4-methylenedioxymethamphetamine). Pharmacological, neuropsychiatric and behavioral aspects].
    Ugeskrift for laeger, 1995, Feb-06, Volume: 157, Issue:6

    Topics: Brain Diseases; Hallucinogens; Humans; Mental Disorders; N-Methyl-3,4-methylenedioxyamphetamine; Sub

1995
[MDMA ("Ecstasy")--a dangerous drug or psychotherapeutic drug?].
    Der Nervenarzt, 1994, Volume: 65, Issue:11

    Topics: Dose-Response Relationship, Drug; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Psychotherapy; Sub

1994
Exertional heat stroke induced by amphetamine analogues. Does dantrolene have a place?
    Anaesthesia, 1993, Volume: 48, Issue:12

    Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Adult; Blood Coagulation Disorders; Dancing; Dantrolene;

1993
[Morbidity and mortality caused by use of ecstasy].
    Nederlands tijdschrift voor geneeskunde, 1994, Sep-10, Volume: 138, Issue:37

    Topics: Chemical and Drug Induced Liver Injury; Humans; Multiple Organ Failure; N-Methyl-3,4-methylenedioxya

1994
[MDMA--"ecstasy"].
    Medizinische Monatsschrift fur Pharmazeuten, 1996, Volume: 19, Issue:1

    Topics: Cross-Sectional Studies; Germany; Hallucinogens; Humans; Incidence; N-Methyl-3,4-methylenedioxyamphe

1996
A guide to non-opiate illicit drugs.
    The Practitioner, 1996, Volume: 240, Issue:1560

    Topics: Adolescent; Cannabis; Central Nervous System Stimulants; Hallucinogens; Humans; Illicit Drugs; N-Met

1996
Ecstasy intoxication: an overlap between serotonin syndrome and neuroleptic malignant syndrome.
    Clinical neuropharmacology, 1996, Volume: 19, Issue:2

    Topics: Adolescent; Adult; Female; Hallucinogens; Humans; Infant; Male; N-Methyl-3,4-methylenedioxyamphetami

1996
New dimensions in toxicology: hyperthermic syndrome following amphetamine derivatives.
    Intensive care medicine, 1996, Volume: 22, Issue:7

    Topics: Cause of Death; Diagnosis, Differential; Emergencies; Fever; Humans; N-Methyl-3,4-methylenedioxyamph

1996
Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy').
    Drug safety, 1996, Volume: 15, Issue:2

    Topics: Animals; Brain; Hallucinogens; Heart; Humans; Mental Disorders; N-Methyl-3,4-methylenedioxyamphetami

1996
The effects of methylenedioxymethamphetamine (MDMA, "Ecstasy") on monoaminergic neurotransmission in the central nervous system.
    Progress in neurobiology, 1996, Volume: 49, Issue:5

    Topics: Action Potentials; Animals; Brain; Brain Damage, Chronic; Dopamine; Fever; Guinea Pigs; Haplorhini;

1996
[MDMA or ecstasy: pharmacologic, toxicologic and clinical aspects].
    Medicina clinica, 1996, Oct-26, Volume: 107, Issue:14

    Topics: Animals; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related Disorders

1996
[Entactogenic drugs "ecstasy" (MDMA), "eve" (MDE) and other ring-substituted methamphetamine derivatives. A new class of substances among illegal designer drugs?].
    Der Nervenarzt, 1996, Volume: 67, Issue:5

    Topics: 3,4-Methylenedioxyamphetamine; Animals; Designer Drugs; Humans; N-Methyl-3,4-methylenedioxyamphetami

1996
[Ecstasy, a new designer drug in the techno-scene].
    Psychiatrische Praxis, 1996, Volume: 23, Issue:6

    Topics: Designer Drugs; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Peer Group; Social En

1996
MDMA (Ecstacy): useful information for health professionals involved in drug education programs.
    Journal of drug education, 1996, Volume: 26, Issue:4

    Topics: Adult; Hallucinogens; Health Education; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Re

1996
[MDMA ("Ecstasy") use--an overview of psychiatric and medical sequelae].
    Fortschritte der Neurologie-Psychiatrie, 1997, Volume: 65, Issue:2

    Topics: Brain; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Neurologic Examination; Psychoses, Substance-

1997
[Ecstasy--the status in French-speaking Switzerland. Composition of seized drugs, analysis of biological specimens and short review of its pharmacological action and toxicity].
    Praxis, 1997, Mar-25, Volume: 86, Issue:13

    Topics: Chromatography, High Pressure Liquid; Gas Chromatography-Mass Spectrometry; Hallucinogens; Humans; N

1997
Sorted.
    Accident and emergency nursing, 1997, Volume: 5, Issue:2

    Topics: Adolescent; Adult; Emergency Nursing; Hallucinogens; Humans; Illicit Drugs; N-Methyl-3,4-methylenedi

1997
ABC of mental health. Addiction and dependence--I: Illicit drugs.
    BMJ (Clinical research ed.), 1997, Aug-02, Volume: 315, Issue:7103

    Topics: Amphetamines; Benzodiazepines; Cocaine; Humans; Illicit Drugs; N-Methyl-3,4-methylenedioxyamphetamin

1997
[Ecstasy: a pharmacological review].
    Revista de saude publica, 1998, Volume: 32, Issue:5

    Topics: Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related Disorders

1998
[Poisoning with amphetamines and designer drugs].
    Der Internist, 1999, Volume: 40, Issue:6

    Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Designer Drugs; Drug Overdose; Humans; Illicit Drugs; I

1999
Ten years of 'ecstasy'.
    Journal of the Royal Society of Medicine, 1999, Volume: 92, Issue:2

    Topics: Adolescent; Adult; Female; Heat Stroke; History, 20th Century; Humans; Illicit Drugs; Liver Failure;

1999
Recreational drug misuse: issues for the cardiologist.
    Heart (British Cardiac Society), 2000, Volume: 83, Issue:6

    Topics: Adolescent; Adult; Amphetamines; Cannabis; Cardiovascular Diseases; Child; Cocaine; Drug Overdose; F

2000
Metabolic consequences of drug misuse.
    British journal of anaesthesia, 2000, Volume: 85, Issue:1

    Topics: Cocaine-Related Disorders; Delirium; Fever; Heroin Dependence; Humans; Hyponatremia; N-Methyl-3,4-me

2000
[Emergencies due to drug abuse].
    Der Internist, 2000, Volume: 41, Issue:9

    Topics: Adrenergic Uptake Inhibitors; Amphetamine; Cocaine; Diagnosis, Differential; Emergency Treatment; Ge

2000
Investigating the neurocognitive deficits associated with chronic drug misuse.
    Current opinion in neurobiology, 2001, Volume: 11, Issue:2

    Topics: Animals; Chronic Disease; Cocaine-Related Disorders; Cognition Disorders; Humans; Marijuana Abuse; N

2001
Party-drugs: sociocultural and individual background and risks.
    International journal of clinical pharmacology and therapeutics, 2001, Volume: 39, Issue:8

    Topics: Adolescent; Adolescent Behavior; Adult; Designer Drugs; Female; Germany; Hallucinogens; Humans; Male

2001
3,4-methylenedioxymethamphetamine (MDMA): a review.
    Current psychiatry reports, 2001, Volume: 3, Issue:6

    Topics: Brain; Depression; Hallucinogens; Humans; Malignant Hyperthermia; N-Methyl-3,4-methylenedioxyampheta

2001
How strong is the evidence that brain serotonin neurons are damaged in human users of ecstasy?
    Pharmacology, biochemistry, and behavior, 2002, Volume: 71, Issue:4

    Topics: Brain; Brain Chemistry; Chronic Disease; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetami

2002
Acid House and Thatcherism: noise, the mob, and the English countryside.
    The British journal of sociology, 2002, Volume: 53, Issue:1

    Topics: Adolescent; Civil Disorders; England; Humans; Music; N-Methyl-3,4-methylenedioxyamphetamine; Politic

2002
[Adverse renal effects of legal and illicit drugs].
    Therapeutische Umschau. Revue therapeutique, 2002, Volume: 59, Issue:3

    Topics: Acute Kidney Injury; Adolescent; Adult; Alcoholism; Amphetamines; Anti-Anxiety Agents; Benzodiazepin

2002
MDMA ('ecstasy') and other 'club drugs'. The new epidemic.
    Pediatric clinics of North America, 2002, Volume: 49, Issue:2

    Topics: Adolescent; Adolescent Behavior; Adult; Disease Outbreaks; Hallucinogens; Humans; N-Methyl-3,4-methy

2002
Surviving fulminant hepatic failure.
    The American journal of nursing, 2002, Volume: Suppl

    Topics: Acute Disease; Adolescent; Anuria; Critical Care; Diagnosis, Differential; Female; Graft Rejection;

2002
Club drugs: methylenedioxymethamphetamine, flunitrazepam, ketamine hydrochloride, and gamma-hydroxybutyrate.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2002, Jun-01, Volume: 59, Issue:11

    Topics: Flunitrazepam; Humans; Illicit Drugs; Ketamine; N-Methyl-3,4-methylenedioxyamphetamine; Sodium Oxyba

2002
[Chronic neurotoxic damage in ecstasy (MDMA) users. Review of the current state of research].
    Der Nervenarzt, 2002, Volume: 73, Issue:5

    Topics: Animals; Brain; Brain Damage, Chronic; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Psychoses, Su

2002
[MDMA ("ecstasy"): a currently used drug in Spain].
    Revista clinica espanola, 1991, Volume: 188, Issue:2

    Topics: 3,4-Methylenedioxyamphetamine; Chemical Phenomena; Chemistry; Designer Drugs; Humans; N-Methyl-3,4-m

1991
["Ecstasy" and "ice": the return of the amphetamines].
    Harefuah, 1991, Jun-16, Volume: 120, Issue:12

    Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Designer Drugs; Humans; N-Methyl-3,4-methylene

1991
Toxicity of MDA (3,4-methylenedioxyamphetamine) considered for relevance to hazards of MDMA (Ecstasy) abuse.
    Alcohol and drug research, 1987, Volume: 7, Issue:3

    Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Humans; Lethal Dose 50; N-Methyl-3,4-methylene

1987
Biological evaluation of compounds for their physical dependence potential and abuse liability. X. Drug testing programs of the Committee on Problems of Drug Dependence, Inc. (1986).
    NIDA research monograph, 1987, Volume: 76

    Topics: 3,4-Methylenedioxyamphetamine; Animals; Appetite Depressants; Bridged-Ring Compounds; Chemical Pheno

1987

Trials

28 trials available for n-methyl-3,4-methylenedioxyamphetamine and Chemical Dependence

ArticleYear
The effects of MDMA-assisted therapy on alcohol and substance use in a phase 3 trial for treatment of severe PTSD.
    Drug and alcohol dependence, 2022, 04-01, Volume: 233

    Topics: Adult; Alcoholism; Combined Modality Therapy; Ethanol; Humans; N-Methyl-3,4-methylenedioxyamphetamin

2022
Cluster randomised controlled trial of an online intervention to prevent ecstasy and new psychoactive substance use among adolescents: final results and implications for implementation.
    BMJ open, 2018, 11-25, Volume: 8, Issue:11

    Topics: Adolescent; Adolescent Behavior; Australia; Cluster Analysis; Female; Health Knowledge, Attitudes, P

2018
Electrophysiological evidence of atypical processing underlying mental set shifting in ecstasy polydrug and polydrug users.
    Experimental and clinical psychopharmacology, 2013, Volume: 21, Issue:6

    Topics: Adult; Analysis of Variance; Attention; Central Nervous System Stimulants; Cognition Disorders; Elec

2013
A cluster randomised controlled trial of the Climate Schools: Ecstasy and Emerging Drugs Module in Australian secondary schools: study protocol.
    BMC public health, 2013, Dec-12, Volume: 13

    Topics: Adolescent; Australia; Female; Humans; Illicit Drugs; Male; N-Methyl-3,4-methylenedioxyamphetamine;

2013
A window into the intoxicated mind? Speech as an index of psychoactive drug effects.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2014, Volume: 39, Issue:10

    Topics: Adolescent; Adult; Artificial Intelligence; Double-Blind Method; Female; Humans; Illicit Drugs; Male

2014
No evidence that MDMA-induced enhancement of emotional empathy is related to peripheral oxytocin levels or 5-HT1a receptor activation.
    PloS one, 2014, Volume: 9, Issue:6

    Topics: Adolescent; Adult; Emotions; Empathy; Female; Humans; Interpersonal Relations; Male; N-Methyl-3,4-me

2014
Brief interventions to reduce Ecstasy use: a multi-site randomized controlled trial.
    Behavior therapy, 2014, Volume: 45, Issue:6

    Topics: Female; Health Education; Humans; Internet; Male; Motivation; Motivational Interviewing; N-Methyl-3,

2014
Effectiveness of a universal internet-based prevention program for ecstasy and new psychoactive substances: a cluster randomized controlled trial.
    Addiction (Abingdon, England), 2016, Volume: 111, Issue:8

    Topics: Adolescent; Adolescent Behavior; Australia; Female; Health Knowledge, Attitudes, Practice; Humans; I

2016
Disrupted 'reflection' impulsivity in cannabis users but not current or former ecstasy users.
    Journal of psychopharmacology (Oxford, England), 2009, Volume: 23, Issue:1

    Topics: Adult; Demography; Disruptive, Impulse Control, and Conduct Disorders; Female; Hallucinogens; Humans

2009
Avoiding counterproductive results: an experimental pretest of a harm reduction intervention on attitude toward party drugs among users and nonusers.
    Substance use & misuse, 2009, Volume: 44, Issue:4

    Topics: Adolescent; Adult; Analysis of Variance; Attitude to Health; Female; Harm Reduction; Health Educatio

2009
Equivalent effects of acute tryptophan depletion on REM sleep in ecstasy users and controls.
    Psychopharmacology, 2009, Volume: 206, Issue:2

    Topics: Adult; Cross-Over Studies; Double-Blind Method; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyam

2009
Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study.
    Journal of psychopharmacology (Oxford, England), 2013, Volume: 27, Issue:1

    Topics: Adult; Female; Follow-Up Studies; Humans; Illicit Drugs; Male; N-Methyl-3,4-methylenedioxyamphetamin

2013
Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study.
    Journal of psychopharmacology (Oxford, England), 2013, Volume: 27, Issue:1

    Topics: Adult; Female; Follow-Up Studies; Humans; Illicit Drugs; Male; N-Methyl-3,4-methylenedioxyamphetamin

2013
Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study.
    Journal of psychopharmacology (Oxford, England), 2013, Volume: 27, Issue:1

    Topics: Adult; Female; Follow-Up Studies; Humans; Illicit Drugs; Male; N-Methyl-3,4-methylenedioxyamphetamin

2013
Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study.
    Journal of psychopharmacology (Oxford, England), 2013, Volume: 27, Issue:1

    Topics: Adult; Female; Follow-Up Studies; Humans; Illicit Drugs; Male; N-Methyl-3,4-methylenedioxyamphetamin

2013
Effects of (+/-) 3,4-methylene-dioxymethamphetamine (ecstasy) on dopamine system function in humans.
    Behavioural brain research, 2002, Aug-21, Volume: 134, Issue:1-2

    Topics: Adolescent; Adult; Aggression; Bromocriptine; Depressive Disorder; Dopamine; Dopamine Agonists; Dopa

2002
Ecstasy and drug consumption patterns: a Canadian rave population study.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2002, Volume: 47, Issue:6

    Topics: Canada; Drug Administration Schedule; Hallucinogens; Humans; Incidence; N-Methyl-3,4-methylenedioxya

2002
Saccadic peak velocity and EEG as end-points for a serotonergic challenge test.
    Human psychopharmacology, 2002, Volume: 17, Issue:2

    Topics: Adolescent; Adult; Cross-Over Studies; Dexfenfluramine; Dose-Response Relationship, Drug; Double-Bli

2002
Angry cognitive bias, trait aggression and impulsivity in substance users.
    Psychopharmacology, 2004, Volume: 171, Issue:3

    Topics: Aggression; Analysis of Variance; Anger; Cognition; Double-Blind Method; Humans; Impulsive Behavior;

2004
Neural correlates of working memory in pure and polyvalent ecstasy (MDMA) users.
    Neuroreport, 2003, Oct-27, Volume: 14, Issue:15

    Topics: Adult; Amphetamine; Brain; Central Nervous System Stimulants; Cognition; Female; Hallucinogens; Huma

2003
Neural mechanisms of working memory in ecstasy (MDMA) users who continue or discontinue ecstasy and amphetamine use: evidence from an 18-month longitudinal functional magnetic resonance imaging study.
    Biological psychiatry, 2004, Sep-01, Volume: 56, Issue:5

    Topics: Adult; Amphetamine; Cannabis; Central Nervous System Stimulants; Cerebral Cortex; Dose-Response Rela

2004
Pattern of cannabis use in ecstasy polydrug users: moderate cannabis use may compensate for self-rated aggression and somatic symptoms.
    Human psychopharmacology, 2005, Volume: 20, Issue:4

    Topics: Adult; Aggression; Alcohol Drinking; Cognition Disorders; Drug Interactions; Family; Female; Humans;

2005
Neuropsychiatric alterations in MDMA users: preliminary findings.
    Annals of the New York Academy of Sciences, 2005, Volume: 1053

    Topics: Adult; Cerebrovascular Circulation; Electroencephalography; Female; Hallucinogens; Humans; Male; Mar

2005
An evaluation of a brief motivational intervention among young ecstasy and cocaine users: no effect on substance and alcohol use outcomes.
    Addiction (Abingdon, England), 2006, Volume: 101, Issue:7

    Topics: Adolescent; Adult; Alcohol Drinking; Behavior Therapy; Cocaine-Related Disorders; England; Female; H

2006
An extended nondrug MDMA-like experience evoked through posthypnotic suggestion.
    Journal of psychoactive drugs, 2006, Volume: 38, Issue:3

    Topics: Adult; Aged; Female; Hallucinogens; Humans; Hypnosis; Male; Middle Aged; N-Methyl-3,4-methylenedioxy

2006
Prospective memory impairment in "ecstasy" (MDMA) users.
    Psychopharmacology, 2007, Volume: 194, Issue:4

    Topics: Adult; Analysis of Variance; Female; Humans; Male; Marijuana Abuse; Memory Disorders; N-Methyl-3,4-m

2007
Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 1998, Volume: 19, Issue:4

    Topics: Adult; Affect; Cognition; Female; Hallucinogens; Humans; Impulsive Behavior; Male; N-Methyl-3,4-meth

1998
[Pregnancy outcome after ecstasy use; 43 cases followed by the Teratology Information Service of the National Institute for Public Health and Environment (RIVM)].
    Nederlands tijdschrift voor geneeskunde, 1999, Jan-02, Volume: 143, Issue:1

    Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Adolescent; Adult; Female; Follow-Up Studies; Ha

1999
Patterns of drug use among young men in Piedmont (Italy).
    Drug and alcohol dependence, 2001, Nov-01, Volume: 64, Issue:3

    Topics: Adolescent; Confidence Intervals; Cross-Sectional Studies; Hallucinogens; Humans; Italy; Male; Milit

2001
Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug.
    Journal of psychopharmacology (Oxford, England), 2001, Volume: 15, Issue:4

    Topics: Adult; Cognition Disorders; Female; Hallucinogens; Humans; Male; Memory, Short-Term; Mental Disorder

2001
Second thoughts on 3,4-methylenedioxymethamphetamine (MDMA) neurotoxicity.
    Archives of general psychiatry, 1990, Volume: 47, Issue:3

    Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Clinical Trials as Topic; Designer Drugs; Huma

1990

Other Studies

720 other studies available for n-methyl-3,4-methylenedioxyamphetamine and Chemical Dependence

ArticleYear
Drug use, harm-reduction practices and attitudes toward the utilisation of drug safety testing services in an Irish cohort of festival-goers.
    Irish journal of medical science, 2022, Volume: 191, Issue:4

    Topics: Adolescent; Adult; Attitude; Harm Reduction; Holidays; Humans; Illicit Drugs; Middle Aged; Music; N-

2022
Self-reported PTSD is associated with increased use of MDMA in adolescents with substance use disorders.
    European journal of psychotraumatology, 2021, Volume: 12, Issue:1

    Topics: Adolescent; Diagnosis, Dual (Psychiatry); Germany; Hallucinogens; Humans; N-Methyl-3,4-methylenediox

2021
Toward a typology of hallucinogen users in the United States.
    Drug and alcohol dependence, 2021, 12-01, Volume: 229, Issue:Pt B

    Topics: Adolescent; Adult; Hallucinogens; Humans; Logistic Models; Male; N-Methyl-3,4-methylenedioxyamphetam

2021
Changes in and correlates of Australian public attitudes toward illicit drug use.
    Drug and alcohol review, 2022, Volume: 41, Issue:5

    Topics: Australia; Cannabis; Cocaine; Hallucinogens; Heroin; Humans; Illicit Drugs; Methamphetamine; N-Methy

2022
MDMA/ecstasy use and psilocybin use are associated with lowered odds of psychological distress and suicidal thoughts in a sample of US adults.
    Journal of psychopharmacology (Oxford, England), 2022, Volume: 36, Issue:1

    Topics: Adolescent; Adult; Aged; Female; Hallucinogens; Health Surveys; Humans; Lysergic Acid Diethylamide;

2022
Lifetime use of MDMA/ecstasy and psilocybin is associated with reduced odds of major depressive episodes.
    Journal of psychopharmacology (Oxford, England), 2022, Volume: 36, Issue:1

    Topics: Adolescent; Adult; Aged; Depressive Disorder, Major; Female; Hallucinogens; Health Surveys; Humans;

2022
Qualitative Screening of Amphetamine- and Ketamine-Type Abuse Drugs in Urine Employing Dual Mode Extraction Column by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS-MS).
    Journal of analytical toxicology, 2023, Jan-24, Volume: 46, Issue:9

    Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Chromatography, Liquid; Ephedrine; Humans; Illicit Drugs

2023
[Fatal serotonin syndrome induced by ecstasy consumption].
    Revue medicale de Liege, 2022, Volume: 77, Issue:1

    Topics: Adult; Emergency Service, Hospital; Fever; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Ser

2022
Analysis of recreational psychedelic substance use experiences classified by substance.
    Psychopharmacology, 2022, Volume: 239, Issue:2

    Topics: Hallucinogens; Humans; Lysergic Acid Diethylamide; N-Methyl-3,4-methylenedioxyamphetamine; Psilocybi

2022
Concerts, bars, parties, and raves: Differential risk for drug use among high school seniors according to venue attendance.
    Substance abuse, 2022, Volume: 43, Issue:1

    Topics: Adolescent; Central Nervous System Stimulants; Cocaine; Ethanol; Humans; Methamphetamine; N-Methyl-3

2022
A qualitative investigation exploring why dance festivals are risky environments for drug use and potential adverse outcomes.
    Harm reduction journal, 2022, 02-05, Volume: 19, Issue:1

    Topics: Dancing; Holidays; Humans; Illicit Drugs; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related

2022
Recreational drug use and prospective memory.
    Psychopharmacology, 2022, Volume: 239, Issue:3

    Topics: Female; Humans; Memory Disorders; Memory, Episodic; N-Methyl-3,4-methylenedioxyamphetamine; Neuropsy

2022
Injecting drug use opportunities and reasons for choosing not to inject: A population-based study of Australian young adults who use stimulants.
    Drug and alcohol review, 2022, Volume: 41, Issue:4

    Topics: Australia; Central Nervous System Stimulants; Female; Humans; Male; Methamphetamine; N-Methyl-3,4-me

2022
Survey of substance use among adolescent drug offenders referred from juvenile courts in Taiwan: Clinical epidemiology of single versus multiple illicit substance use.
    Journal of the Formosan Medical Association = Taiwan yi zhi, 2022, Volume: 121, Issue:11

    Topics: Adolescent; Criminals; Depressive Disorder, Major; Humans; Illicit Drugs; Ketamine; Methamphetamine;

2022
Use of illicit drugs, alcohol and tobacco in Spain and Portugal during the COVID-19 crisis in 2020 as measured by wastewater-based epidemiology.
    The Science of the total environment, 2022, Aug-25, Volume: 836

    Topics: Amphetamine; Cocaine; Communicable Disease Control; COVID-19; Humans; Illicit Drugs; Methamphetamine

2022
Long-term monitoring of drug consumption patterns during the COVID-19 pandemic in a small-sized community in Brazil through wastewater-based epidemiology.
    Chemosphere, 2022, Volume: 302

    Topics: Amphetamine; Brazil; Caffeine; Cocaine; COVID-19; Dronabinol; Humans; Illicit Drugs; N-Methyl-3,4-me

2022
Changes in substance use among HIV-negative MSM: A longitudinal analysis, 1995-2019.
    The International journal on drug policy, 2022, Volume: 106

    Topics: Cannabis; Cocaine; Cohort Studies; HIV Infections; Homosexuality, Male; Humans; Male; N-Methyl-3,4-m

2022
Risky Sexual Practices, Sexually Transmitted Infections, Motivations, and Mental Health among Heterosexual Women and Men Who Practice Sexualized Drug Use in Spain.
    International journal of environmental research and public health, 2022, 05-24, Volume: 19, Issue:11

    Topics: Adolescent; Adult; Aged; Cross-Sectional Studies; Female; Heterosexuality; HIV Infections; Homosexua

2022
Illicit drug consumption estimated using wastewater analysis and compared by settlement size in New Zealand.
    The Science of the total environment, 2022, Oct-15, Volume: 843

    Topics: Chromatography, Liquid; Cocaine; Fentanyl; Heroin; Humans; Illicit Drugs; Methamphetamine; N-Methyl-

2022
Common opioids and stimulants in autopsy and DUID cases: A comparison of measured concentrations.
    Forensic science international, 2022, Volume: 338

    Topics: Amphetamine; Analgesics, Opioid; Autopsy; Central Nervous System Stimulants; Cocaine; Coma; Heroin;

2022
[Impact of the COVID-19 pandemic on recreational drug intoxications].
    Nederlands tijdschrift voor geneeskunde, 2022, 07-06, Volume: 166

    Topics: Adolescent; Cocaine; Communicable Disease Control; COVID-19; Dronabinol; Emergency Service, Hospital

2022
Adolescent and adult time trends in US hallucinogen use, 2002-19: any use, and use of ecstasy, LSD and PCP.
    Addiction (Abingdon, England), 2022, Volume: 117, Issue:12

    Topics: Adolescent; Adult; Cross-Sectional Studies; Hallucinogens; Humans; Lysergic Acid Diethylamide; N-Met

2022
Recreational drug toxicity with severe hyperthermia: Rapid onsite treatment and clinical course.
    The American journal of emergency medicine, 2022, Volume: 62

    Topics: Central Nervous System Stimulants; Holidays; Humans; Hyperthermia; Hyperthermia, Induced; Illicit Dr

2022
Coping motives mediate the relationship between PTSD and MDMA use in adolescents with substance use disorders.
    Addiction science & clinical practice, 2022, 09-04, Volume: 17, Issue:1

    Topics: Adaptation, Psychological; Adolescent; Female; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine;

2022
Wastewater-based monitoring of illicit drugs in Cyprus by UPLC-MS/MS: The impact of the COVID-19 pandemic.
    The Science of the total environment, 2023, Jan-01, Volume: 854

    Topics: Amphetamine; Chromatography, Liquid; Cocaine; Communicable Disease Control; COVID-19; Cyprus; Humans

2023
Pooled Urine Analysis at a Belgian Music Festival: Trends in Alcohol Consumption and Recreational Drug Use.
    Prehospital and disaster medicine, 2022, Volume: 37, Issue:6

    Topics: Alcohol Drinking; Belgium; Cocaine; Cross-Sectional Studies; Ethanol; Holidays; Humans; Illicit Drug

2022
Triangulating Amsterdam's illicit stimulant use trends by wastewater analysis and recreational drug use monitoring.
    Forensic science international, 2022, Volume: 340

    Topics: Amphetamines; Central Nervous System Stimulants; Cocaine; Humans; Illicit Drugs; Methamphetamine; N-

2022
Associations between MDMA/ecstasy use and physical health in a U.S. population-based survey sample.
    Journal of psychopharmacology (Oxford, England), 2022, Volume: 36, Issue:10

    Topics: Adult; Diabetes Mellitus; Hallucinogens; Humans; Hypertension; N-Methyl-3,4-methylenedioxyamphetamin

2022
Methylone pre-exposure differentially impacts the aversive effects of MDPV and MDMA in male and female Sprague-Dawley rats: Implications for abuse vulnerability.
    Pharmacology, biochemistry, and behavior, 2022, Volume: 220

    Topics: Animals; Benzodioxoles; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Female;

2022
Sexualized drug use among men who have sex with men in Madrid and Barcelona: The gateway to new drug use?
    Frontiers in public health, 2022, Volume: 10

    Topics: Adult; Child, Preschool; HIV Infections; Homosexuality, Male; Humans; Male; Methamphetamine; N-Methy

2022
Sexualized drug use among men who have sex with men in Madrid and Barcelona: The gateway to new drug use?
    Frontiers in public health, 2022, Volume: 10

    Topics: Adult; Child, Preschool; HIV Infections; Homosexuality, Male; Humans; Male; Methamphetamine; N-Methy

2022
Sexualized drug use among men who have sex with men in Madrid and Barcelona: The gateway to new drug use?
    Frontiers in public health, 2022, Volume: 10

    Topics: Adult; Child, Preschool; HIV Infections; Homosexuality, Male; Humans; Male; Methamphetamine; N-Methy

2022
Sexualized drug use among men who have sex with men in Madrid and Barcelona: The gateway to new drug use?
    Frontiers in public health, 2022, Volume: 10

    Topics: Adult; Child, Preschool; HIV Infections; Homosexuality, Male; Humans; Male; Methamphetamine; N-Methy

2022
Encounters with police drug detection dogs at music festivals amongst people who regularly use ecstasy and/or other illicit stimulants in Australia.
    Drug and alcohol review, 2023, Volume: 42, Issue:3

    Topics: Animals; Australia; Central Nervous System Stimulants; Dogs; Holidays; Humans; Music; N-Methyl-3,4-m

2023
Substance Use and Attendance Motives of Electronic Dance Music (EDM) Event Attendees: A Survey Study.
    International journal of environmental research and public health, 2023, 01-19, Volume: 20, Issue:3

    Topics: Adult; Child, Preschool; Dancing; Ethanol; Female; Hallucinogens; Humans; Illicit Drugs; Male; Music

2023
Long-term wastewater-based surveillance and impacts of the COVID-19 pandemic on drug use trends in a U.S. Northeast rural town.
    The Science of the total environment, 2023, Jun-15, Volume: 877

    Topics: Amphetamine; Cocaine; COVID-19; Fentanyl; Humans; Hydrocodone; Methadone; N-Methyl-3,4-methylenediox

2023
First results of the French OCTOPUS survey among festival attendees: a latent class analysis.
    Harm reduction journal, 2023, 03-29, Volume: 20, Issue:1

    Topics: Cocaine; Cross-Sectional Studies; Holidays; Humans; Ketamine; Latent Class Analysis; N-Methyl-3,4-me

2023
Adverse drug effects as a deterrent against willingness to use in the future among nightclub/festival attendees.
    Drug and alcohol review, 2023, Volume: 42, Issue:6

    Topics: Adult; Drug-Related Side Effects and Adverse Reactions; Holidays; Humans; Illicit Drugs; Ketamine; M

2023
Abrupt peaks in perceived risk of occasional drug use after changing the question order in a repeated self-administered survey.
    Frontiers in public health, 2023, Volume: 11

    Topics: Adolescent; Affect; Cannabis; Cocaine; Heroin; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Subst

2023
Tusi: a new ketamine concoction complicating the drug landscape.
    The American journal of drug and alcohol abuse, 2023, Sep-03, Volume: 49, Issue:5

    Topics: Cocaine; Hallucinogens; Humans; Ketamine; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; S

2023
Identifying early intervention opportunities for illicit stimulant use: A cross-sectional study of factors associated with illicit stimulant use among young people accessing integrated youth services in British Columbia, Canada.
    Journal of substance use and addiction treatment, 2023, Volume: 151

    Topics: Adolescent; Amphetamines; British Columbia; Cocaine; Cross-Sectional Studies; Female; Gender Identit

2023
Assessing the impact of a major electronic music festival on the consumption patterns of illicit and licit psychoactive substances in a Mediterranean city using wastewater analysis.
    The Science of the total environment, 2023, Sep-20, Volume: 892

    Topics: Amphetamine; Analgesics, Opioid; Cocaine; Ethanol; Heroin; Holidays; Humans; Illicit Drugs; Music; N

2023
What Do Young Adults Expect from the Recreational Use of Ecstasy (3,4-Methylenedioxymethamphetamine/Molly)? A Latent Class Analysis of a Convenience Sample of Dutch Young Adults.
    European addiction research, 2023, Volume: 29, Issue:3

    Topics: Adolescent; Animals; Ethnicity; Female; Humans; Latent Class Analysis; Male; N-Methyl-3,4-methylened

2023
COVID-19-Related Shifts in Polysubstance Use.
    Substance use & misuse, 2023, Volume: 58, Issue:11

    Topics: Communicable Disease Control; COVID-19; Female; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Pand

2023
Festivals following the easing of COVID-19 restrictions: Prevalence of new psychoactive substances and illicit drugs.
    Environment international, 2023, Volume: 178

    Topics: Cocaine; COVID-19; Heroin; Holidays; Humans; Illicit Drugs; N-Methyl-3,4-methylenedioxyamphetamine;

2023
Concomitant Drug Use among Opioid-Dependent Patients with and without Attention Deficit Hyperactivity Disorder: Does Methylphenidate Merit a Trial?
    European addiction research, 2023, Volume: 29, Issue:5

    Topics: Amphetamine; Analgesics, Opioid; Attention Deficit Disorder with Hyperactivity; Central Nervous Syst

2023
Substance use, harm reduction attitudes and behaviors among attendees of nature rave parties in Israel.
    Harm reduction journal, 2023, 08-09, Volume: 20, Issue:1

    Topics: Attitude; Cross-Sectional Studies; Female; Harm Reduction; Humans; Illicit Drugs; Israel; Male; N-Me

2023
Effects of ambient temperature on locomotor activity and place conditioning elicited by abused psychostimulants in mice: Role of 3,4-methylenedioxy moiety.
    Drug and alcohol dependence, 2023, 09-01, Volume: 250

    Topics: Animals; Central Nervous System Stimulants; Conditioning, Operant; Disease Models, Animal; Dose-Resp

2023
Early onset Parkinson's disease in the cycle of 3,4-methylenedioxymethamphetamine and substance use: a case report.
    Journal of medical case reports, 2023, Sep-23, Volume: 17, Issue:1

    Topics: Adult; Dopamine; Humans; Male; Methamphetamine; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine;

2023
Trends in drivers testing positive for drugs of abuse in oral fluid from 2018 to 2021 in France.
    Forensic science international, 2023, Volume: 352

    Topics: Adolescent; Adult; Aged; Amphetamine; Automobile Driving; Cannabinoid Receptor Agonists; Chromatogra

2023
Substance use and variation in sexual partnership rates among young MSM and young transgender women: Disaggregating between and within-person associations.
    Drug and alcohol dependence, 2023, 11-01, Volume: 252

    Topics: Cocaine; Female; HIV Infections; Homosexuality, Male; Humans; Male; Methamphetamine; N-Methyl-3,4-me

2023
Mix of new substances psychoactive, NPS, found in blotters sold in two Colombian cities.
    Forensic science international, 2019, Volume: 304

    Topics: Administration, Sublingual; Colombia; Designer Drugs; Dimethoxyphenylethylamine; DOM 2,5-Dimethoxy-4

2019
Development of an addiction index and delineation 15-year trends of illicit drugs from the Taiwan national drug enhancement database.
    Journal of psychiatric research, 2020, Volume: 120

    Topics: Amphetamine-Related Disorders; Anesthetics, Dissociative; Cannabis; Central Nervous System Stimulant

2020
[High-risk drug use: epidemiological pattern through hair testing in the forensic context].
    Revista espanola de salud publica, 2019, Nov-26, Volume: 93

    Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Adult; Amphetamine; Cannabinoids; Cocaine; Cross-Sectiona

2019
Polysubstance use patterns and novel synthetics: A cluster analysis from three U.S. cities.
    PloS one, 2019, Volume: 14, Issue:12

    Topics: Cannabis; Cities; Cluster Analysis; Cocaine; Female; Heroin; Humans; Illicit Drugs; Male; N-Methyl-3

2019
A Retrospective of Prevalence of Drugs of Abuse by Hair Analysis in Shanghai using LC-MS-MS.
    Journal of analytical toxicology, 2020, Apr-02, Volume: 44, Issue:5

    Topics: 3,4-Methylenedioxyamphetamine; Adult; Amphetamines; Central Nervous System Stimulants; China; Chroma

2020
Trends in drug use among electronic dance music party attendees in New York City, 2016-2019.
    Drug and alcohol dependence, 2020, 04-01, Volume: 209

    Topics: Adolescent; Adult; Cross-Sectional Studies; Dancing; Female; Hallucinogens; Humans; Illicit Drugs; M

2020
High ambient temperature increases the toxicity and lethality of 3,4-methylenedioxymethamphetamine and methcathinone.
    Pharmacology, biochemistry, and behavior, 2020, Volume: 192

    Topics: Ammonia; Animals; Brain; Central Nervous System Stimulants; Disease Models, Animal; Female; Glutamic

2020
Nothing Ventured, Nothing Gained: Regulations Cripple Potentially Life-Saving Research of Illicit Substances.
    ACS chemical neuroscience, 2020, 05-20, Volume: 11, Issue:10

    Topics: Hallucinogens; Humans; Lysergic Acid Diethylamide; N-Methyl-3,4-methylenedioxyamphetamine; Psilocybi

2020
Comparing ecstasy users and non-users in a population-based and co-twin control design across multiple traits.
    Addictive behaviors, 2020, Volume: 108

    Topics: Adolescent; Adult; Educational Status; Female; Hallucinogens; Humans; Male; Middle Aged; N-Methyl-3,

2020
Sexual Risk Behaviors among African Americans Who Use MDMA (Molly/Ecstasy): Implications for HIV Prevention.
    Social work in public health, 2020, 06-01, Volume: 35, Issue:5

    Topics: Black or African American; HIV Infections; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Risk-Taki

2020
"How do online and offline sampling compare in a multinational study of drug use and nightlife behaviour?"
    The International journal on drug policy, 2020, Volume: 82

    Topics: Drug Users; Europe; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Pharmaceutical Preparations; Sub

2020
Diffusion of Ecstasy in the Electronic Dance Music Scene.
    Substance use & misuse, 2020, Volume: 55, Issue:13

    Topics: Adult; Dancing; Electronics; Female; Humans; Illicit Drugs; Music; N-Methyl-3,4-methylenedioxyamphet

2020
Patterns of ecstasy use amongst live music event attendees and their opinions on pill testing: a cross sectional study.
    Substance abuse treatment, prevention, and policy, 2020, 08-05, Volume: 15, Issue:1

    Topics: Adolescent; Adult; Australia; Cross-Sectional Studies; Drug Contamination; Female; Humans; Illicit D

2020
Shifts in Unintentional Exposure to Drugs Among People Who Use Ecstasy in the Electronic Dance Music Scene, 2016-2019.
    The American journal on addictions, 2021, Volume: 30, Issue:1

    Topics: Adult; Dancing; Drug Contamination; Female; Hair Analysis; Harm Reduction; Humans; Illicit Drugs; In

2021
Virtual raves and happy hours during COVID-19: New drug use contexts for electronic dance music partygoers.
    The International journal on drug policy, 2021, Volume: 93

    Topics: Adult; COVID-19; Dancing; Electronics; Humans; Illicit Drugs; Music; N-Methyl-3,4-methylenedioxyamph

2021
What is the drug of choice of young festivalgoers?
    Drug and alcohol dependence, 2020, 11-01, Volume: 216

    Topics: 3,4-Methylenedioxyamphetamine; Australia; Cocaine; Hallucinogens; Holidays; Humans; Illicit Drugs; M

2020
MDMA Use by Paris Medical Students: Prevalence and Characteristics.
    Substance use & misuse, 2021, Volume: 56, Issue:1

    Topics: Adolescent; Aged; Cross-Sectional Studies; Europe; France; Humans; Male; N-Methyl-3,4-methylenedioxy

2021
Developing a new national MDMA policy: Results of a multi-decision multi-criterion decision analysis.
    Journal of psychopharmacology (Oxford, England), 2021, Volume: 35, Issue:5

    Topics: Crime; Decision Support Techniques; Hallucinogens; Health Policy; Humans; N-Methyl-3,4-methylenediox

2021
Ketamine Use Among People Who Regularly Use Ecstasy and Other Illicit Stimulants in Australia: Trends and Characteristics of Use, 2009-2019.
    Journal of studies on alcohol and drugs, 2021, Volume: 82, Issue:2

    Topics: Adult; Australia; Central Nervous System Stimulants; Cross-Sectional Studies; Female; Harm Reduction

2021
Equasy revisited.
    Journal of psychopharmacology (Oxford, England), 2021, Volume: 35, Issue:5

    Topics: Humans; N-Methyl-3,4-methylenedioxyamphetamine; Psychotherapy; Substance-Related Disorders

2021
Illicit Drug Use and Associated Problems in the Nightlife Scene: A Potential Setting for Prevention.
    International journal of environmental research and public health, 2021, 04-30, Volume: 18, Issue:9

    Topics: Adolescent; Adult; Hallucinogens; Humans; Illicit Drugs; N-Methyl-3,4-methylenedioxyamphetamine; Sub

2021
Visitors of the Dutch drug checking services: Profile and drug use experience.
    The International journal on drug policy, 2021, Volume: 95

    Topics: Drug Contamination; Humans; Illicit Drugs; Male; N-Methyl-3,4-methylenedioxyamphetamine; Netherlands

2021
Neuroscience literacy and substance use prevention: How well do young people understand their brain?
    Health promotion journal of Australia : official journal of Australian Association of Health Promotion Professionals, 2022, Volume: 33, Issue:2

    Topics: Adolescent; Adult; Brain; Female; Harm Reduction; Humans; Literacy; Male; N-Methyl-3,4-methylenediox

2022
Verbal behavior related to drug reinforcement in polysubstance cannabis users: Comparison across drugs.
    Experimental and clinical psychopharmacology, 2022, Volume: 30, Issue:2

    Topics: Cannabis; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related Disorders

2022
Out of the night-time and into the day: Ketamine and MDMA as therapies for mental disorders.
    The Australian and New Zealand journal of psychiatry, 2021, Volume: 55, Issue:8

    Topics: Hallucinogens; Humans; Ketamine; Mental Disorders; Methamphetamine; N-Methyl-3,4-methylenedioxyamphe

2021
Hair Testing for Drugs of Abuse and New Psychoactive Substances in a High-Risk Population.
    Journal of analytical toxicology, 2017, Jun-01, Volume: 41, Issue:5

    Topics: Cyclohexanones; Cyclohexylamines; Hair; Humans; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methyle

2017
Psychomotor Tremor and Proprioceptive Control Problems in Current and Former Stimulant Drug Users: An Accelerometer Study of Heavy Users of Amphetamine, MDMA, and Other Recreational Stimulants.
    Journal of clinical pharmacology, 2017, Volume: 57, Issue:10

    Topics: Accelerometry; Adult; Amphetamine; Arm; Central Nervous System Stimulants; Drug Users; Female; Human

2017
Updating of working memory in ecstasy polydrug users: Findings from fNIRS.
    Human psychopharmacology, 2017, Volume: 32, Issue:3

    Topics: Adolescent; Adult; Cerebral Cortex; Drug Users; Female; Humans; Illicit Drugs; Male; Memory, Short-T

2017
The effects of using answer sheets on reported drug use and data quality in a classroom survey: A cluster-randomized study.
    Drug and alcohol dependence, 2017, 09-01, Volume: 178

    Topics: Adolescent; Alcohols; Chile; Data Accuracy; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Nicotian

2017
Illicit drug consumption in school populations measured by wastewater analysis.
    Drug and alcohol dependence, 2017, 09-01, Volume: 178

    Topics: Amphetamine; Cannabinoids; Cannabis; Cocaine; Humans; Illicit Drugs; Italy; Ketamine; Mass Spectrome

2017
Dynamic surface-enhanced Raman spectroscopy and Chemometric methods for fast detection and intelligent identification of methamphetamine and 3, 4-Methylenedioxy methamphetamine in human urine.
    Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2018, Jan-15, Volume: 189

    Topics: Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Principal Component Analysis; Spect

2018
Hair testing to assess both known and unknown use of drugs amongst ecstasy users in the electronic dance music scene.
    The International journal on drug policy, 2017, Volume: 48

    Topics: Adolescent; Adult; Chromatography, High Pressure Liquid; Dancing; Female; Hair; Hallucinogens; Harm

2017
Recreational drug use at a major music festival: trend analysis of anonymised pooled urine.
    Clinical toxicology (Philadelphia, Pa.), 2018, Volume: 56, Issue:4

    Topics: Adolescent; Adult; Amphetamine; Chromatography, High Pressure Liquid; Cocaine; Cross-Sectional Studi

2018
Shifting characteristics of ecstasy users ages 12-34 in the United States, 2007-2014.
    Drug and alcohol dependence, 2017, 12-01, Volume: 181

    Topics: Adolescent; Adult; Child; Cross-Sectional Studies; Drug Users; Female; Humans; Illicit Drugs; Male;

2017
Effects of MDMA (ecstasy) on apoptosis and heat shock protein (HSP70) expression in adult rat testis.
    Toxicology mechanisms and methods, 2018, Volume: 28, Issue:3

    Topics: Animals; Apoptosis; Body Temperature Regulation; Dose-Response Relationship, Drug; Gene Expression R

2018
Emergency Department Patient Burden from an Electronic Dance Music Festival.
    The Journal of emergency medicine, 2018, Volume: 54, Issue:4

    Topics: Adolescent; Adult; Alcoholism; Chicago; Dancing; Drug Overdose; Emergency Medical Services; Emergenc

2018
Nine reasons why ecstasy is not quite what it used to be.
    The International journal on drug policy, 2018, Volume: 51

    Topics: Drug and Narcotic Control; Europe; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; So

2018
Nonmedical prescription drug use among African Americans who use MDMA (ecstasy/molly): Implications for risk reduction.
    Addictive behaviors, 2018, Volume: 79

    Topics: Adolescent; Adult; Analgesics, Opioid; Benzodiazepines; Black or African American; Central Nervous S

2018
"Ecstasy" to addiction: Mechanisms and reinforcing effects of three synthetic cathinone analogs of MDMA.
    Neuropharmacology, 2018, 05-01, Volume: 133

    Topics: Animals; Benzazepines; Central Nervous System Stimulants; Conditioning, Operant; Disease Models, Ani

2018
Street drug use among emergency patients in a Public Hospital in Turkey.
    Nigerian journal of clinical practice, 2018, Volume: 21, Issue:1

    Topics: Adolescent; Adult; Cannabis; Child; Consciousness Disorders; Emergency Service, Hospital; Female; Ho

2018
Risky business: Behaviors associated with indoor tanning in US high school students.
    Dermatology online journal, 2017, Sep-15, Volume: 23, Issue:9

    Topics: Adolescent; Alcohol Drinking; Cigarette Smoking; Cocaine-Related Disorders; Female; Health Risk Beha

2017
Patterns of injecting and non-injecting drug use by sexual behaviour in people who inject drugs attending services in England, Wales and Northern Ireland, 2013-2016.
    The International journal on drug policy, 2018, Volume: 55

    Topics: Adult; Cocaine; England; Female; Heterosexuality; Humans; Illicit Drugs; Ketamine; Male; Methadone;

2018
Estimation of the consumption of illicit drugs during special events in two communities in Western Kentucky, USA using sewage epidemiology.
    The Science of the total environment, 2018, Aug-15, Volume: 633

    Topics: Amphetamine; Anniversaries and Special Events; Cocaine; Environmental Monitoring; Humans; Illicit Dr

2018
Investigating the correlation between wastewater analysis and roadside drug testing in South Australia.
    Drug and alcohol dependence, 2018, 06-01, Volume: 187

    Topics: Cannabinoids; Cannabis; Driving Under the Influence; Humans; Illicit Drugs; Methamphetamine; N-Methy

2018
New types of drug use and risks of drug use among men who have sex with men: a cross-sectional study in Hangzhou, China.
    BMC infectious diseases, 2018, 04-17, Volume: 18, Issue:1

    Topics: Adolescent; Adult; Alcoholism; China; Cross-Sectional Studies; HIV Infections; Homosexuality, Male;

2018
Typology of new psychoactive substance use among the general Australian population.
    Drug and alcohol dependence, 2018, 07-01, Volume: 188

    Topics: Adolescent; Adult; Amphetamine; Australia; Cannabinoids; Cannabis; Cocaine; Female; Humans; Illicit

2018
Intracranial Vascular Complications of "Molly" Usage: Case Report and Review of the Literature.
    Connecticut medicine, 2016, Volume: 80, Issue:8

    Topics: Central Nervous System Stimulants; Cerebellum; Computed Tomography Angiography; Female; Hallucinogen

2016
Substance-induced anxiety disorder after one dose of 3,4-methylenedioxymethamphetamine: a case report.
    Journal of medical case reports, 2018, May-25, Volume: 12, Issue:1

    Topics: Adult; Anxiety Disorders; Behavior Therapy; Hallucinogens; Humans; Male; N-Methyl-3,4-methylenedioxy

2018
The role of Ecstasy (MDMA) in managing intimacy and conflict in stable relationships.
    Culture, health & sexuality, 2018, Volume: 20, Issue:10

    Topics: Adolescent; Adult; Conflict, Psychological; Female; Humans; Interpersonal Relations; Interviews as T

2018
Comparing methamphetamine, MDMA, cocaine, codeine and methadone use between the Auckland region and four Australian states using wastewater-based epidemiology (WBE).
    The New Zealand medical journal, 2018, 07-13, Volume: 131, Issue:1478

    Topics: Australia; Chromatography, Liquid; Cities; Cocaine; Codeine; Humans; Methadone; Methamphetamine; N-M

2018
Severe hyponatremia complicated by seizure following 3,4-methylenedioxymethamphetamine ingestion.
    Emergency medicine Australasia : EMA, 2018, Volume: 30, Issue:5

    Topics: Adolescent; Brain Diseases; Eating; Female; Fluid Therapy; Glasgow Coma Scale; Humans; Hyponatremia;

2018
SIADH and water intoxication related to ecstasy.
    BMJ case reports, 2018, Aug-29, Volume: 2018

    Topics: Diagnosis, Differential; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; N-Methyl-3,4-meth

2018
Substance usage intention does not affect attentional bias: implications from Ecstasy/MDMA users and alcohol drinkers.
    Addictive behaviors, 2019, Volume: 88

    Topics: Adolescent; Adult; Alcohol Drinking; Attentional Bias; Craving; Cues; Female; Humans; Intention; Mal

2019
Regular MDMA use is associated with decreased risk of drug injection among street-involved youth who use illicit drugs.
    Drug and alcohol dependence, 2018, 11-01, Volume: 192

    Topics: Adolescent; Canada; Cohort Studies; Female; Hallucinogens; Homeless Youth; Humans; Illicit Drugs; Ma

2018
Determinants of high availability of methamphetamine, cannabis, LSD and ecstasy in New Zealand: Are drug dealers promoting methamphetamine rather than cannabis?
    The International journal on drug policy, 2018, Volume: 61

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cannabinoids; Cannabis; Female; Humans; Illicit Drugs; L

2018
Difference in long-term relapse rates between youths with ketamine use and those with stimulants use.
    Substance abuse treatment, prevention, and policy, 2018, 12-22, Volume: 13, Issue:1

    Topics: Adolescent; Central Nervous System Stimulants; Child; Excitatory Amino Acid Antagonists; Female; Hum

2018
Illegal substance use among 1,309 music festival attendees: An investigation using oral fluid sample drug tests, breathalysers and questionnaires.
    Scandinavian journal of public health, 2019, Volume: 47, Issue:4

    Topics: Adolescent; Adult; Blood Alcohol Content; Breath Tests; Cannabis; Cross-Sectional Studies; Female; H

2019
'Never drop without your significant other, cause that way lies ruin': The boundary work of couples who use MDMA together.
    The International journal on drug policy, 2019, Volume: 71

    Topics: Ceremonial Behavior; Female; Humans; Interpersonal Relations; Interviews as Topic; Male; N-Methyl-3,

2019
Macular hourglass-like hemorrhage after ecstasy use.
    Journal francais d'ophtalmologie, 2019, Volume: 42, Issue:9

    Topics: Adult; Humans; Macula Lutea; Male; N-Methyl-3,4-methylenedioxyamphetamine; Retinal Hemorrhage; Subst

2019
Regional changes in ∆FosB expression in rat brain following MDMA self-administration predict increased sensitivity to effects of locally infused MDMA.
    Addiction biology, 2020, Volume: 25, Issue:5

    Topics: Adrenergic Uptake Inhibitors; Animals; Brain; Disease Models, Animal; Male; N-Methyl-3,4-methylenedi

2020
Posting, texting, and related social risk behavior while high.
    Substance abuse, 2020, Volume: 41, Issue:3

    Topics: Adolescent; Adult; Female; Humans; Male; Marijuana Use; N-Methyl-3,4-methylenedioxyamphetamine; Phot

2020
Male and female ecstasy users: differences in patterns of use, sleep quality and mental health outcomes.
    Drug and alcohol dependence, 2013, Sep-01, Volume: 132, Issue:1-2

    Topics: Adult; Affect; Amphetamine-Related Disorders; Female; Guilt; Hallucinogens; Humans; Male; Mental Hea

2013
Heteromeric nicotinic receptors are involved in the sensitization and addictive properties of MDMA in mice.
    Progress in neuro-psychopharmacology & biological psychiatry, 2013, Jul-01, Volume: 44

    Topics: Analysis of Variance; Animals; Benzazepines; Brain; Cholinergic Agents; Conditioning, Operant; Dihyd

2013
Dental health of Irish alcohol/drug abuse treatment centre residents.
    Community dental health, 2012, Volume: 29, Issue:4

    Topics: Adolescent; Adult; Age Factors; Aged; Alcoholism; Amphetamine-Related Disorders; Beer; Cocaine-Relat

2012
ERP evidence suggests executive dysfunction in ecstasy polydrug users.
    Psychopharmacology, 2013, Volume: 228, Issue:3

    Topics: Brain; Case-Control Studies; Electroencephalography; Evoked Potentials; Executive Function; Female;

2013
Concentrations of drugs determined in blood samples collected from suspected drugged drivers in England and Wales.
    Journal of forensic and legal medicine, 2013, Volume: 20, Issue:4

    Topics: Adolescent; Adult; Amphetamine; Automobile Driving; Central Nervous System Depressants; Chromatograp

2013
Young adults' recreational social environment as a predictor of ecstasy use initiation: findings of a population-based prospective study.
    Addiction (Abingdon, England), 2013, Volume: 108, Issue:10

    Topics: Australia; Female; Follow-Up Studies; Hallucinogens; Humans; Illicit Drugs; Male; N-Methyl-3,4-methy

2013
Ecstasy use and depression: a 4-year longitudinal study among an Australian general community sample.
    Psychopharmacology, 2013, Volume: 229, Issue:4

    Topics: Adult; Australia; Depression; Female; Humans; Longitudinal Studies; Male; Multivariate Analysis; N-M

2013
Severity of club drug dependence and perceived need for treatment among a sample of adult club drug users in Shanghai, China.
    Social psychiatry and psychiatric epidemiology, 2014, Volume: 49, Issue:3

    Topics: Adolescent; Adult; China; Depression; Drug Users; Female; Humans; Illicit Drugs; Male; Motivation; N

2014
Coping style and ecstasy use motives as predictors of current mood symptoms in ecstasy users.
    Addictive behaviors, 2013, Volume: 38, Issue:10

    Topics: Adaptation, Psychological; Adolescent; Adult; Affective Symptoms; Anxiety; Australia; Child; Cross-S

2013
Electrophysiological indices of response inhibition in human polydrug users.
    Journal of psychopharmacology (Oxford, England), 2013, Volume: 27, Issue:9

    Topics: Adult; Analysis of Variance; Drug Combinations; Drug Users; Electrophysiological Phenomena; Executiv

2013
Severe chronic hepatitis secondary to prolonged use of ecstasy and cocaine.
    Clinics and research in hepatology and gastroenterology, 2013, Volume: 37, Issue:5

    Topics: Adult; Ascites; Biopsy; Chemical and Drug Induced Liver Injury, Chronic; Cocaine; Female; Hallucinog

2013
Assessment of the abuse potential of MDMA in the conditioned place preference paradigm: role of CB1 receptors.
    Progress in neuro-psychopharmacology & biological psychiatry, 2013, Dec-02, Volume: 47

    Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Brain; Conditioning, Operant; Disease

2013
The association between tramadol hydrochloride misuse and other substances use in an adolescent population: Phase I of a prospective survey.
    Addictive behaviors, 2014, Volume: 39, Issue:1

    Topics: Adolescent; Alcohol Drinking; Amphetamine-Related Disorders; Analgesics, Opioid; Female; Humans; Ira

2014
Depression, impulsiveness, sleep, and memory in past and present polydrug users of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy).
    Psychopharmacology, 2014, Volume: 231, Issue:4

    Topics: Adolescent; Adult; Alcohol-Related Disorders; Amphetamine-Related Disorders; Attitude to Health; Dep

2014
Basal functioning of the hypothalamic-pituitary-adrenal (HPA) axis and psychological distress in recreational ecstasy polydrug users.
    Psychopharmacology, 2014, Volume: 231, Issue:7

    Topics: Anxiety; Case-Control Studies; Circadian Rhythm; Depression; Drug Users; Female; Humans; Hydrocortis

2014
Enantiomer profiling of high loads of amphetamine and MDMA in communal sewage: a Dutch perspective.
    The Science of the total environment, 2014, Jul-15, Volume: 487

    Topics: Amphetamines; Cities; Environmental Monitoring; Illicit Drugs; N-Methyl-3,4-methylenedioxyamphetamin

2014
The recent expansion in the Australian cocaine market: who are the new users and what are the harms?
    Current drug abuse reviews, 2013, Volume: 6, Issue:2

    Topics: Adolescent; Adult; Age Distribution; Australia; Central Nervous System Stimulants; Cocaine-Related D

2013
Estimating daily and diurnal variations of illicit drug use in Hong Kong: a pilot study of using wastewater analysis in an Asian metropolitan city.
    Forensic science international, 2013, Dec-10, Volume: 233, Issue:1-3

    Topics: Chromatography, Liquid; Cocaine; Hong Kong; Humans; Ketamine; Methamphetamine; N-Methyl-3,4-methylen

2013
Increased cortisol levels in hair of recent Ecstasy/MDMA users.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2014, Volume: 24, Issue:3

    Topics: Female; Hair; Hallucinogens; Humans; Hydrocortisone; Illicit Drugs; Immunoassay; Luminescent Measure

2014
Temporal and visual source memory deficits among ecstasy/polydrug users.
    Human psychopharmacology, 2014, Volume: 29, Issue:2

    Topics: Cocaine-Related Disorders; Female; Hallucinogens; Humans; Illicit Drugs; Judgment; Male; Memory; Mem

2014
Club drugs: coming to a patient near you.
    The Nurse practitioner, 2014, Mar-13, Volume: 39, Issue:3

    Topics: Adolescent; Adult; Female; Flunitrazepam; Humans; Illicit Drugs; Ketamine; Lysergic Acid Diethylamid

2014
The effect of the ecstasy 'come-down' on the diagnosis of ecstasy dependence.
    Drug and alcohol dependence, 2014, Jun-01, Volume: 139

    Topics: Adolescent; Adult; Factor Analysis, Statistical; Female; Humans; Illicit Drugs; Interviews as Topic;

2014
Drug use and sexual risk among gay and bisexual men who frequent party venues.
    AIDS and behavior, 2014, Volume: 18, Issue:11

    Topics: Adult; Amphetamine-Related Disorders; Bisexuality; Homosexuality, Male; Humans; Ketamine; Male; Meth

2014
Spatial differences and temporal changes in illicit drug use in Europe quantified by wastewater analysis.
    Addiction (Abingdon, England), 2014, Volume: 109, Issue:8

    Topics: Amphetamines; Cannabinoids; Chromatography, Liquid; Cocaine; Environmental Monitoring; Europe; Human

2014
An examination of sociodemographic correlates of ecstasy use among high school seniors in the United States.
    Substance use & misuse, 2014, Volume: 49, Issue:13

    Topics: Adolescent; Cross-Sectional Studies; Female; Humans; Illicit Drugs; Male; N-Methyl-3,4-methylenediox

2014
Posterior spinal artery aneurysm rupture after 'Ecstasy' abuse.
    Journal of neurointerventional surgery, 2015, Volume: 7, Issue:7

    Topics: Adolescent; Aneurysm, Ruptured; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Rela

2015
Brain serotonin synthesis in MDMA (ecstasy) polydrug users: an alpha-[(11) C]methyl-l-tryptophan study.
    Journal of neurochemistry, 2014, Volume: 131, Issue:5

    Topics: Adult; Antidepressive Agents, Second-Generation; Brain; Brain Mapping; Female; Humans; Male; N-Methy

2014
Self-reported prevalence of dependence of MDMA compared to cocaine, mephedrone and ketamine among a sample of recreational poly-drug users.
    The International journal on drug policy, 2015, Volume: 26, Issue:1

    Topics: Adolescent; Adult; Amphetamine-Related Disorders; Cocaine-Related Disorders; Cross-Sectional Studies

2015
Measuring effects of MDMA (ecstasy) abuse on the rate of cerebral serotonin synthesis.
    Journal of neurochemistry, 2014, Volume: 131, Issue:5

    Topics: Brain; Female; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Serotonin; Substance-Related Di

2014
Driving under the influence among frequent ecstasy consumers in Australia: trends over time and the role of risk perceptions.
    Drug and alcohol dependence, 2014, Nov-01, Volume: 144

    Topics: Adolescent; Adult; Alcohol Drinking; Australia; Automobile Driving; Central Nervous System Stimulant

2014
Illnesses and deaths among persons attending an electronic dance-music festival - New York City, 2013.
    MMWR. Morbidity and mortality weekly report, 2014, Dec-19, Volume: 63, Issue:50

    Topics: Adolescent; Adult; Alcohol Drinking; Cocaine; Dancing; Emergency Service, Hospital; Female; Holidays

2014
Changes in serotonin transporter (5-HTT) gene expression in peripheral blood cells after MDMA intake.
    Psychopharmacology, 2015, Volume: 232, Issue:11

    Topics: Adult; Affect; Double-Blind Method; Female; Gene Expression; Humans; Male; N-Methyl-3,4-methylenedio

2015
The significance of ecstasy use to dental practice.
    The New York state dental journal, 2014, Volume: 80, Issue:6

    Topics: Adolescent; Contraindications; Dental Care; Hallucinogens; Humans; Illicit Drugs; Mouth Diseases; N-

2014
Greater sexual risk-taking in female and male recreational MDMA/ecstasy users compared with alcohol drinkers: a questionnaire study.
    Human psychopharmacology, 2015, Volume: 30, Issue:4

    Topics: Alcohol Drinking; Female; Humans; Illicit Drugs; Male; N-Methyl-3,4-methylenedioxyamphetamine; Risk-

2015
Self-reported use of novel psychoactive substances in a US nationally representative survey: Prevalence, correlates, and a call for new survey methods to prevent underreporting.
    Drug and alcohol dependence, 2015, Nov-01, Volume: 156

    Topics: Adolescent; Adult; Alkaloids; Cannabinoids; Cocaine; Female; Hallucinogens; Humans; Illicit Drugs; L

2015
Wastewater-Based Epidemiology of Stimulant Drugs: Functional Data Analysis Compared to Traditional Statistical Methods.
    PloS one, 2015, Volume: 10, Issue:9

    Topics: Amphetamine; Cities; Environmental Monitoring; Epidemiological Monitoring; Europe; Humans; Illicit D

2015
Co-ingestion of energy drinks with alcohol and other substances among a sample of people who regularly use ecstasy.
    Drug and alcohol review, 2016, Volume: 35, Issue:3

    Topics: Adult; Alcohol Drinking; Australia; Central Nervous System Stimulants; Energy Drinks; Female; Harm R

2016
Significant Misuse of Sildenafil in London Nightclubs.
    Substance use & misuse, 2015, Volume: 50, Issue:11

    Topics: Adolescent; Adult; Cocaine; Homosexuality, Male; Humans; Illicit Drugs; London; Male; Methamphetamin

2015
Assessing Drug Consumption Behavior With the Heidelberger Drogenbogen (Heidelberg Drug Scales): Reliabilities, Validities, and Cut-Off Criteria.
    Substance use & misuse, 2015, Volume: 50, Issue:13

    Topics: Adolescent; Adult; Amphetamine-Related Disorders; Cocaine-Related Disorders; Female; Hallucinogens;

2015
Oxytocin receptor gene variation predicts subjective responses to MDMA.
    Social neuroscience, 2016, Volume: 11, Issue:6

    Topics: Adolescent; Adult; Analysis of Variance; Dose-Response Relationship, Drug; Double-Blind Method; Fema

2016
History of Illicit Stimulant Use Is Not Associated with Long-Lasting Changes in Learning of Fine Motor Skills in Humans.
    Neural plasticity, 2016, Volume: 2016

    Topics: Adolescent; Adult; Amphetamine; Female; Humans; Learning; Male; Motor Skills; N-Methyl-3,4-methylene

2016
Detection of "bath salts" and other novel psychoactive substances in hair samples of ecstasy/MDMA/"Molly" users.
    Drug and alcohol dependence, 2016, Apr-01, Volume: 161

    Topics: Adolescent; Adult; Alkaloids; Animals; Drug Users; Female; Hair; Humans; Illicit Drugs; Male; Metham

2016
Drug testing in Europe: monitoring results of the Trans European Drug Information (TEDI) project.
    Drug testing and analysis, 2017, Volume: 9, Issue:2

    Topics: Adult; Amphetamine; Cocaine; Drug Contamination; Drug Users; Europe; Humans; Illicit Drugs; Male; N-

2017
Acute amnestic syndrome due to MDMA exposure.
    Journal of neurology, 2016, Volume: 263, Issue:5

    Topics: Amnesia; Brain; Hallucinogens; Humans; Illicit Drugs; Male; N-Methyl-3,4-methylenedioxyamphetamine;

2016
On your toes: Detecting mediastinal air on the chest radiograph in ecstasy abusers.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2016, Mar-30, Volume: 106, Issue:5

    Topics: Barotrauma; Chest Pain; Hallucinogens; Humans; Male; Mediastinal Emphysema; N-Methyl-3,4-methylenedi

2016
Ecstasy is making a comeback, European drugs report warns.
    BMJ (Clinical research ed.), 2016, May-31, Volume: 353

    Topics: Drug and Narcotic Control; Europe; Hallucinogens; Humans; Illicit Drugs; N-Methyl-3,4-methylenedioxy

2016
Underreporting of ecstasy use among high school seniors in the US.
    Drug and alcohol dependence, 2016, Aug-01, Volume: 165

    Topics: Adolescent; Cross-Sectional Studies; Female; Hallucinogens; Humans; Illicit Drugs; Male; N-Methyl-3,

2016
Using the Theory of Planned Behavior to predict implementation of harm reduction strategies among MDMA/ecstasy users.
    Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors, 2016, Volume: 30, Issue:4

    Topics: Adolescent; Adult; Attitude; Craving; Female; Harm Reduction; Humans; Intention; Male; Middle Aged;

2016
Cocaine, MDMA and methamphetamine residues in wastewater: Consumption trends (2009-2015) in South East Queensland, Australia.
    The Science of the total environment, 2016, Oct-15, Volume: 568

    Topics: Cocaine; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Queensland; Rural Populati

2016
Exploring functional data analysis and wavelet principal component analysis on ecstasy (MDMA) wastewater data.
    BMC medical research methodology, 2016, 07-12, Volume: 16

    Topics: Cities; Europe; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Principal Component Analysis; Reprod

2016
Decoding the Structure of Abuse Potential for New Psychoactive Substances: Structure-Activity Relationships for Abuse-Related Effects of 4-Substituted Methcathinone Analogs.
    Current topics in behavioral neurosciences, 2017, Volume: 32

    Topics: Amphetamine; Animals; Behavior, Animal; Dopamine Plasma Membrane Transport Proteins; Fenfluramine; H

2017
Comparison of pharmaceutical, illicit drug, alcohol, nicotine and caffeine levels in wastewater with sale, seizure and consumption data for 8 European cities.
    BMC public health, 2016, 10-01, Volume: 16, Issue:1

    Topics: Alcohol Drinking; Amphetamines; Beverages; Caffeine; Central Nervous System Stimulants; Cities; Coca

2016
Past 12-month and lifetime comorbidity and poly-drug use of ecstasy users among young adults in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
    Drug and alcohol dependence, 2008, Sep-01, Volume: 97, Issue:1-2

    Topics: Adolescent; Adult; Age Factors; Alcoholism; Amphetamine-Related Disorders; Comorbidity; Diagnosis, D

2008
Trends in population drug use in New Zealand: findings from national household surveying of drug use in 1998, 2001, 2003, and 2006.
    The New Zealand medical journal, 2008, May-23, Volume: 121, Issue:1274

    Topics: Adult; Alcohol Drinking; Alcoholism; Amphetamine-Related Disorders; Cross-Sectional Studies; Female;

2008
Multivariate modeling of club drug use initiation among gay and bisexual men.
    Substance use & misuse, 2008, Volume: 43, Issue:7

    Topics: Adolescent; Adult; Aged; Bisexuality; Cocaine; Homosexuality, Male; Humans; Ketamine; Longitudinal S

2008
Attributions for psychobiological changes in ecstasy/MDMA and other polydrug users.
    Journal of psychopharmacology (Oxford, England), 2009, Volume: 23, Issue:7

    Topics: Adult; Attitude; Drug Users; Female; Humans; Illicit Drugs; Life Change Events; Male; Mental Disorde

2009
Reduced memory and attention performance in a population-based sample of young adults with a moderate lifetime use of cannabis, ecstasy and alcohol.
    Journal of psychopharmacology (Oxford, England), 2009, Volume: 23, Issue:5

    Topics: Adult; Alcohol Drinking; Attention; Cannabis; Cognition; Dose-Response Relationship, Drug; Female; H

2009
Ketamine pretreatment exacerbated 3,4-methylenedioxymethamphetamine-induced central dopamine toxicity.
    The Chinese journal of physiology, 2008, Apr-30, Volume: 51, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transpo

2008
Tri-city study of Ecstasy use problems: a latent class analysis.
    Drug and alcohol dependence, 2008, Dec-01, Volume: 98, Issue:3

    Topics: Adult; Amphetamine-Related Disorders; Depression; Family; Female; Hallucinogens; Humans; Logistic Mo

2008
Predicting ecstasy use among young people at risk: a prospective study of initially ecstasy-naive subjects.
    Journal of drug education, 2008, Volume: 38, Issue:2

    Topics: Adolescent; Adult; Female; Forecasting; Humans; Logistic Models; Male; Marijuana Abuse; N-Methyl-3,4

2008
Is emotional intelligence impaired in ecstasy-polydrug users?
    Journal of psychopharmacology (Oxford, England), 2010, Volume: 24, Issue:2

    Topics: Affect; Analysis of Variance; Emotional Intelligence; Female; Hallucinogens; Humans; Male; Marijuana

2010
Ecstasy (MDMA) and high prevalence psychiatric symptomatology: somatic anxiety symptoms are associated with polydrug, not ecstasy, use.
    Journal of psychopharmacology (Oxford, England), 2010, Volume: 24, Issue:2

    Topics: Adolescent; Adult; Anxiety; Depression; Female; Hallucinogens; Humans; Male; Marijuana Abuse; Multiv

2010
Partying on? Life after BZP-based party pills.
    The New Zealand medical journal, 2008, Oct-03, Volume: 121, Issue:1283

    Topics: Adolescent; Adult; Central Nervous System Stimulants; Drug and Narcotic Control; Female; Hallucinoge

2008
Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users.
    Brain : a journal of neurology, 2008, Volume: 131, Issue:Pt 11

    Topics: Adolescent; Brain; Brain Mapping; Cerebrovascular Circulation; Female; Follow-Up Studies; Hallucinog

2008
Careers in ecstasy use: do ecstasy users cease of their own accord? Implications for intervention development.
    BMC public health, 2008, Oct-28, Volume: 8

    Topics: Female; Health Promotion; Humans; Interviews as Topic; Male; Motivation; N-Methyl-3,4-methylenedioxy

2008
Development and characterization of a novel animal model of intermittent MDMA ("Ecstasy") exposure during adolescence.
    Annals of the New York Academy of Sciences, 2008, Volume: 1139

    Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Adult; Animals; Anxiety; Behavior, Animal; Body Temperatu

2008
Young adult Ecstasy users and multiple sexual partners: understanding the factors underlying this HIV risk practice.
    Journal of psychoactive drugs, 2008, Volume: 40, Issue:3

    Topics: Adolescent; Adult; Age Factors; Cross-Sectional Studies; Data Collection; Female; Georgia; Hallucino

2008
Factors associated with driving under the influence of alcohol and drugs among an Australian sample of regular ecstasy users.
    Drug and alcohol dependence, 2009, Feb-01, Volume: 100, Issue:1-2

    Topics: Adolescent; Adult; Alcohol Drinking; Australia; Automobile Driving; Female; Humans; Male; Middle Age

2009
Are we aware of ecstasy effects?
    Internal and emergency medicine, 2009, Volume: 4, Issue:2

    Topics: Brain; Fatal Outcome; Female; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Radiogr

2009
Dissociative and sympathomimetic toxicity associated with recreational use of 1-(3-trifluoromethylphenyl) piperazine (TFMPP) and 1-benzylpiperzine (BZP).
    Journal of medical toxicology : official journal of the American College of Medical Toxicology, 2008, Volume: 4, Issue:4

    Topics: Adolescent; Bruxism; Dissociative Disorders; Electrocardiography; Gas Chromatography-Mass Spectromet

2008
N-acetylaspartate (NAA) correlates inversely with cannabis use in a frontal language processing region of neocortex in MDMA (Ecstasy) polydrug users: a 3 T magnetic resonance spectroscopy study.
    Pharmacology, biochemistry, and behavior, 2009, Volume: 92, Issue:1

    Topics: Amphetamine-Related Disorders; Aspartic Acid; Biomarkers; Brain Chemistry; Female; Hallucinogens; Hu

2009
The effect of Ecstasy on memory is moderated by a functional polymorphism in the cathechol-O-methyltransferase (COMT) gene.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2009, Volume: 19, Issue:2

    Topics: Adolescent; Adult; Catechol O-Methyltransferase; Female; Follow-Up Studies; Genotype; Humans; Intell

2009
Use of and attitudes toward club drugs by medical students.
    Journal of addictive diseases, 2008, Volume: 27, Issue:4

    Topics: Adult; Anesthetics, Intravenous; Anti-Anxiety Agents; Central Nervous System Stimulants; Dextrometho

2008
Self-reported psychopathology among young, low-income, female ecstasy users.
    Journal of addictive diseases, 2008, Volume: 27, Issue:4

    Topics: Academic Medical Centers; Adolescent; Adult; Ambulatory Care Facilities; Analysis of Variance; Cross

2008
Dinosaur girls, candy girls, and Trinity: voices of Taiwanese club drug users.
    Journal of ethnicity in substance abuse, 2008, Volume: 7, Issue:3

    Topics: Adolescent; Adult; Data Collection; Female; Focus Groups; Hallucinogens; Health Personnel; Humans; I

2008
[Main illegal drugs consumed in France].
    Revue de l'infirmiere, 2008, Issue:146

    Topics: Amphetamine-Related Disorders; Cocaine-Related Disorders; France; Heroin Dependence; Humans; Illicit

2008
Use of ecstasy and other psychoactive substances among school-attending adolescents in Taiwan: national surveys 2004-2006.
    BMC public health, 2009, Jan-21, Volume: 9

    Topics: Adolescent; Adolescent Behavior; Confidence Intervals; Cross-Sectional Studies; Female; Hallucinogen

2009
Importance of psychiatric confounding in non-randomized studies of heavy ecstasy users.
    Psychological medicine, 2009, Volume: 39, Issue:5

    Topics: Alcohol Drinking; Alcoholism; Amphetamine-Related Disorders; Bias; Cognition Disorders; Comorbidity;

2009
Risky behaviour on drug classification.
    Lancet (London, England), 2009, Feb-21, Volume: 373, Issue:9664

    Topics: Advisory Committees; Hallucinogens; Humans; Legislation, Drug; N-Methyl-3,4-methylenedioxyamphetamin

2009
High suicide risk after the development of cognitive and working memory deficits caused by cannabis, cocaine and ecstasy use.
    Substance abuse, 2007, Volume: 28, Issue:1

    Topics: Adult; Cocaine-Related Disorders; Cognition Disorders; Humans; Male; Marijuana Abuse; Memory Disorde

2007
MDMA (ecstasy) use is associated with reduced BOLD signal change during semantic recognition in abstinent human polydrug users: a preliminary fMRI study.
    Journal of psychopharmacology (Oxford, England), 2010, Volume: 24, Issue:2

    Topics: Adult; Brain; Cocaine-Related Disorders; Female; Hallucinogens; Humans; Magnetic Resonance Imaging;

2010
Unsuspected exposure to cocaine in preschool children from a Mediterranean city detected by hair analysis.
    Therapeutic drug monitoring, 2009, Volume: 31, Issue:3

    Topics: Amphetamines; Cannabis; Child; Cocaine; Female; Gas Chromatography-Mass Spectrometry; Hair; Humans;

2009
An investigation of the subacute effects of ecstasy on neuropsychological performance, sleep and mood in regular ecstasy users.
    Journal of psychopharmacology (Oxford, England), 2010, Volume: 24, Issue:2

    Topics: Adult; Affect; Age Factors; Decision Making; Female; Hallucinogens; Humans; Intelligence; Male; N-Me

2010
The high prevalence of substance use disorders among recent MDMA users compared with other drug users: Implications for intervention.
    Addictive behaviors, 2009, Volume: 34, Issue:8

    Topics: Adolescent; Adult; Age of Onset; Amphetamine-Related Disorders; Child; Epidemiologic Methods; Female

2009
Multiple drug ingestion by ecstasy abusers in the United States.
    Journal of analytical toxicology, 2009, Volume: 33, Issue:3

    Topics: 3,4-Methylenedioxyamphetamine; Drug Contamination; Forensic Toxicology; Hallucinogens; Humans; Illic

2009
Illicit use of pharmaceutical opioids among young polydrug users in Ohio.
    Addictive behaviors, 2009, Volume: 34, Issue:8

    Topics: Adolescent; Adult; Amphetamine-Related Disorders; Analgesics, Opioid; Depression; Diagnosis, Dual (P

2009
Morbidity in a population of low-income, female users of MDMA and other drugs.
    Substance use & misuse, 2009, Volume: 44, Issue:7

    Topics: Adolescent; Adult; Comorbidity; Female; Humans; Illicit Drugs; Marijuana Smoking; N-Methyl-3,4-methy

2009
[A young man' spontaneous pneumomediastinum].
    Annales francaises d'anesthesie et de reanimation, 2009, Volume: 28, Issue:5

    Topics: Hallucinations; Hallucinogens; Humans; Male; Mediastinal Emphysema; Mental Disorders; N-Methyl-3,4-m

2009
Sildenafil (Viagra) and club drug use in gay and bisexual men: the role of drug combinations and context.
    American journal of men's health, 2007, Volume: 1, Issue:2

    Topics: Bisexuality; Cocaine; Drug Combinations; Homosexuality, Male; Humans; Illicit Drugs; Ketamine; Leisu

2007
Hallucinogen-related disorders in a national sample of adolescents: the influence of ecstasy/MDMA use.
    Drug and alcohol dependence, 2009, Sep-01, Volume: 104, Issue:1-2

    Topics: Adolescent; Child; Crime; Ethnicity; Female; Hallucinogens; Humans; Male; Mental Health; N-Methyl-3,

2009
[Unilatelaral iris plateau syndrome after the use of ecstasy].
    Vojnosanitetski pregled, 2009, Volume: 66, Issue:6

    Topics: Adult; Female; Hallucinogens; Humans; Intraocular Pressure; N-Methyl-3,4-methylenedioxyamphetamine;

2009
The spatial epidemiology of cocaine, methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) use: a demonstration using a population measure of community drug load derived from municipal wastewater.
    Addiction (Abingdon, England), 2009, Volume: 104, Issue:11

    Topics: Cocaine; Environmental Monitoring; Epidemiological Monitoring; Humans; Methamphetamine; N-Methyl-3,4

2009
Association of MDMA/ecstasy and other substance use with self-reported sexually transmitted diseases among college-aged adults: a national study.
    Public health, 2009, Volume: 123, Issue:8

    Topics: Adolescent; Adolescent Behavior; Age of Onset; Cross-Sectional Studies; Emergency Medical Services;

2009
Test-re-test reliability of DSM-IV adopted criteria for 3,4-methylenedioxymethamphetamine (MDMA) abuse and dependence: a cross-national study.
    Addiction (Abingdon, England), 2009, Volume: 104, Issue:10

    Topics: Adolescent; Adult; Australia; Diagnosis, Differential; Diagnostic and Statistical Manual of Mental D

2009
Enhanced intensity dependence and aggression history indicate previous regular ecstasy use in abstinent polydrug users.
    Progress in neuro-psychopharmacology & biological psychiatry, 2009, Nov-13, Volume: 33, Issue:8

    Topics: Adult; Aggression; Analysis of Variance; Brain Mapping; Dichotic Listening Tests; Discrimination, Ps

2009
Medicine or ecstasy? The importance of the logo.
    Fundamental & clinical pharmacology, 2010, Volume: 24, Issue:2

    Topics: Adolescent; Adult; Crime; Drug and Narcotic Control; Drug Industry; Female; France; Humans; Illicit

2010
Sexual and injecting risk behaviours among regular ecstasy users.
    Addictive behaviors, 2010, Volume: 35, Issue:2

    Topics: Adolescent; Adult; Australia; Female; Hallucinogens; Health Knowledge, Attitudes, Practice; HIV Infe

2010
Methylenedioxymethamphetamine-related deaths in Taiwan: 2001-2008.
    Journal of analytical toxicology, 2009, Volume: 33, Issue:7

    Topics: Accidents; Adolescent; Adult; Autopsy; Cause of Death; Excitatory Amino Acid Antagonists; Female; Fl

2009
The association between the negative effects attributed to ecstasy use and measures of cognition and mood among users.
    Experimental and clinical psychopharmacology, 2009, Volume: 17, Issue:5

    Topics: Affect; Association Learning; Cognition; Executive Function; Female; Hallucinogens; Humans; Intellig

2009
A fatal case of myocardial damage due to misuse of the "designer drug" MDMA.
    Legal medicine (Tokyo, Japan), 2009, Volume: 11, Issue:6

    Topics: Adult; Autopsy; Brain; Fatal Outcome; Female; Heart; Humans; Kidney; Liver; Myocardium; N-Methyl-3,4

2009
Modifiable risk factors of ecstasy use: risk perception, current dependence, perceived control, and depression.
    Addictive behaviors, 2010, Volume: 35, Issue:3

    Topics: Adolescent; Adult; Depressive Disorder; Female; Florida; Hallucinogens; Humans; Male; Middle Aged; M

2010
Sleep deprivation differentially impairs cognitive performance in abstinent methylenedioxymethamphetamine ("Ecstasy") users.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2009, Nov-04, Volume: 29, Issue:44

    Topics: Adult; Cognition; Cognition Disorders; Female; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine;

2009
Typology of club drug use among young adults recruited using time-space sampling.
    Drug and alcohol dependence, 2010, Mar-01, Volume: 107, Issue:2-3

    Topics: Adjuvants, Anesthesia; Adolescent; Adult; Cocaine; Dopamine Uptake Inhibitors; Drug Users; Excitator

2010
During pregnancy, recreational drug-using women stop taking ecstasy (3,4-methylenedioxy-N-methylamphetamine) and reduce alcohol consumption, but continue to smoke tobacco and cannabis: initial findings from the Development and Infancy Study.
    Journal of psychopharmacology (Oxford, England), 2010, Volume: 24, Issue:9

    Topics: Adult; Alcohol Drinking; Female; Hallucinogens; Humans; Illicit Drugs; Longitudinal Studies; Marijua

2010
Is moderate substance use associated with altered executive functioning in a population-based sample of young adults?
    Human psychopharmacology, 2009, Volume: 24, Issue:8

    Topics: Adult; Alcohol Drinking; Cognition Disorders; Databases, Factual; Executive Function; Female; Humans

2009
The agony of the ecstasy: serotonin and obstructive sleep apnea.
    Neurology, 2009, Dec-08, Volume: 73, Issue:23

    Topics: Animals; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Serotonin; Sleep Apnea, Obstructive; Substa

2009
Sleep apnea in young abstinent recreational MDMA ("ecstasy") consumers.
    Neurology, 2009, Dec-08, Volume: 73, Issue:23

    Topics: Adolescent; Adult; Age Factors; Female; Humans; Illicit Drugs; Male; Middle Aged; N-Methyl-3,4-methy

2009
Patterns of ecstasy use and associated harm: results of a Brazilian online survey.
    Substance use & misuse, 2009, Volume: 44, Issue:14

    Topics: Adolescent; Adult; Age Factors; Brazil; Female; Harm Reduction; Health Knowledge, Attitudes, Practic

2009
Patterns and harms of pharmaceutical drug use among ecstasy users in Australia.
    Adicciones, 2009, Volume: 21, Issue:4

    Topics: Adolescent; Adult; Australia; Female; Humans; Male; Middle Aged; N-Methyl-3,4-methylenedioxyamphetam

2009
Brain serotonin, psychoactive drugs, and effects on reproduction.
    Central nervous system agents in medicinal chemistry, 2009, Volume: 9, Issue:4

    Topics: Affect; Amphetamine-Related Disorders; Animals; Biological Clocks; Brain; Cognition Disorders; Depre

2009
Impact of severity of drug use on discrete emotions recognition in polysubstance abusers.
    Drug and alcohol dependence, 2010, Jun-01, Volume: 109, Issue:1-3

    Topics: Adolescent; Adult; Alcoholism; Cocaine-Related Disorders; Data Interpretation, Statistical; Educatio

2010
The influence of 5-HTT and COMT genotypes on verbal fluency in ecstasy users.
    Journal of psychopharmacology (Oxford, England), 2010, Volume: 24, Issue:9

    Topics: Adult; Catechol O-Methyltransferase; Executive Function; Female; Genotype; Hallucinogens; Heterozygo

2010
Depressive and anxiety symptomatology in ecstasy users: the relative contribution of genes, trauma, life stress and drug use.
    Psychopharmacology, 2010, Volume: 209, Issue:1

    Topics: Adolescent; Adult; Affect; Anxiety; Depression; Female; Hallucinogens; Humans; Male; N-Methyl-3,4-me

2010
Everyday and prospective memory deficits in ecstasy/polydrug users.
    Journal of psychopharmacology (Oxford, England), 2011, Volume: 25, Issue:4

    Topics: Cognition; Cognition Disorders; Comprehension; Female; Humans; Illicit Drugs; Male; Memory; Memory D

2011
Comparing probability and non-probability sampling methods in Ecstasy research: implications for the internet as a research tool.
    Substance use & misuse, 2010, Volume: 45, Issue:3

    Topics: Adolescent; Adult; Drug Users; Epidemiologic Methods; Female; Health Surveys; Humans; Illicit Drugs;

2010
Ecstasy: as harmful as heroin?
    Journal of law and medicine, 2009, Volume: 17, Issue:3

    Topics: Crime; Drug and Narcotic Control; Hallucinogens; Humans; Illicit Drugs; N-Methyl-3,4-methylenedioxya

2009
Multiorgan failure from 1-benzylpiperazine ingestion--legal high or lethal high?
    Clinical toxicology (Philadelphia, Pa.), 2010, Volume: 48, Issue:3

    Topics: Drug Synergism; Female; Hallucinogens; Humans; Illicit Drugs; Male; Multiple Organ Failure; N-Methyl

2010
Factor structure of the Chinese version of the University of Rhode Island change assessment in Taiwanese adolescents who abuse MDMA or methamphetamine.
    The American journal of drug and alcohol abuse, 2010, Volume: 36, Issue:2

    Topics: Adolescent; Adolescent Behavior; Asian People; Attitude to Health; Factor Analysis, Statistical; Fem

2010
An investigation of factors associated with depressive symptoms among a sample of regular ecstasy consumers.
    Neuropsychobiology, 2010, Volume: 61, Issue:4

    Topics: Adolescent; Adult; Chi-Square Distribution; Depression; Female; Humans; Male; N-Methyl-3,4-methylene

2010
Neurocognitive impairments in MDMA and other drug users: MDMA alone may not be a cognitive risk factor.
    Journal of clinical and experimental neuropsychology, 2010, Volume: 32, Issue:4

    Topics: Adolescent; Adult; Cognition Disorders; Female; Hallucinogens; Humans; Inhibition, Psychological; Lo

2010
Evidence of increased activation underlying cognitive control in ecstasy and cannabis users.
    NeuroImage, 2010, Aug-15, Volume: 52, Issue:2

    Topics: Brain; Brain Mapping; Cannabinoids; Cerebrovascular Circulation; Cognition; Executive Function; Fema

2010
Ecstasy (MDMA)-addicted subjects show increased serum levels of brain-derived neurotrophic factor, independently from a rise of drug-induced psychotic symptoms.
    Addiction biology, 2010, Volume: 15, Issue:3

    Topics: Adolescent; Brain; Brain-Derived Neurotrophic Factor; Enzyme-Linked Immunosorbent Assay; Female; Hum

2010
Morbidity associated with MDMA (ecstasy) abuse: a survey of emergency department admissions.
    Human & experimental toxicology, 2011, Volume: 30, Issue:4

    Topics: Adolescent; Adult; Emergency Service, Hospital; Female; Hallucinogens; Humans; Illicit Drugs; Israel

2011
Bruxism after 3,4-methylenedioxymethamphetamine (ecstasy) abuse.
    Clinical toxicology (Philadelphia, Pa.), 2010, Volume: 48, Issue:8

    Topics: Bruxism; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Serotonin; Serotonin Agents; Substance-Rela

2010
Factors associated with condom use among young adult ecstasy users.
    International journal of public health, 2010, Volume: 55, Issue:6

    Topics: Adolescent; Adult; Condoms; Cross-Sectional Studies; Female; Georgia; Humans; Interviews as Topic; M

2010
Contextualising psychological distress among regular ecstasy users: the importance of sociodemographic factors and patterns of drug use.
    Drug and alcohol review, 2010, Volume: 29, Issue:3

    Topics: Adolescent; Adult; Amphetamine-Related Disorders; Australia; Demography; Female; Humans; Male; N-Met

2010
Drug-facilitated sexual assault in Ontario, Canada: toxicological and DNA findings.
    Journal of forensic and legal medicine, 2010, Volume: 17, Issue:6

    Topics: Adult; Alcoholic Intoxication; Amphetamines; Cannabinoids; Cocaine; Confidence Intervals; Crime Vict

2010
Illicit drugs in Canadian municipal wastewater and estimates of community drug use.
    Environmental pollution (Barking, Essex : 1987), 2010, Volume: 158, Issue:10

    Topics: Amphetamine; Canada; Cities; Cocaine; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamp

2010
Simultaneous quantification of amphetamines, caffeine and ketamine in urine by hollow fiber liquid phase microextraction combined with gas chromatography-flame ionization detector.
    Talanta, 2010, Aug-15, Volume: 82, Issue:3

    Topics: Amphetamines; Caffeine; Calibration; Chromatography, Gas; Drug Monitoring; Flame Ionization; Humans;

2010
Twenty-three deaths with gamma-hydroxybutyrate overdose in western Sweden between 2000 and 2007.
    Acta anaesthesiologica Scandinavica, 2010, Volume: 54, Issue:8

    Topics: Adolescent; Adult; Central Nervous System Stimulants; Cocaine; Drug Overdose; Female; Hallucinogens;

2010
[Maternal and obstetrical data in a retrospective cohort of 170 newborns from polydrug using mothers, in the Paris area, 1999-2008].
    Journal de gynecologie, obstetrique et biologie de la reproduction, 2010, Volume: 39, Issue:8

    Topics: Abortion, Induced; Cocaine-Related Disorders; Cohort Studies; Ethanol; Female; Heroin Dependence; Hu

2010
Comparative epidemiology of betel nut use versus ecstasy use among Taiwanese adolescents: findings from a national survey.
    Drug and alcohol dependence, 2011, Jan-15, Volume: 113, Issue:2-3

    Topics: Adolescent; Adolescent Behavior; Areca; Female; Health Surveys; Humans; Male; N-Methyl-3,4-methylene

2011
A short self-report measure of problems with executive function suitable for administration via the Internet.
    Behavior research methods, 2010, Volume: 42, Issue:3

    Topics: Adolescent; Adult; Cognition; Executive Function; Female; Humans; Internet; Male; Memory; Middle Age

2010
Attitude towards and use of ecstasy in medical university interns' based on HBM.
    Journal of preventive medicine and hygiene, 2009, Volume: 50, Issue:4

    Topics: Adult; Cross-Sectional Studies; Female; Health Knowledge, Attitudes, Practice; Humans; Internship an

2009
Drug abuse in plastic surgery patients: optimizing detection and minimizing complications.
    Plastic and reconstructive surgery, 2011, Volume: 127, Issue:1

    Topics: Amphetamines; Analgesics, Opioid; Benzodiazepines; Cocaine-Related Disorders; Humans; Marijuana Abus

2011
Long-term neuronal damage and recovery after a single dose of MDMA: expression and distribution of serotonin transporter in the rat brain.
    Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology, 2010, Volume: 12, Issue:3

    Topics: Aggression; Animals; Basal Metabolism; Brain; Gene Expression Regulation; Genetic Predisposition to

2010
Mortality among individuals with cannabis, cocaine, amphetamine, MDMA, and opioid use disorders: a nationwide follow-up study of Danish substance users in treatment.
    Drug and alcohol dependence, 2011, Apr-01, Volume: 114, Issue:2-3

    Topics: Adult; Amphetamine; Analgesics, Opioid; Cannabis; Cocaine; Cohort Studies; Denmark; Female; Follow-U

2011
Trazodone, meta-chlorophenylpiperazine (an hallucinogenic drug and trazodone metabolite), and the hallucinogen trifluoromethylphenylpiperazine cross-react with the EMIT®II ecstasy immunoassay in urine.
    Journal of analytical toxicology, 2010, Volume: 34, Issue:9

    Topics: Antidepressive Agents; Cross Reactions; False Positive Reactions; Hallucinogens; Humans; Illicit Dru

2010
Evidence of neurotoxicity of ecstasy: sustained effects on electroencephalographic activity in polydrug users.
    PloS one, 2010, Nov-23, Volume: 5, Issue:11

    Topics: Adolescent; Adult; Alpha Rhythm; Attention Deficit Disorder with Hyperactivity; Electroencephalograp

2010
Detection of phentermine in hair samples from drug suspects.
    Forensic science international, 2011, Apr-15, Volume: 207, Issue:1-3

    Topics: Adult; Amphetamine; Central Nervous System Stimulants; Female; Forensic Toxicology; Gas Chromatograp

2011
Persistent nigrostriatal dopaminergic abnormalities in ex-users of MDMA ('Ecstasy'): an 18F-dopa PET study.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2011, Volume: 36, Issue:4

    Topics: Adult; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Humans; Male; Middle Aged; N-Methyl-3,4-me

2011
Modelling the adverse effects associated with ecstasy use.
    Addiction (Abingdon, England), 2011, Volume: 106, Issue:4

    Topics: Affect; Alcohol Drinking; Anxiety; Binomial Distribution; Confusion; Dose-Response Relationship, Dru

2011
Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs.
    Addiction (Abingdon, England), 2011, Volume: 106, Issue:4

    Topics: Adolescent; Adult; Case-Control Studies; Chronic Disease; Cognition; Cognition Disorders; Confoundin

2011
Legal highs: the dark side of medicinal chemistry.
    Nature, 2011, Jan-06, Volume: 469, Issue:7328

    Topics: Amphetamines; Animals; Depression; Designer Drugs; Drug Design; Electronic Mail; Hallucinogens; Huma

2011
A 26-year-old woman with sudden onset cerebral edema.
    Journal of emergency nursing, 2011, Volume: 37, Issue:1

    Topics: Acute Disease; Adult; Brain Edema; Confusion; Diuretics, Osmotic; Emergency Treatment; Fatal Outcome

2011
Sewage epidemiology--a real-time approach to estimate the consumption of illicit drugs in Brussels, Belgium.
    Environment international, 2011, Volume: 37, Issue:3

    Topics: Belgium; Biological Oxygen Demand Analysis; Cocaine; Demography; Heroin; Humans; Illicit Drugs; Meth

2011
Prospective memory functioning among ecstasy/polydrug users: evidence from the Cambridge Prospective Memory Test (CAMPROMPT).
    Psychopharmacology, 2011, Volume: 215, Issue:4

    Topics: Amphetamine-Related Disorders; Cannabis; Case-Control Studies; Female; Humans; Male; Marijuana Abuse

2011
Population drug use in Australia: a wastewater analysis.
    Forensic science international, 2011, Jul-15, Volume: 210, Issue:1-3

    Topics: Australia; Cocaine; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Narcotics; Sewa

2011
Trends and pattern of drug abuse deaths in Maryland teenagers.
    Journal of forensic sciences, 2011, Volume: 56, Issue:4

    Topics: Adolescent; Age Distribution; Black People; Butanes; Cause of Death; Chlorofluorocarbons, Methane; C

2011
Preliminary evidence of hippocampal damage in chronic users of ecstasy.
    Journal of neurology, neurosurgery, and psychiatry, 2012, Volume: 83, Issue:1

    Topics: Adult; Case-Control Studies; Hallucinogens; Hippocampus; Humans; Magnetic Resonance Imaging; Male; M

2012
Deaths involving MDMA and the concomitant use of pharmaceutical drugs.
    Journal of analytical toxicology, 2011, Volume: 35, Issue:4

    Topics: Adult; Drug Interactions; Female; Humans; Male; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine;

2011
Recent trends in pharmaceutical drug use among frequent injecting drug users, frequent methamphetamine users and frequent ecstasy users in New Zealand, 2006-2009.
    Drug and alcohol review, 2011, Volume: 30, Issue:3

    Topics: Adult; Amphetamine-Related Disorders; Female; Humans; Illicit Drugs; Male; Methamphetamine; N-Methyl

2011
Liquid ecstasy intoxication: clinical features of 505 consecutive emergency department patients.
    Emergency medicine journal : EMJ, 2011, Volume: 28, Issue:6

    Topics: Age Distribution; Antidotes; Databases, Factual; Drug Overdose; Emergency Service, Hospital; Emergen

2011
Ecstasy use and suicidal behavior among adolescents: findings from a national survey.
    Suicide & life-threatening behavior, 2011, Volume: 41, Issue:4

    Topics: Adolescent; Age Factors; Child; Data Collection; Family; Female; Humans; Logistic Models; Male; N-Me

2011
'Ecstasy use, by itself, does not result in residual neurotoxicity'- a powerful argument?
    Addiction (Abingdon, England), 2011, Volume: 106, Issue:7

    Topics: Cognition Disorders; Epidemiologic Factors; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Substanc

2011
Reducing "white rush" use: emergency department and multidisciplinary community agency collaboration.
    Journal of emergency nursing, 2011, Volume: 37, Issue:5

    Topics: Community Health Services; Community-Institutional Relations; Emergency Service, Hospital; Female; H

2011
Ecstasy use and associated risk factors among Asian-American youth: findings from a national survey.
    Journal of ethnicity in substance abuse, 2011, Volume: 10, Issue:2

    Topics: Adolescent; Adult; Age Factors; Asian; Child; Crime; Data Collection; Female; Humans; Male; N-Methyl

2011
Refined sewer epidemiology mass balances and their application to heroin, cocaine and ecstasy.
    Environment international, 2011, Volume: 37, Issue:7

    Topics: Cocaine; Heroin; Humans; Illicit Drugs; N-Methyl-3,4-methylenedioxyamphetamine; Sewage; Substance Ab

2011
Impact of a transient instability of the ecstasy market on health concerns and drug use patterns in The Netherlands.
    The International journal on drug policy, 2012, Volume: 23, Issue:2

    Topics: European Union; Hallucinogens; Harm Reduction; Health Policy; Humans; N-Methyl-3,4-methylenedioxyamp

2012
MDMA (Ecstasy) association with impaired fMRI BOLD thalamic coherence and functional connectivity.
    Drug and alcohol dependence, 2012, Jan-01, Volume: 120, Issue:1-3

    Topics: Adolescent; Adult; Case-Control Studies; Female; Functional Neuroimaging; Humans; Magnetic Resonance

2012
[Drunkenness, driving and sexual relations in young cocaine and ecstasy users].
    Adicciones, 2011, Volume: 23, Issue:3

    Topics: Adolescent; Adult; Alcoholic Intoxication; Automobile Driving; Cocaine-Related Disorders; Female; Ha

2011
Reward sensitivity and outcome expectancies as predictors of ecstasy use in young adults.
    Addictive behaviors, 2011, Volume: 36, Issue:12

    Topics: Adolescent; Adult; Australia; Female; Hallucinogens; Humans; Male; N-Methyl-3,4-methylenedioxyamphet

2011
Marked decline in 3,4-methylenedioxymethamphetamine (MDMA) based on wastewater analysis.
    Journal of studies on alcohol and drugs, 2011, Volume: 72, Issue:5

    Topics: Australia; Chromatography, High Pressure Liquid; Cocaine; Cross-Sectional Studies; Humans; Illicit D

2011
Electrophysiological indices of altered working memory processes in long-term ecstasy users.
    Human psychopharmacology, 2011, Volume: 26, Issue:7

    Topics: Adult; Cognition; Electroencephalography; Evoked Potentials; Female; Hallucinogens; Humans; Male; Me

2011
Ecstasy use and self-reported disturbances in sleep.
    Human psychopharmacology, 2011, Volume: 26, Issue:7

    Topics: Adolescent; Adult; Age Factors; Female; Hallucinogens; Humans; Male; Middle Aged; N-Methyl-3,4-methy

2011
Effectiveness of and challenges faced by surveillance systems.
    Drug testing and analysis, 2011, Volume: 3, Issue:9

    Topics: Australia; Cocaine; Humans; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine;

2011
Prospective memory deficits in Ecstasy users: effects of longer ongoing task delay interval.
    Journal of clinical and experimental neuropsychology, 2011, Volume: 33, Issue:10

    Topics: Adolescent; Adult; Alcohols; Analysis of Variance; Female; Humans; Male; Memory Disorders; Memory, E

2011
The influence of genetic and environmental factors among MDMA users in cognitive performance.
    PloS one, 2011, Volume: 6, Issue:11

    Topics: Attention; Cannabis; Cognition; Dose-Response Relationship, Drug; Environment; Female; Genotype; Hum

2011
Evidence for chronically altered serotonin function in the cerebral cortex of female 3,4-methylenedioxymethamphetamine polydrug users.
    Archives of general psychiatry, 2012, Volume: 69, Issue:4

    Topics: Adolescent; Adult; Amphetamine-Related Disorders; Cerebral Cortex; Female; Fluorine Radioisotopes; F

2012
Emerging psychoactive substance use among regular ecstasy users in Australia.
    Drug and alcohol dependence, 2012, Jul-01, Volume: 124, Issue:1-2

    Topics: Adolescent; Adult; Australia; Drug Users; Female; Humans; Illicit Drugs; Male; Middle Aged; N-Methyl

2012
Effects of ecstasy/polydrug use on memory for associative information.
    Psychopharmacology, 2012, Volume: 222, Issue:4

    Topics: Adult; Association Learning; Drug Users; Female; Humans; Illicit Drugs; Male; Memory; N-Methyl-3,4-m

2012
The effects of multitasking on psychological stress reactivity in recreational users of cannabis and MDMA.
    Human psychopharmacology, 2012, Volume: 27, Issue:2

    Topics: Adult; Affect; Age Factors; Cannabis; Female; Hallucinogens; Humans; Male; Marijuana Abuse; N-Methyl

2012
Residual effects of ecstasy (3,4-methylenedioxymethamphetamine) on low level visual processes.
    Human psychopharmacology, 2012, Volume: 27, Issue:2

    Topics: Adolescent; Adult; Cannabis; Case-Control Studies; Female; Figural Aftereffect; Hallucinogens; Human

2012
Drug detection dogs in Australia: more bark than bite?
    Drug and alcohol review, 2012, Volume: 31, Issue:6

    Topics: Adult; Animals; Australia; Cross-Sectional Studies; Dogs; Female; Humans; Illicit Drugs; Male; N-Met

2012
Estimation of community-wide drugs use via stereoselective profiling of sewage.
    The Science of the total environment, 2012, Apr-15, Volume: 423

    Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; England; Humans; Illicit Drugs; Methamphetamine; N-Meth

2012
Measuring research influence on drug policy: a case example of two epidemiological monitoring systems.
    The International journal on drug policy, 2013, Volume: 24, Issue:1

    Topics: Access to Information; Administrative Personnel; Decision Making; Drug and Narcotic Control; Epidemi

2013
Simultaneous polysubstance use among Danish 3,4-methylenedioxymethamphetamine and hallucinogen users: combination patterns and proposed biological bases.
    Human psychopharmacology, 2012, Volume: 27, Issue:4

    Topics: Adolescent; Adult; Cross-Sectional Studies; Data Collection; Denmark; Female; Hair; Hallucinogens; H

2012
Moral decision-making in polysubstance dependent individuals.
    Drug and alcohol dependence, 2012, Dec-01, Volume: 126, Issue:3

    Topics: Adult; Alcoholism; Case-Control Studies; Cocaine-Related Disorders; Decision Making; Heroin Dependen

2012
Neural correlates of the severity of cocaine, heroin, alcohol, MDMA and cannabis use in polysubstance abusers: a resting-PET brain metabolism study.
    PloS one, 2012, Volume: 7, Issue:6

    Topics: Adult; Brain; Cannabis; Cocaine; Demography; Ethanol; Female; Heroin; Humans; Illicit Drugs; Male; N

2012
Drugs of abuse in wastewater and suspended particulate matter--further developments in sewage epidemiology.
    Environment international, 2012, Nov-01, Volume: 48

    Topics: Cocaine; Czech Republic; Environmental Monitoring; Illicit Drugs; Methamphetamine; N-Methyl-3,4-meth

2012
Self-reports of executive dysfunction in current ecstasy/polydrug Users.
    Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology, 2012, Volume: 25, Issue:3

    Topics: Adolescent; Adult; Cognition Disorders; Diagnostic Self Evaluation; Drug Users; Executive Function;

2012
Motor cortex and corticospinal excitability in humans with a history of illicit stimulant use.
    Journal of applied physiology (Bethesda, Md. : 1985), 2012, Volume: 113, Issue:9

    Topics: Adolescent; Adult; Amphetamine-Related Disorders; Central Nervous System Stimulants; Electromyograph

2012
Interview as intervention: the case of young adult multidrug users in the club scene.
    Journal of substance abuse treatment, 2013, Volume: 44, Issue:3

    Topics: Adolescent; Adult; Benzodiazepines; Cocaine-Related Disorders; Female; Florida; Focus Groups; Humans

2013
[Emotion regulation among psychostimulants drug users at techno parties].
    L'Encephale, 2012, Volume: 38, Issue:5

    Topics: Affective Symptoms; Awareness; Central Nervous System Stimulants; Cocaine-Related Disorders; Comorbi

2012
Increase in serious ecstasy-related incidents in the Netherlands.
    Lancet (London, England), 2012, Oct-20, Volume: 380, Issue:9851

    Topics: Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Netherlands; Substance-Related Disord

2012
Do prenatally methamphetamine-exposed adult male rats display general predisposition to drug abuse in the conditioned place preference test?
    Physiological research, 2012, Volume: 61, Issue:Suppl 2

    Topics: Amphetamine; Animals; Behavior, Animal; Central Nervous System Stimulants; Conditioning, Psychologic

2012
Types of polydrug use among Spanish adolescents.
    Addictive behaviors, 2013, Volume: 38, Issue:3

    Topics: Adolescent; Age of Onset; Alcohol Drinking; Amphetamine-Related Disorders; Child; Cocaine-Related Di

2013
MDMA can increase cortisol levels by 800% in dance clubbers.
    Journal of psychopharmacology (Oxford, England), 2013, Volume: 27, Issue:1

    Topics: Arginine Vasopressin; Catechol O-Methyltransferase; Cytochrome P-450 CYP2D6; Female; Humans; Hydroco

2013
Reply to 'MDMA can increase cortical levels by 800% in dance clubbers' Parrott et al.
    Journal of psychopharmacology (Oxford, England), 2013, Volume: 27, Issue:1

    Topics: Arginine Vasopressin; Catechol O-Methyltransferase; Cytochrome P-450 CYP2D6; Female; Humans; Hydroco

2013
Cognitive function in ecstasy naive abstinent drug dependants and MDMA users.
    Current drug abuse reviews, 2013, Volume: 6, Issue:1

    Topics: Adult; Affect; Case-Control Studies; Cognition; Depression; Drug Users; Female; Humans; Illicit Drug

2013
Sexual identity and drug use harm among high-risk, active substance users.
    Culture, health & sexuality, 2013, Volume: 15, Issue:3

    Topics: Adolescent; Adult; Aged; Alcoholism; Bisexuality; British Columbia; Crack Cocaine; Cross-Sectional S

2013
Circumstances of initiation into new-type drug use among adults in Shanghai: are there differences by types of first new-type drug used?
    Drug and alcohol dependence, 2013, Aug-01, Volume: 131, Issue:3

    Topics: Adolescent; Adult; China; Drug Users; Female; Humans; Illicit Drugs; Ketamine; Male; Methamphetamine

2013
Re: "Spice, bath salts, and the U.S. Military: the emergence of synthetic cannabinoid receptor agonists and cathinones in the U.S. Armed Forces".
    Military medicine, 2013, Volume: 178, Issue:1

    Topics: Alkaloids; Cannabinoid Receptor Agonists; Cannabinoids; Designer Drugs; Humans; Illicit Drugs; Milit

2013
Methodological problems with ecstasy and the SCL-90.
    Psychopharmacology, 2002, Volume: 162, Issue:2

    Topics: Evaluation Studies as Topic; Hallucinogens; Humans; Mental Disorders; N-Methyl-3,4-methylenedioxyamp

2002
Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users.
    Psychopharmacology, 2002, Volume: 162, Issue:2

    Topics: Adolescent; Adult; Association Learning; Attention; Cognition Disorders; Decision Making; Female; Ha

2002
Tooth surface loss: does recreational drug use contribute?
    Clinical oral investigations, 2002, Volume: 6, Issue:2

    Topics: Adolescent; Adult; Amphetamines; Bicuspid; Case-Control Studies; Central Nervous System Stimulants;

2002
Ecstasy is low in league table of major causes of deaths.
    BMJ (Clinical research ed.), 2002, Aug-10, Volume: 325, Issue:7359

    Topics: Cause of Death; England; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Re

2002
Changes in cardiovascular responsiveness and cardiotoxicity elicited during binge administration of Ecstasy.
    The Journal of pharmacology and experimental therapeutics, 2002, Volume: 302, Issue:3

    Topics: Acetylcholine; Animals; Atropine; Blood Pressure; Drug Interactions; Electrocardiography; Hallucinog

2002
Attentional processes in abstinent methylenedioxymethamphetamine (ecstasy) users.
    Applied neuropsychology, 2002, Volume: 9, Issue:2

    Topics: Adult; Attention; Case-Control Studies; Female; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine

2002
Mental disorders in ecstasy users: a prospective-longitudinal investigation.
    Drug and alcohol dependence, 2002, Oct-01, Volume: 68, Issue:2

    Topics: Adolescent; Adult; Causality; Cross-Sectional Studies; Female; Germany; Hallucinogens; Humans; Male;

2002
The BDI of the beholder: an eye to experimental design.
    Journal of psychopharmacology (Oxford, England), 2002, Volume: 16, Issue:3

    Topics: Depression; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Personality Inventory; Psychometrics; Ra

2002
Transient haemolytic anaemia due to ecstasy in a patient on HAART.
    International journal of STD & AIDS, 2002, Volume: 13, Issue:9

    Topics: Administration, Oral; Adult; Anemia, Hemolytic; Antiretroviral Therapy, Highly Active; Drug Interact

2002
[Acute liver failure following the use of ecstasy (MDMA)].
    Zeitschrift fur Gastroenterologie, 2002, Volume: 40, Issue:8

    Topics: Adolescent; Biopsy; Chemical and Drug Induced Liver Injury; Diagnosis, Differential; Female; Humans;

2002
Spontaneous cervical and mediastinal air emphysema after ecstasy abuse.
    Anesthesia and analgesia, 2002, Volume: 95, Issue:4

    Topics: Adult; Hallucinogens; Humans; Male; Mediastinal Emphysema; N-Methyl-3,4-methylenedioxyamphetamine; S

2002
[Designer drugs].
    Medicina clinica, 2002, Sep-28, Volume: 119, Issue:10

    Topics: Designer Drugs; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related Disorders

2002
Assessing the temporal relationship between race and ecstasy use among high school seniors.
    Journal of drug education, 2002, Volume: 32, Issue:3

    Topics: Adolescent; Adolescent Behavior; Adult; Chi-Square Distribution; Female; Humans; Illicit Drugs; Male

2002
Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users.
    Human psychopharmacology, 2002, Volume: 17, Issue:6

    Topics: Anxiety; Depression; Humans; Illicit Drugs; Internet; Memory Disorders; N-Methyl-3,4-methylenedioxya

2002
Rave culture and drug rape.
    Journal of pediatric and adolescent gynecology, 2002, Volume: 15, Issue:4

    Topics: Adolescent; Amphetamine-Related Disorders; Canada; Culture; Dancing; Female; Hallucinogens; Humans;

2002
Review of deaths related to taking ecstasy, England and Wales, 1997-2000.
    BMJ (Clinical research ed.), 2003, Jan-11, Volume: 326, Issue:7380

    Topics: Adolescent; Adult; Cause of Death; England; Female; Hallucinogens; Humans; Incidence; Male; Middle A

2003
Determinants of loneliness of young adult drug users.
    The Journal of psychology, 2002, Volume: 136, Issue:6

    Topics: Adolescent; Adult; Case-Control Studies; Factor Analysis, Statistical; Female; Humans; Loneliness; M

2002
Subarachnoid haemorrhage with "Ecstasy" abuse in a young adult.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2002, Volume: 23, Issue:4

    Topics: Adolescent; Cerebral Angiography; Headache; Hemiplegia; Humans; Intracranial Aneurysm; Male; N-Methy

2002
"Ecstasy" and neurotoxic effects on the brain.
    Toxicology letters, 2003, Jan-13, Volume: 136, Issue:3

    Topics: Brain Chemistry; Cerebrovascular Circulation; Glucose; Hallucinogens; Humans; N-Methyl-3,4-methylene

2003
Narcotics at street level in Denmark. A prospective investigation from 1995 to 2000.
    Forensic science international, 2003, Jan-28, Volume: 131, Issue:2-3

    Topics: Amphetamine; Analysis of Variance; Cocaine; Denmark; Drug Contamination; Drug Packaging; Hallucinoge

2003
Cognitive deficits and cognitive normality in recreational cannabis and Ecstasy/MDMA users.
    Human psychopharmacology, 2003, Volume: 18, Issue:2

    Topics: Cannabis; Cognition; Cognition Disorders; Hallucinogens; Humans; Illicit Drugs; N-Methyl-3,4-methyle

2003
Long-term effects of "ecstasy" use on serotonin transporters of the brain investigated by PET.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2003, Volume: 44, Issue:3

    Topics: Adult; Brain; Carbon Radioisotopes; Carrier Proteins; Female; Hallucinogens; Humans; Image Processin

2003
Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users.
    Psychopharmacology, 2003, Volume: 167, Issue:1

    Topics: Adult; Affect; Brain; Carbon Radioisotopes; Carrier Proteins; Cognition; Cross-Sectional Studies; Fe

2003
The agony of ecstasy: responding to growing MDMA use among college students.
    Journal of American college health : J of ACH, 2002, Volume: 51, Issue:3

    Topics: Adolescent; Adult; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Student Health Ser

2002
Intravenous drug injection habits: drug users' self-reports versus researchers' perception.
    Pharmacology, 2003, Volume: 68, Issue:1

    Topics: Adult; Cocaine; Female; Heroin; Humans; Male; Morphine; N-Methyl-3,4-methylenedioxyamphetamine; Outp

2003
Dataset on deaths related to taking ecstasy looks incomplete.
    BMJ (Clinical research ed.), 2003, Apr-12, Volume: 326, Issue:7393

    Topics: England; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related Disorders;

2003
[On ecstasy].
    Annales pharmaceutiques francaises, 2003, Volume: 61, Issue:3

    Topics: Animals; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Neurons; Neurotoxicity Syndr

2003
Forensic cases involving the use of GHB in The Netherlands.
    Forensic science international, 2003, Apr-23, Volume: 133, Issue:1-2

    Topics: Automobile Driving; Cause of Death; Forensic Medicine; Gas Chromatography-Mass Spectrometry; Halluci

2003
Correlates of ecstasy use among students surveyed through the 1997 College Alcohol Study.
    Journal of drug education, 2003, Volume: 33, Issue:1

    Topics: Adolescent; Adolescent Behavior; Adult; Alcohol Drinking; Female; Hallucinogens; Humans; N-Methyl-3,

2003
[Drug Design].
    Medicina clinica, 2003, Jun-07, Volume: 121, Issue:1

    Topics: Drug Design; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related Disord

2003
Selective neurocognitive deficits associated with multiple doses of ecstasy/MDMA: a reply to Cole.
    Journal of psychopharmacology (Oxford, England), 2003, Volume: 17, Issue:2

    Topics: Clinical Trials as Topic; Cognition Disorders; Dose-Response Relationship, Drug; Hallucinogens; Huma

2003
Increased visual cortical excitability in ecstasy users: a transcranial magnetic stimulation study.
    Journal of neurology, neurosurgery, and psychiatry, 2003, Volume: 74, Issue:8

    Topics: Adult; Female; Hallucinations; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Occipital Lobe;

2003
Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users.
    Progress in neuro-psychopharmacology & biological psychiatry, 2003, Volume: 27, Issue:5

    Topics: Adult; Analysis of Variance; Cognition Disorders; Female; Hippocampus; Humans; Male; Memory Disorder

2003
Profiles of urine samples from participants at rave party in Taiwan: prevalence of ketamine and MDMA abuse.
    Forensic science international, 2003, Sep-09, Volume: 136, Issue:1-3

    Topics: Amphetamines; Gas Chromatography-Mass Spectrometry; Humans; Ketamine; N-Methyl-3,4-methylenedioxyamp

2003
Ecstasy (MDMA): effects and patterns of use reported by users in São Paulo.
    Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999), 2003, Volume: 25, Issue:1

    Topics: Adolescent; Adult; Brazil; Female; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Substance-R

2003
Ecstasy's after-effects.
    Nature, 2003, Sep-18, Volume: 425, Issue:6955

    Topics: Animals; Haplorhini; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; National Insti

2003
Acute basilar artery occlusion treated by thromboaspiration in a cocaine and ecstasy abuser.
    Neurology, 2003, Sep-23, Volume: 61, Issue:6

    Topics: Abciximab; Adult; Antibodies, Monoclonal; Brain Ischemia; Catheterization; Cerebral Hemorrhage; Coca

2003
Importance of cyberspace for the assessment of the drug abuse market: preliminary results from the Psychonaut 2002 project.
    Cyberpsychology & behavior : the impact of the Internet, multimedia and virtual reality on behavior and society, 2003, Volume: 6, Issue:4

    Topics: Behavior, Addictive; Humans; Illicit Drugs; Information Dissemination; Information Storage and Retri

2003
Hypothalamic-pituitary-adrenal axis responses to stress in subjects with 3,4-methylenedioxy-methamphetamine ('ecstasy') use history: correlation with dopamine receptor sensitivity.
    Psychiatry research, 2003, Sep-30, Volume: 120, Issue:2

    Topics: Adrenocorticotropic Hormone; Adult; Bromocriptine; Cognition; Diagnostic and Statistical Manual of M

2003
Reinforcing, subjective, and physiological effects of MDMA in humans: a comparison with d-amphetamine and mCPP.
    Drug and alcohol dependence, 2003, Oct-24, Volume: 72, Issue:1

    Topics: Adolescent; Adult; Affect; Cross-Over Studies; Dextroamphetamine; Dopamine Agonists; Female; Halluci

2003
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 33-2003. A 37-year-old man with a history of alcohol and drug abuse and sudden onset of leg weakness.
    The New England journal of medicine, 2003, Oct-23, Volume: 349, Issue:17

    Topics: Adult; Alcoholism; Arthritis, Gouty; Biopsy; Colchicine; Diagnosis, Differential; Gout Suppressants;

2003
Atrial fibrillation in an adolescent--the agony of ecstasy.
    Pediatric emergency care, 2003, Volume: 19, Issue:5

    Topics: Adolescent; Alcohol Drinking; Atrial Fibrillation; Diagnosis, Differential; Emergencies; Humans; Mal

2003
Rapidly progressive parkinsonism in a self-reported user of ecstasy and other drugs.
    Movement disorders : official journal of the Movement Disorder Society, 2003, Volume: 18, Issue:11

    Topics: Adult; Antiparkinson Agents; Disease Progression; Hallucinogens; Hepatitis C; Humans; Indoles; Male;

2003
Reduced cortical gray matter density in human MDMA (Ecstasy) users: a voxel-based morphometry study.
    Drug and alcohol dependence, 2003, Dec-11, Volume: 72, Issue:3

    Topics: Adolescent; Adult; Brain Mapping; Cerebral Cortex; Female; Humans; Illicit Drugs; Image Processing,

2003
Plasma amino acids in ecstasy users.
    Neuro endocrinology letters, 2003, Volume: 24, Issue:5

    Topics: Adolescent; Amino Acids; Delirium; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Su

2003
A contextual profile of club drug use among adults in Chicago.
    Addiction (Abingdon, England), 2003, Volume: 98, Issue:12

    Topics: Adolescent; Adult; Central Nervous System Stimulants; Chicago; Ethnicity; Female; Hallucinogens; Hum

2003
The role of an international nightlife resort in the proliferation of recreational drugs.
    Addiction (Abingdon, England), 2003, Volume: 98, Issue:12

    Topics: Adolescent; Adult; Alcohol Drinking; Cocaine-Related Disorders; Cross-Sectional Studies; Female; Hal

2003
Relationship between ecstasy use and depression: a study controlling for poly-drug use.
    Psychopharmacology, 2004, Volume: 173, Issue:3-4

    Topics: Adult; Attention; Bias; Depression; Emotions; Female; Humans; Illicit Drugs; Male; N-Methyl-3,4-meth

2004
Factors associated with Ecstasy use in Turkish students.
    Addiction (Abingdon, England), 2004, Volume: 99, Issue:1

    Topics: Adolescent; Adult; Female; Humans; Logistic Models; Male; N-Methyl-3,4-methylenedioxyamphetamine; Pr

2004
The external validity of results derived from ecstasy users recruited using purposive sampling strategies.
    Drug and alcohol dependence, 2004, Jan-07, Volume: 73, Issue:1

    Topics: Adolescent; Adult; Age Factors; Alcohol Drinking; Amphetamine-Related Disorders; Comorbidity; Cross-

2004
Diagnostic tattoo in a parturient with 'ecstasy' use.
    Anaesthesia, 2003, Volume: 58, Issue:12

    Topics: Adolescent; Female; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Pregnancy; Pregna

2003
Circuit parties and patterns of drug use in a subset of gay men.
    Journal of addictive diseases, 2003, Volume: 22, Issue:4

    Topics: Adult; Anniversaries and Special Events; Female; HIV Infections; Homosexuality, Male; Humans; Ketami

2003
Patterns of ecstasy use in Australia: findings from a national household survey.
    Addiction (Abingdon, England), 2004, Volume: 99, Issue:2

    Topics: Adolescent; Adult; Australia; Cross-Sectional Studies; Female; Hallucinogens; Humans; Male; N-Methyl

2004
Shedding new light on the "safe" club drug: methylenedioxymethamphetamine (ecstasy)-related fatalities.
    Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 2004, Volume: 11, Issue:2

    Topics: Adolescent; Adult; Alcohol Drinking; Amphetamine-Related Disorders; Cause of Death; Cohort Studies;

2004
Prepulse inhibition and habituation of acoustic startle response in male MDMA ('ecstasy') users, cannabis users, and healthy controls.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2004, Volume: 29, Issue:5

    Topics: Acoustic Stimulation; Adult; Habituation, Psychophysiologic; Hallucinogens; Humans; Male; Marijuana

2004
Neurocognitive function in users of MDMA: the importance of clinically significant patterns of use.
    Psychological medicine, 2004, Volume: 34, Issue:2

    Topics: Adolescent; Adult; Brain; Cognition Disorders; Depression; Diagnostic and Statistical Manual of Ment

2004
Drugs, recreational drug use and attitudes towards doping of high school athletes.
    International journal of sports medicine, 2004, Volume: 25, Issue:2

    Topics: Adolescent; Alcohols; Cannabis; Doping in Sports; Female; France; Humans; Illicit Drugs; Male; N-Met

2004
Ecstasy use in South Africa: findings from the South African Community Epidemiology Network on Drug Use (SACENDU) project (January 1997-December 2001).
    Substance use & misuse, 2004, Volume: 39, Issue:1

    Topics: Adolescent; Adult; Crime; Demography; Epidemiologic Studies; Female; Hallucinogens; Humans; Male; N-

2004
Street drug use among young patients with Type 1 diabetes in the UK.
    Diabetic medicine : a journal of the British Diabetic Association, 2004, Volume: 21, Issue:3

    Topics: Adolescent; Adult; Cannabis; Cocaine; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Dopamine Upt

2004
Tracking ecstasy trends in the United States with data from three national drug surveillance systems.
    Journal of drug education, 2003, Volume: 33, Issue:3

    Topics: Health Surveys; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Population Surveillance; Prevalence;

2003
[Synthetic drugs: from use to multiple consumption. Some associated risks and a proposal for therapeutic intervention].
    Atencion primaria, 2004, Mar-15, Volume: 33, Issue:4

    Topics: Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Risk Factors; Substance-Related Disor

2004
Impaired executive function in male MDMA ("ecstasy") users.
    Psychopharmacology, 2004, Volume: 175, Issue:3

    Topics: Adolescent; Adult; Cognition; Female; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Substanc

2004
The designer drug situation in Ibiza.
    Forensic science international, 2004, Mar-10, Volume: 140, Issue:2-3

    Topics: Designer Drugs; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Prevalence; Spain; Substance Abuse D

2004
Sources of information about MDMA (3,4-methylenedioxymethamphetamine): perceived accuracy, importance, and implications for prevention among young adult users.
    Drug and alcohol dependence, 2004, Apr-09, Volume: 74, Issue:1

    Topics: Adolescent; Adult; Analysis of Variance; Cross-Sectional Studies; Female; Humans; Internet; Male; N-

2004
[Conclusion of an investigation into the actual condition about "chemical drugs"].
    Chudoku kenkyu : Chudoku Kenkyukai jun kikanshi = The Japanese journal of toxicology, 2004, Volume: 17, Issue:1

    Topics: Chemistry Techniques, Analytical; Designer Drugs; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Su

2004
Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study.
    Addictive behaviors, 2004, Volume: 29, Issue:4

    Topics: Adult; Alcohol Drinking; Central Nervous System Stimulants; Female; Hallucinogens; Humans; Illicit D

2004
[From case to case: Magdalena's world].
    Pflege Zeitschrift, 2004, Volume: 57, Issue:4

    Topics: Adolescent; Counseling; Female; Humans; Inservice Training; N-Methyl-3,4-methylenedioxyamphetamine;

2004
Proton magnetic resonance spectroscopy in ecstasy (MDMA) users.
    Neuroscience letters, 2004, May-20, Volume: 362, Issue:2

    Topics: Adult; Aspartic Acid; Brain; Female; Humans; Magnetic Resonance Spectroscopy; Male; N-Methyl-3,4-met

2004
Psychosocial profiles of older adolescent MDMA users.
    Drug and alcohol dependence, 2004, Jun-11, Volume: 74, Issue:3

    Topics: Adolescent; Adult; Analysis of Variance; Chi-Square Distribution; Female; HIV Infections; Humans; Lo

2004
Information from your family doctor. Club drugs--myths and risks.
    American family physician, 2004, Jun-01, Volume: 69, Issue:11

    Topics: Flunitrazepam; Humans; Ketamine; Leisure Activities; N-Methyl-3,4-methylenedioxyamphetamine; Sodium

2004
Amphetamines and 3,4-methylendioxymetamphetamine (MDMA): evaluation of KIMS (kinetic interaction of microparticles in solution) assay at two cut-off levels.
    Clinical chemistry and laboratory medicine, 2004, Volume: 42, Issue:5

    Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Adult; Amphetamines; Chromatography, High Pressure Liquid

2004
Functional MRI study of working memory in MDMA users.
    Psychopharmacology, 2004, Volume: 177, Issue:1-2

    Topics: Adult; Analysis of Variance; Female; Humans; Magnetic Resonance Imaging; Male; Memory; N-Methyl-3,4-

2004
A voxel-based PET investigation of the long-term effects of "Ecstasy" consumption on brain serotonin transporters.
    The American journal of psychiatry, 2004, Volume: 161, Issue:7

    Topics: Adult; Brain; Carbon Radioisotopes; Carrier Proteins; Dose-Response Relationship, Drug; Female; Huma

2004
[Synthetic drugs consumed at "rave parties"].
    Annales pharmaceutiques francaises, 2004, Volume: 62, Issue:3

    Topics: Amphetamine-Related Disorders; Amphetamines; France; Hallucinogens; Humans; Illicit Drugs; N-Methyl-

2004
Corneal abrasion from Vick's Vapor.
    The American journal of emergency medicine, 2004, Volume: 22, Issue:4

    Topics: Adolescent; Corneal Diseases; Drug Combinations; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamin

2004
Unprotected anal intercourse associated with recreational drug use among young men who have sex with men depends on partner type and intercourse role.
    Sexually transmitted diseases, 2004, Volume: 31, Issue:8

    Topics: Adult; Alcohol Drinking; British Columbia; Cannabis; Cohort Studies; HIV Infections; Homosexuality,

2004
Ecstasy agonistes: a retracted study on a controversial substance raises questions about the reliability of government-sponsored research on drugs.
    The Chronicle of higher education, 2004, Feb-27, Volume: 50, Issue:25

    Topics: Animals; Biomedical Research; Brain; Financing, Government; Humans; N-Methyl-3,4-methylenedioxyamphe

2004
Outcome expectancies and ecstasy use in visitors of rave parties in The Netherlands.
    European addiction research, 2004, Volume: 10, Issue:4

    Topics: Adolescent; Adult; Affect; Awareness; Cross-Sectional Studies; Female; Hallucinogens; Health Educati

2004
MDMA/Ecstasy use among young people in Ohio: perceived risk and barriers to intervention.
    Journal of psychoactive drugs, 2004, Volume: 36, Issue:2

    Topics: Adolescent; Adult; Case-Control Studies; Female; Focus Groups; Humans; Interviews as Topic; Male; N-

2004
Memory-related hippocampal dysfunction in poly-drug ecstasy (3,4-methylenedioxymethamphetamine) users.
    Psychopharmacology, 2005, Volume: 180, Issue:4

    Topics: Adult; Amphetamine; Brain Mapping; Cannabis; Female; Hallucinogens; Hippocampus; Humans; Magnetic Re

2005
Impulsivity, risk taking and recreational 'ecstasy' (MDMA) use.
    Drug and alcohol dependence, 2004, Oct-05, Volume: 76, Issue:1

    Topics: Adolescent; Adult; Analysis of Variance; Chi-Square Distribution; Female; Humans; Illicit Drugs; Imp

2004
A behavioural economic analysis of alcohol, amphetamine, cocaine and ecstasy purchases by polysubstance misusers.
    Drug and alcohol dependence, 2004, Oct-05, Volume: 76, Issue:1

    Topics: Adolescent; Adult; Alcoholic Beverages; Amphetamine; Analysis of Variance; Choice Behavior; Cocaine;

2004
Persistent neuropsychological problems after 7 years of abstinence from recreational Ecstasy (MDMA): a case study.
    Psychological reports, 2004, Volume: 95, Issue:1

    Topics: Adrenergic Uptake Inhibitors; Adult; Depressive Disorder; Erectile Dysfunction; Follow-Up Studies; H

2004
Toward an ecstasy and other club drug (EOCD) prevention intervention for rave attendees.
    Journal of drug education, 2004, Volume: 34, Issue:1

    Topics: Adult; District of Columbia; Female; Homosexuality; Humans; Illicit Drugs; Male; N-Methyl-3,4-methyl

2004
Loud noise enhances nigrostriatal dopamine toxicity induced by MDMA in mice.
    Microscopy research and technique, 2004, Jul-01, Volume: 64, Issue:4

    Topics: Animals; Body Temperature; Dopamine; Drug Administration Schedule; Drug Interactions; Hallucinogens;

2004
N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy').
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2005, Volume: 30, Issue:3

    Topics: Animals; Disease Models, Animal; Dopamine; Humans; Kinetics; Male; Microdialysis; N-Methyl-3,4-methy

2005
Preexposure to MDMA ("Ecstasy") delays acquisition but facilitates MDMA-induced reinstatement of amphetamine self-administration behavior in rats.
    Pharmacology, biochemistry, and behavior, 2004, Volume: 79, Issue:2

    Topics: Animals; Behavior, Animal; Brain; Dextroamphetamine; Drug Interactions; Extinction, Psychological; H

2004
Evidence for executive deficits among users of MDMA (Ecstasy).
    British journal of psychology (London, England : 1953), 2004, Volume: 95, Issue:Pt 4

    Topics: Adult; Cognition; Cognition Disorders; Female; Hallucinogens; Humans; Male; N-Methyl-3,4-methylenedi

2004
Club drugs: reasons for and consequences of use.
    Journal of psychoactive drugs, 2004, Volume: 36, Issue:3

    Topics: Adolescent; Adult; Central Nervous System Stimulants; Dextromethorphan; Female; Flunitrazepam; Hallu

2004
Differential effects of MDMA, cocaine, and cannabis use severity on distinctive components of the executive functions in polysubstance users: a multiple regression analysis.
    Addictive behaviors, 2005, Volume: 30, Issue:1

    Topics: Adult; Alcoholism; Cocaine-Related Disorders; Cognition Disorders; Female; Humans; Male; Marijuana A

2005
The acute and sub-acute effects of 'ecstasy' (MDMA) on processing of facial expressions: preliminary findings.
    Drug and alcohol dependence, 2004, Dec-07, Volume: 76, Issue:3

    Topics: Adult; Emotions; Facial Expression; Female; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Re

2004
Ecstasy/MDMA and cannabis: the complexities of their interactive neuropsychobiological effects.
    Journal of psychopharmacology (Oxford, England), 2004, Volume: 18, Issue:4

    Topics: Cannabis; Drug Interactions; Hallucinogens; Humans; Marijuana Abuse; N-Methyl-3,4-methylenedioxyamph

2004
[Speed users (metamphetamines): a return journey between ecstasy (MDMA) and cocaine. Clinical, preventive and health-care questions].
    Atencion primaria, 2004, Volume: 34, Issue:10

    Topics: Adolescent; Adult; Central Nervous System Stimulants; Cocaine-Related Disorders; Hallucinogens; Huma

2004
Visuo-spatial working memory deficits in current and former users of MDMA ('ecstasy').
    Human psychopharmacology, 2005, Volume: 20, Issue:2

    Topics: Adult; Age Factors; Alcohol Drinking; Analysis of Variance; Educational Status; Hallucinogens; Human

2005
[Acute giant cell hepatitis in a 17-year old man].
    Praxis, 2004, Dec-08, Volume: 93, Issue:50

    Topics: Adolescent; Chemical and Drug Induced Liver Injury; Giant Cells; Hallucinogens; Humans; Jaundice; Li

2004
Is ecstasy perceived to be safe? A critical survey.
    Drug and alcohol dependence, 2005, Feb-14, Volume: 77, Issue:2

    Topics: Adolescent; Adult; Data Collection; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Perception; Risk

2005
Spontaneous pneumomediastinum and myocarditis following Ecstasy use: a case report.
    European journal of emergency medicine : official journal of the European Society for Emergency Medicine, 2005, Volume: 12, Issue:1

    Topics: Adolescent; Dancing; Electrocardiography; Emergency Medicine; Humans; Male; Mediastinal Emphysema; M

2005
Oral health sensations associated with illicit drug abuse.
    British dental journal, 2005, Feb-12, Volume: 198, Issue:3

    Topics: Adolescent; Adult; Bruxism; Facial Pain; Female; Hong Kong; Humans; Male; Mouth Diseases; N-Methyl-3

2005
Association of a functional polymorphism in the serotonin transporter gene with abnormal emotional processing in ecstasy users.
    The American journal of psychiatry, 2005, Volume: 162, Issue:3

    Topics: Adult; Affective Symptoms; Depressive Disorder; Diagnosis, Dual (Psychiatry); Female; Genotype; Huma

2005
Characteristics of ecstasy users in Sãio Paulo, Brazil.
    Substance use & misuse, 2005, Volume: 40, Issue:3

    Topics: Adult; Anxiety; Brazil; Catchment Area, Health; Depression; Disruptive, Impulse Control, and Conduct

2005
Subarachnoid hemorrhage and death following coingestion of MDMA with other drugs.
    Journal of the Chinese Medical Association : JCMA, 2004, Volume: 67, Issue:12

    Topics: Adult; Common Cold; Death; Female; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Pu

2004
Memory performance in polyvalent MDMA (ecstasy) users who continue or discontinue MDMA use.
    Drug and alcohol dependence, 2005, Jun-01, Volume: 78, Issue:3

    Topics: Adult; Brain; Cross-Sectional Studies; Demography; Female; Follow-Up Studies; Hallucinogens; Humans;

2005
Risk and benefit perceptions of party drug use.
    Addictive behaviors, 2006, Volume: 31, Issue:1

    Topics: Adolescent; Adult; Australia; Cross-Sectional Studies; Female; Harm Reduction; Health Knowledge, Att

2006
Pathways into ecstasy use: the role of prior cannabis use and ecstasy availability.
    Drug and alcohol dependence, 2005, Sep-01, Volume: 79, Issue:3

    Topics: Adolescent; Adult; Age of Onset; Comorbidity; Data Collection; Data Interpretation, Statistical; Fem

2005
Prevalence and correlates of current depressive symptomatology among a community sample of MDMA users in Ohio.
    Addictive behaviors, 2006, Volume: 31, Issue:1

    Topics: Adult; Cross-Sectional Studies; Depressive Disorder; Female; Hallucinogens; Humans; Logistic Models;

2006
Assessment of exposure to opiates and cocaine during pregnancy in a Mediterranean city: preliminary results of the "Meconium Project".
    Forensic science international, 2005, Oct-04, Volume: 153, Issue:1

    Topics: Abortion, Induced; Adult; Arecoline; Body Height; Cholinergic Agonists; Cocaine; Dopamine Uptake Inh

2005
Comment on Soar, et al.'s case study of problems and use of Ecstasy.
    Psychological reports, 2005, Volume: 96, Issue:2

    Topics: Cognition Disorders; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related Disorders; Ti

2005
Drug use practices among MDMA/ecstasy users in Ohio: a latent class analysis.
    Drug and alcohol dependence, 2005, Aug-01, Volume: 79, Issue:2

    Topics: Adolescent; Adult; Female; Hallucinogens; Humans; Male; Models, Statistical; N-Methyl-3,4-methylened

2005
The differential effects of ecstasy/polydrug use on executive components: shifting, inhibition, updating and access to semantic memory.
    Psychopharmacology, 2005, Volume: 182, Issue:2

    Topics: Adult; Cognition; Female; Humans; Male; Memory; Memory Disorders; N-Methyl-3,4-methylenedioxyampheta

2005
Psychological symptoms and drug use severity among Israeli adolescents presenting for outpatient drug abuse treatment.
    Journal of adolescence, 2005, Volume: 28, Issue:4

    Topics: Adolescent; Ambulatory Care; Attention Deficit and Disruptive Behavior Disorders; Depression; Female

2005
Reasoning deficits in ecstasy (MDMA) polydrug users.
    Psychopharmacology, 2005, Volume: 181, Issue:3

    Topics: Adult; Amphetamine-Related Disorders; Attention; Cocaine-Related Disorders; Female; Humans; Illicit

2005
Five-year trends in patterns of drug use among people who use stimulants in dance contexts in the United Kingdom.
    Addiction (Abingdon, England), 2005, Volume: 100, Issue:8

    Topics: Adolescent; Adult; Cross-Sectional Studies; Dancing; Female; Hallucinogens; Humans; Illicit Drugs; M

2005
The rise of club drugs in a heroin society: the case of Hong Kong.
    Substance use & misuse, 2005, Volume: 40, Issue:9-10

    Topics: Adult; Anesthetics, Dissociative; Dancing; Focus Groups; Hallucinogens; Health Policy; Health Survey

2005
Club drug use in Germany.
    Substance use & misuse, 2005, Volume: 40, Issue:9-10

    Topics: Adolescent; Adult; Amphetamine-Related Disorders; Child; Cross-Sectional Studies; Cultural Character

2005
Club drug use among young men who have sex with men in NYC: a preliminary epidemiological profile.
    Substance use & misuse, 2005, Volume: 40, Issue:9-10

    Topics: Adolescent; Adult; Anesthetics, Dissociative; Central Nervous System Stimulants; Chronic Disease; Cr

2005
Conceptions of risk in the lives of club drug-using youth.
    Substance use & misuse, 2005, Volume: 40, Issue:9-10

    Topics: Adolescent; Adult; Anthropology, Cultural; Attitude to Health; Depression; Female; Hallucinogens; He

2005
An in-depth qualitative examination of the ecstasy experience: results of a focus group with ecstasy-using college students.
    Substance use & misuse, 2005, Volume: 40, Issue:9-10

    Topics: Adolescent; Adult; Dancing; Female; Focus Groups; Hallucinogens; Humans; Male; Motivation; N-Methyl-

2005
From "Candy Kids" to "Chemi-Kids": a typology of young adults who attend raves in the midwestern United States.
    Substance use & misuse, 2005, Volume: 40, Issue:9-10

    Topics: Adult; Comorbidity; Cross-Sectional Studies; Cultural Characteristics; Dancing; Female; Focus Groups

2005
Criminal involvement among young male ecstasy users.
    Substance use & misuse, 2005, Volume: 40, Issue:9-10

    Topics: Adult; Crime; Hallucinogens; Health Surveys; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; R

2005
A PDA-based system for online recording and analysis of concurrent events in complex behavioral processes.
    Behavior research methods, 2005, Volume: 37, Issue:1

    Topics: Adult; Behaviorism; Computers, Handheld; Data Collection; Data Interpretation, Statistical; Female;

2005
Mental disorders in current and former heavy ecstasy (MDMA) users.
    Addiction (Abingdon, England), 2005, Volume: 100, Issue:9

    Topics: Adult; Amphetamine-Related Disorders; Anxiety Disorders; Cognition Disorders; Cross-Sectional Studie

2005
Reversibility of ecstasy-induced reduction in serotonin transporter availability in polydrug ecstasy users.
    European journal of nuclear medicine and molecular imaging, 2006, Volume: 33, Issue:2

    Topics: Adolescent; Adult; Brain; Female; Follow-Up Studies; Humans; Isoquinolines; Male; N-Methyl-3,4-methy

2006
The effects of stereotype threat on cognitive function in ecstasy users.
    Journal of psychopharmacology (Oxford, England), 2006, Volume: 20, Issue:4

    Topics: Adolescent; Adult; Brain Damage, Chronic; Cognition; Cues; Female; Hallucinogens; Humans; Logistic M

2006
Ecstasy use and its association with sexual behaviors among drug users in New York City.
    Journal of community health, 2005, Volume: 30, Issue:5

    Topics: Adolescent; Adult; Female; Humans; Interviews as Topic; Male; N-Methyl-3,4-methylenedioxyamphetamine

2005
Bilateral angle-closure glaucoma after combined consumption of "ecstasy" and marijuana.
    The American journal of emergency medicine, 2005, Volume: 23, Issue:6

    Topics: Adult; Cannabis; Emergency Medicine; Female; Glaucoma, Angle-Closure; Gonioscopy; Humans; Illicit Dr

2005
Correlates of Ecstasy use in middle age and beyond.
    Drug and alcohol review, 2005, Volume: 24, Issue:1

    Topics: Aged; Attitude; Australia; Female; Hallucinogens; Humans; Illicit Drugs; Male; Middle Aged; N-Methyl

2005
Concealment of drugs by police detainees: lessons learned from adverse incidents and from 'routine' clinical practice.
    Journal of clinical forensic medicine, 2005, Volume: 12, Issue:5

    Topics: Adolescent; Adult; Airway Obstruction; Amphetamines; Cannabinoids; Cocaine; Crime; Deglutition; Dopa

2005
Patterns of use and harm reduction practices of ecstasy users in Australia.
    Drug and alcohol dependence, 2006, Apr-28, Volume: 82, Issue:2

    Topics: Adult; Australia; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Patient Acceptance of Health Care;

2006
Methylenedioxymethamphetamine (ecstasy)-related hyperthermia.
    The Journal of emergency medicine, 2005, Volume: 29, Issue:4

    Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Fatal Outcome; Female; Fever; Hallucinogens; Humans

2005
Ecstasy (MDMA) exposure and neuropsychological functioning: a polydrug perspective.
    Journal of the International Neuropsychological Society : JINS, 2005, Volume: 11, Issue:6

    Topics: Adolescent; Adult; Analysis of Variance; Chi-Square Distribution; Cognition; Cognition Disorders; De

2005
Drug-facilitated rape.
    The journal of family planning and reproductive health care, 2002, Volume: 28, Issue:3

    Topics: Alcohol Drinking; Crime Victims; Flunitrazepam; Forensic Medicine; Humans; Memory Disorders; N-Methy

2002
Elevated impulsivity and impaired decision-making in abstinent Ecstasy (MDMA) users compared to polydrug and drug-naïve controls.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2006, Volume: 31, Issue:7

    Topics: Adult; Analysis of Variance; Decision Making; Discrimination, Psychological; Female; Hallucinogens;

2006
Chronic ecstasy (MDMA) use is associated with deficits in task-switching but not inhibition or memory updating executive functions.
    Drug and alcohol dependence, 2006, Jun-28, Volume: 83, Issue:2

    Topics: Adult; Chronic Disease; Cognition Disorders; Female; Humans; Inhibition, Psychological; Male; Memory

2006
Methylone and mCPP, two new drugs of abuse?
    Addiction biology, 2005, Volume: 10, Issue:4

    Topics: Adrenergic Uptake Inhibitors; Biogenic Monoamines; Cross-Sectional Studies; Designer Drugs; Humans;

2005
A reliable model of intravenous MDMA self-administration in naïve mice.
    Psychopharmacology, 2006, Volume: 184, Issue:2

    Topics: Animals; Autoradiography; Conditioning, Operant; Dopamine Plasma Membrane Transport Proteins; Dopami

2006
Prescription drug abuse among ecstasy users in Miami.
    Journal of addictive diseases, 2005, Volume: 24, Issue:4

    Topics: Adolescent; Adult; Alprazolam; Catchment Area, Health; Diazepam; Drug Prescriptions; Ethnicity; Fema

2005
Acute medical problems due to Ecstasy use. Case-series of emergency department visits.
    Swiss medical weekly, 2005, Oct-29, Volume: 135, Issue:43-44

    Topics: Adolescent; Adult; Emergency Service, Hospital; Female; Humans; Male; Medical Audit; N-Methyl-3,4-me

2005
The Netherlands XTC Toxicity (NeXT) study: objectives and methods of a study investigating causality, course, and clinical relevance.
    International journal of methods in psychiatric research, 2005, Volume: 14, Issue:4

    Topics: Adolescent; Adult; Analysis of Variance; Brain; Diagnostic Imaging; Female; Humans; Male; N-Methyl-3

2005
The varieties of ecstatic experience: an exploration of the subjective experiences of ecstasy.
    Journal of psychopharmacology (Oxford, England), 2006, Volume: 20, Issue:5

    Topics: Adolescent; Adult; Affect; Aged; Drug Interactions; Esthetics; Female; Hallucinogens; Humans; Male;

2006
Development of murine monoclonal antibodies to methamphetamine and methamphetamine analogues.
    Journal of immunological methods, 2006, Feb-20, Volume: 309, Issue:1-2

    Topics: Animals; Antibodies, Monoclonal; Antibody Affinity; Antibody Specificity; Haptens; Humans; Hybridoma

2006
Sex, touch, and HIV risk among ecstasy users.
    AIDS and behavior, 2006, Volume: 10, Issue:2

    Topics: Adolescent; Adult; Catchment Area, Health; Cross-Sectional Studies; Female; Georgia; HIV Seropositiv

2006
Concurrent use of methamphetamine, MDMA, LSD, ketamine, GHB, and flunitrazepam among American youths.
    Drug and alcohol dependence, 2006, Sep-01, Volume: 84, Issue:1

    Topics: Adolescent; Adult; Age of Onset; Data Collection; Demography; Female; Flunitrazepam; Humans; Inciden

2006
Symptoms of anxiety and depression in childhood and use of MDMA: prospective, population based study.
    BMJ (Clinical research ed.), 2006, Apr-08, Volume: 332, Issue:7545

    Topics: Adolescent; Adult; Anxiety Disorders; Child; Child, Preschool; Depressive Disorder; Female; Hallucin

2006
National Drugs Campaign--the GP's role in reducing illicit drug use.
    Australian family physician, 2006, Volume: 35, Issue:3

    Topics: Adolescent; Alcohol-Related Disorders; Amphetamine-Related Disorders; Australia; Communications Medi

2006
Memory impairment in now abstinent MDMA users and continued users: a longitudinal follow-up.
    Neurology, 2006, Mar-14, Volume: 66, Issue:5

    Topics: Adult; Follow-Up Studies; Humans; Longitudinal Studies; Memory; Memory Disorders; N-Methyl-3,4-methy

2006
Increased risk of "club" drug use among gay and bisexual high school students in British Columbia.
    The Journal of adolescent health : official publication of the Society for Adolescent Medicine, 2006, Volume: 38, Issue:4

    Topics: Adolescent; Adult; Anesthetics, Dissociative; Bisexuality; British Columbia; Central Nervous System

2006
Recreational ecstasy use: acute effects potentiated by ambient conditions?
    Neuropsychobiology, 2006, Volume: 53, Issue:2

    Topics: Adult; Dancing; Drug Synergism; Environment; Female; Hallucinogens; Humans; Male; Music; N-Methyl-3,

2006
MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgement processes.
    Journal of psychopharmacology (Oxford, England), 2006, Volume: 20, Issue:3

    Topics: Adolescent; Adult; Alcoholism; Amphetamine-Related Disorders; Attention; Cocaine-Related Disorders;

2006
Vasopressin and oxytocin secretion in response to the consumption of ecstasy in a clubbing population.
    Journal of psychopharmacology (Oxford, England), 2006, Volume: 20, Issue:3

    Topics: Adolescent; Adult; Arginine Vasopressin; Arousal; Female; Homeostasis; Humans; Illicit Drugs; Inappr

2006
Cognitive determinants of MDMA use among college students in Southern Taiwan.
    Addictive behaviors, 2006, Volume: 31, Issue:12

    Topics: Cognition; Female; Hallucinogens; Health Knowledge, Attitudes, Practice; Humans; Intention; Interper

2006
Ecstasy and the antecedents of illicit drug use.
    BMJ (Clinical research ed.), 2006, Apr-08, Volume: 332, Issue:7545

    Topics: Anxiety Disorders; Depressive Disorder; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamin

2006
Differences in club drug use between heterosexual and lesbian/bisexual females.
    Addictive behaviors, 2006, Volume: 31, Issue:12

    Topics: Adolescent; Adult; Age Factors; Amphetamine-Related Disorders; Bisexuality; Cocaine-Related Disorder

2006
A profile of Ecstasy (MDMA) use in São Paulo, Brazil: an ethnographic study.
    Journal of psychoactive drugs, 2006, Volume: 38, Issue:1

    Topics: Adult; Brazil; Demography; Female; Humans; Interviews as Topic; Male; N-Methyl-3,4-methylenedioxyamp

2006
Psychiatric disorders and their correlates among young adult MDMA users in Ohio.
    Journal of psychoactive drugs, 2006, Volume: 38, Issue:1

    Topics: Adolescent; Adult; Analysis of Variance; Depressive Disorder; Female; Humans; Interviews as Topic; M

2006
Incidence and patterns of polydrug use and craving for ecstasy in regular ecstasy users: an ecological momentary assessment study.
    Drug and alcohol dependence, 2006, Dec-01, Volume: 85, Issue:3

    Topics: Adult; Alcoholism; Comorbidity; Demography; Diagnostic and Statistical Manual of Mental Disorders; D

2006
MDMA use is associated with increased spatial BOLD fMRI visual cortex activation in human MDMA users.
    Pharmacology, biochemistry, and behavior, 2006, Volume: 84, Issue:2

    Topics: Adolescent; Adult; Female; Humans; Magnetic Resonance Imaging; Male; N-Methyl-3,4-methylenedioxyamph

2006
Patterns of simultaneous polysubstance use in drug using university students.
    Human psychopharmacology, 2006, Volume: 21, Issue:4

    Topics: Adolescent; Adult; Alcoholism; Cocaine; Ethanol; Female; Humans; Male; Marijuana Abuse; N-Methyl-3,4

2006
Alcohol use and risk taking among regular ecstasy users.
    Substance use & misuse, 2006, Volume: 41, Issue:8

    Topics: Adolescent; Adult; Alcohol Drinking; Australia; Catchment Area, Health; Female; Humans; Male; Middle

2006
Long-term voluntary consumption of MDMA and THC in rats is modified by individual and situational factors.
    Addiction biology, 2006, Volume: 11, Issue:2

    Topics: Animals; Behavior, Animal; Choice Behavior; Disease Models, Animal; Dronabinol; Hallucinogens; Male;

2006
Dancing hot on Ecstasy: physical activity and thermal comfort ratings are associated with the memory and other psychobiological problems reported by recreational MDMA users.
    Human psychopharmacology, 2006, Volume: 21, Issue:5

    Topics: Adolescent; Adult; Chi-Square Distribution; Dancing; Female; Hallucinogens; Humans; Male; Memory; N-

2006
Characteristics of admissions for primary stimulant dependence during 2001.
    Substance use & misuse, 2006, Volume: 41, Issue:9

    Topics: Adult; Central Nervous System Stimulants; Diagnostic Tests, Routine; Ethnicity; Female; Humans; Male

2006
[Modalities of drug consumption among male prostitutes].
    Sante publique (Vandoeuvre-les-Nancy, France), 2006, Volume: 18, Issue:2

    Topics: Adult; Alcoholism; Amphetamine-Related Disorders; Attitude to Health; Cocaine-Related Disorders; Eth

2006
Impulsivity and BOLD fMRI activation in MDMA users and healthy control subjects.
    Psychiatry research, 2006, Oct-30, Volume: 147, Issue:2-3

    Topics: Adult; Brain; Hallucinogens; Health Status; Humans; Impulsive Behavior; Magnetic Resonance Imaging;

2006
Electroconvulsive therapy in the treatment of depression in a former ecstasy user.
    Journal of psychopharmacology (Oxford, England), 2006, Volume: 20, Issue:6

    Topics: Adrenergic Uptake Inhibitors; Adult; Depressive Disorder, Major; Drug Resistance; Electroconvulsive

2006
Recent-onset ecstasy use: association with deviant behaviors and psychiatric comorbidity.
    Experimental and clinical psychopharmacology, 2006, Volume: 14, Issue:3

    Topics: Adolescent; Adult; Child; Data Collection; Diagnosis, Dual (Psychiatry); Female; Humans; Likelihood

2006
The effect of polymorphism at the serotonin transporter gene on decision-making, memory and executive function in ecstasy users and controls.
    Psychopharmacology, 2006, Volume: 188, Issue:2

    Topics: Case-Control Studies; Cognition; Decision Making; Humans; Memory; N-Methyl-3,4-methylenedioxyampheta

2006
Who is becoming hallucinogen dependent soon after hallucinogen use starts?
    Drug and alcohol dependence, 2007, Mar-16, Volume: 87, Issue:2-3

    Topics: Adolescent; Adult; Age of Onset; Child; Cross-Sectional Studies; Female; Follow-Up Studies; Hallucin

2007
Anxiety, depression, and behavioral symptoms of executive dysfunction in ecstasy users: contributions of polydrug use.
    Drug and alcohol dependence, 2007, Mar-16, Volume: 87, Issue:2-3

    Topics: Affect; Anxiety; Behavioral Symptoms; Depression; Female; Humans; Male; N-Methyl-3,4-methylenedioxya

2007
Ecstasy toxicity: a comparison to methamphetamine and traumatic brain injury.
    Journal of addictive diseases, 2006, Volume: 25, Issue:4

    Topics: Animals; Brain; Brain Injuries; Central Nervous System Stimulants; Cerebral Cortex; Electrophoresis,

2006
[Relations between usage of marihuana and other drugs among teenagers].
    Medicina (Kaunas, Lithuania), 2006, Volume: 42, Issue:10

    Topics: Adolescent; Adolescent Behavior; Age Factors; Alcohol Drinking; Amphetamine-Related Disorders; Attit

2006
Distribution of methylenedioxymethamphetamine (MDMA) and methylenedioxyamphetamine (MDA) in postmortem and antemortem specimens.
    Journal of analytical toxicology, 2006, Volume: 30, Issue:8

    Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Adult; Diagnosis; Female; Forensic Toxicology; Gas Chroma

2006
From "Male Bonding Rituals" to "Suicide Tuesday": A qualitative study of issues faced by gay male ecstasy (MDMA) users.
    Journal of homosexuality, 2006, Volume: 51, Issue:3

    Topics: Adolescent; Adult; Homosexuality, Male; Humans; Illicit Drugs; Interpersonal Relations; Male; Middle

2006
5-Year trends in use of hallucinogens and other adjunct drugs among UK dance drug users.
    European addiction research, 2007, Volume: 13, Issue:1

    Topics: Adult; Cross-Sectional Studies; Female; Hallucinogens; Humans; Incidence; Ketamine; Lysergic Acid Di

2007
Pathways between ecstasy initiation and other drug use.
    Addictive behaviors, 2007, Volume: 32, Issue:7

    Topics: Adolescent; Adult; Child; Cocaine-Related Disorders; Female; Heroin Dependence; Humans; Incidence; M

2007
How to find future ecstasy-users: targeted and snowball sampling in an ethically sensitive context.
    Addictive behaviors, 2007, Volume: 32, Issue:8

    Topics: Adolescent; Adult; Female; Follow-Up Studies; Forecasting; Humans; Interdisciplinary Communication;

2007
The effects of price and perceived quality on the behavioural economics of alcohol, amphetamine, cannabis, cocaine, and ecstasy purchases.
    Drug and alcohol dependence, 2007, Jul-10, Volume: 89, Issue:2-3

    Topics: Adolescent; Adult; Alcohol Drinking; Alcoholic Beverages; Amphetamine; Cannabinoids; Commerce; Consu

2007
Information processing speed in ecstasy (MDMA) users.
    Human psychopharmacology, 2007, Volume: 22, Issue:2

    Topics: Adult; Amphetamine; Cannabis; Cocaine; Ethanol; Humans; Memory; Mental Processes; Multivariate Analy

2007
Mechanisms of prescription drug diversion among drug-involved club- and street-based populations.
    Pain medicine (Malden, Mass.), 2007, Volume: 8, Issue:2

    Topics: Adolescent; Adult; Amphetamine-Related Disorders; Analgesics, Opioid; Antiretroviral Therapy, Highly

2007
Polysubstance use and its correlates in adolescent ecstasy users in Taiwan.
    Addictive behaviors, 2007, Volume: 32, Issue:10

    Topics: Adolescent; Affect; Age Factors; Alcohol Drinking; Analgesics; Areca; Cross-Sectional Studies; Educa

2007
Fatality due to the use of a designer drug MDMA (Ecstasy).
    Legal medicine (Tokyo, Japan), 2007, Volume: 9, Issue:4

    Topics: 3,4-Methylenedioxyamphetamine; Adult; Autopsy; Chromatography, Liquid; Designer Drugs; Fatal Outcome

2007
The relationship between methamphetamine and popper use and risk of HIV seroconversion in the multicenter AIDS cohort study.
    Journal of acquired immune deficiency syndromes (1999), 2007, May-01, Volume: 45, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Adult; Cohort Studies; HIV Seropositivity; Homosexuality, Male;

2007
Is there a case for MDMA-assisted psychotherapy in the UK?
    Journal of psychopharmacology (Oxford, England), 2007, Volume: 21, Issue:2

    Topics: Hallucinogens; History, 20th Century; Humans; Illicit Drugs; N-Methyl-3,4-methylenedioxyamphetamine;

2007
Major depression: the relative contribution of gender, MDMA, and cannabis use.
    Depression and anxiety, 2008, Volume: 25, Issue:3

    Topics: Adult; Comorbidity; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorder

2008
Roadside drug testing: unanswered questions and future challenges.
    Drug and alcohol review, 2007, Volume: 26, Issue:2

    Topics: Australia; Automobile Driving; Breath Tests; Cannabis; Forecasting; Humans; Methamphetamine; N-Methy

2007
A pilot study using the internet to study patterns of party drug use: processes, findings and limitations.
    Drug and alcohol review, 2007, Volume: 26, Issue:2

    Topics: Adolescent; Adult; Australia; Catchment Area, Health; Demography; Female; Humans; Internet; Leisure

2007
Former Soviet Union immigrant and native-born adolescents in Israel: substance use and related problem behavior.
    Journal of ethnicity in substance abuse, 2007, Volume: 6, Issue:1

    Topics: Acculturation; Adolescent; Alcoholism; Amphetamine-Related Disorders; Child; Cross-Cultural Comparis

2007
Ecstasy induced acute bilateral angle closure and transient myopia.
    The British journal of ophthalmology, 2007, Volume: 91, Issue:5

    Topics: Adult; Glaucoma, Angle-Closure; Hallucinogens; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine;

2007
Assessment of cognitive brain function in ecstasy users and contributions of other drugs of abuse: results from an FMRI study.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2008, Volume: 33, Issue:2

    Topics: Adolescent; Adult; Alcohol Drinking; Amphetamine; Attention; Brain; Cocaine; Cognition; Female; Huma

2008
Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study.
    Archives of general psychiatry, 2007, Volume: 64, Issue:6

    Topics: Adult; Attention; Cannabis; Cognition; Cognition Disorders; Cohort Studies; Female; Follow-Up Studie

2007
[A gender comparison of legal and illicit drug consumption].
    Revista medica de Chile, 2007, Volume: 135, Issue:4

    Topics: Adolescent; Adult; Alcohol Drinking; Amphetamine-Related Disorders; Cocaine-Related Disorders; Data

2007
Occipital cortical proton MRS at 4 Tesla in human moderate MDMA polydrug users.
    Psychiatry research, 2007, Aug-15, Volume: 155, Issue:3

    Topics: Adolescent; Adult; Amphetamines; Analgesics, Opioid; Aspartic Acid; Cannabis; Cocaine; Female; Hallu

2007
Reinstatement of MDMA (ecstasy) seeking by exposure to discrete drug-conditioned cues.
    Pharmacology, biochemistry, and behavior, 2007, Volume: 87, Issue:4

    Topics: Animals; Conditioning, Operant; Cues; Extinction, Psychological; Hallucinogens; Injections, Intraven

2007
Neurocognitive function in current and ex-users of ecstasy in comparison to both matched polydrug-using controls and drug-naïve controls.
    Psychopharmacology, 2007, Volume: 194, Issue:3

    Topics: Adult; Case-Control Studies; Cognition Disorders; Hallucinogens; Humans; Illicit Drugs; Learning; Ma

2007
Everyday memory deficits in ecstasy-polydrug users.
    Journal of psychopharmacology (Oxford, England), 2007, Volume: 21, Issue:7

    Topics: Adult; Cannabis; Cognition Disorders; Female; Hallucinogens; Humans; Illicit Drugs; Linear Models; M

2007
Getting into ecstasy: comparing moderate and heavy young adult users.
    Journal of psychoactive drugs, 2007, Volume: 39, Issue:2

    Topics: Adolescent; Adult; Alcohol Drinking; Cross-Sectional Studies; Data Collection; Female; Georgia; Hall

2007
Pathways to ecstasy use in young adults: anxiety, depression or behavioural deviance?
    Drug and alcohol dependence, 2008, Jan-01, Volume: 92, Issue:1-3

    Topics: Adolescent; Adolescent Behavior; Adult; Analysis of Variance; Anxiety; Child; Child Behavior Disorde

2008
Family, peer and individual factors related to methylenedioxymethamphetamine use in Taiwanese adolescents.
    Psychiatry and clinical neurosciences, 2007, Volume: 61, Issue:5

    Topics: Adolescent; Amphetamine-Related Disorders; Educational Status; Family Characteristics; Family Confli

2007
Recreational use of 3,4-methylenedioxymethamphetamine ('ecstasy') relieving symptoms of posterior scleritis.
    Eye (London, England), 2007, Volume: 21, Issue:12

    Topics: Adult; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Scleritis; Substance-Related Disorders;

2007
Drug-related harm: a complex and difficult concept to scale.
    Human psychopharmacology, 2007, Volume: 22, Issue:7

    Topics: Catha; Drug-Related Side Effects and Adverse Reactions; Hallucinogens; Harm Reduction; Humans; N-Met

2007
Monitoring ecstasy content in France: results from the National Surveillance System 1999-2004.
    Substance use & misuse, 2007, Volume: 42, Issue:10

    Topics: Caffeine; Drug and Narcotic Control; Emigration and Immigration; France; Hallucinogens; Humans; Illi

2007
A psycho-economic model of ecstasy consumption and related consequences: a multi-site study with community samples.
    Substance use & misuse, 2007, Volume: 42, Issue:11

    Topics: Adult; Australia; Factor Analysis, Statistical; Female; Humans; Interviews as Topic; Male; N-Methyl-

2007
Behavioral economic analysis of drug preference using multiple choice procedure data.
    Drug and alcohol dependence, 2008, Jan-11, Volume: 93, Issue:1-2

    Topics: Choice Behavior; Economics; Fentanyl; Fluoxetine; Hallucinogens; Humans; Hydromorphone; Injections,

2008
Possible association between 3,4-methylenedioxymethamphetamine abuse and valvular heart disease.
    The American journal of cardiology, 2007, Nov-01, Volume: 100, Issue:9

    Topics: Adult; Dose-Response Relationship, Drug; Female; Hallucinogens; Heart Valve Diseases; Humans; Logist

2007
Specific effects of ecstasy and other illicit drugs on cognition in poly-substance users.
    Psychological medicine, 2008, Volume: 38, Issue:9

    Topics: Adolescent; Adult; Amphetamine; Attention; Cannabis; Central Nervous System Stimulants; Cocaine; Cog

2008
Human laboratory and neuroimaging studies in substance use disorders: developing new treatment approaches.
    The American journal of drug and alcohol abuse, 2007, Volume: 33, Issue:6

    Topics: Amphetamine-Related Disorders; Antipsychotic Agents; Aripiprazole; Brain; Cocaine-Related Disorders;

2007
Symptoms of ecstasy dependence and correlation with psychopathology in Taiwanese adolescents.
    The Journal of nervous and mental disease, 2007, Volume: 195, Issue:10

    Topics: Adolescent; Adolescent Behavior; Attitude to Health; Comorbidity; Diagnosis, Dual (Psychiatry); Fema

2007
Do adolescent ecstasy users have different attitudes towards drugs when compared to marijuana users?
    Drug and alcohol dependence, 2008, Apr-01, Volume: 94, Issue:1-3

    Topics: Adolescent; Attitude; Attitude to Health; Awareness; Child; Female; Health Behavior; Humans; Male; M

2008
Sexual dysfunction in men who abuse illicit drugs: a preliminary report.
    The journal of sexual medicine, 2009, Volume: 6, Issue:4

    Topics: Adult; Amphetamines; Demography; Erectile Dysfunction; Health Status; Heroin Dependence; Humans; Ill

2009
The effects of perceived quality on the behavioural economics of alcohol, amphetamine, cannabis, cocaine, and ecstasy purchases.
    Drug and alcohol dependence, 2008, Apr-01, Volume: 94, Issue:1-3

    Topics: Adult; Alcohol Drinking; Amphetamine; Catchment Area, Health; Cocaine-Related Disorders; Commerce; C

2008
Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
    Journal of psychopharmacology (Oxford, England), 2008, Volume: 22, Issue:5

    Topics: Adult; Cognition Disorders; Drug Synergism; Female; Follow-Up Studies; Hallucinogens; Humans; Illici

2008
Metamemory in recreational ecstasy polydrug users: what do self-reports of memory failures mean?
    Journal of psychopharmacology (Oxford, England), 2008, Volume: 22, Issue:8

    Topics: Adolescent; Adult; Cognition; Cohort Studies; Cross-Sectional Studies; Female; Humans; Male; Memory

2008
Ecstasy use and higher-level cognitive functions: weak effects of ecstasy after control for potential confounds.
    Psychological medicine, 2008, Volume: 38, Issue:9

    Topics: Adult; Affect; Attention; Cannabis; Cognition; Cognition Disorders; Cohort Studies; Cross-Sectional

2008
Impulsivity in Hong Kong-Chinese club-drug users.
    Drug and alcohol dependence, 2008, May-01, Volume: 95, Issue:1-2

    Topics: Adolescent; Adult; Amphetamine-Related Disorders; Asian People; Cross-Cultural Comparison; Cross-Sec

2008
[Analysis of spontaneous comments posted by ecstasy users participating in an online survey].
    Revista panamericana de salud publica = Pan American journal of public health, 2007, Volume: 22, Issue:6

    Topics: Adolescent; Adult; Female; Hallucinogens; Humans; Internet; Male; N-Methyl-3,4-methylenedioxyampheta

2007
[Positive and negative social representation of ecstasy among consumers in Coimbra (Portugal)].
    Adicciones, 2008, Volume: 20, Issue:1

    Topics: Adolescent; Adult; Catchment Area, Health; Dancing; Female; Humans; Illicit Drugs; Incidence; Male;

2008
Problems in three Japanese drug users with Human Immunodeficiency Virus infection.
    The journal of medical investigation : JMI, 2008, Volume: 55, Issue:1-2

    Topics: 5-Methoxytryptamine; Adult; Amyl Nitrite; Antiretroviral Therapy, Highly Active; Asian People; Drug

2008
Recreational drug toxicity.
    Clinical medicine (London, England), 2008, Volume: 8, Issue:1

    Topics: Amphetamines; Benzodiazepines; Cannabis; Cocaine; Humans; Illicit Drugs; N-Methyl-3,4-methylenedioxy

2008
Crystal methamphetamine smoking among regular ecstasy users in Australia: increases in use and associations with harm.
    Drug and alcohol review, 2008, Volume: 27, Issue:3

    Topics: Adult; Amphetamine-Related Disorders; Australia; Central Nervous System Stimulants; Crime; Cross-Sec

2008
Reward-related decision-making deficits and elevated impulsivity among MDMA and other drug users.
    Drug and alcohol dependence, 2008, Jul-01, Volume: 96, Issue:1-2

    Topics: Adult; Alcohol Drinking; Amphetamine-Related Disorders; Cognition Disorders; Control Groups; Decisio

2008
The role of peers in the initiation and continuation of ecstasy use.
    Substance use & misuse, 2008, Volume: 43, Issue:5

    Topics: Adolescent; Adult; Age Factors; Female; Friends; Humans; Interpersonal Relations; Interview, Psychol

2008
A possible perianesthetic serotonin syndrome related to intrathecal fentanyl.
    Journal of clinical anesthesia, 2008, Volume: 20, Issue:2

    Topics: Adult; Analgesics, Opioid; Ephedrine; Ergot Alkaloids; Fentanyl; Humans; Injections, Spinal; Male; M

2008
Simultaneous determination of amphetamine, methamphetamine, 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine in human hair by gas chromatography-mass spectrometry.
    Journal of chromatography. B, Biomedical applications, 1995, Aug-04, Volume: 670, Issue:1

    Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Gas Chromatography-Mass Spectrometry; Hair; Humans; Meth

1995
[Brain functional disorders after taking Ecstasy?].
    Deutsche medizinische Wochenschrift (1946), 1995, Dec-08, Volume: 120, Issue:49

    Topics: Adult; Brain Diseases; Female; Humans; Memory Disorders; N-Methyl-3,4-methylenedioxyamphetamine; Sub

1995
On the neurotoxicity of MDMA and related amphetamine derivatives.
    Journal of clinical psychopharmacology, 1995, Volume: 15, Issue:4

    Topics: Amphetamines; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related Disor

1995
Death after ecstasy ingestion: neuropathological findings.
    Journal of neurology, neurosurgery, and psychiatry, 1995, Volume: 58, Issue:6

    Topics: Adult; Brain; Fatal Outcome; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related

1995
Cerebral infarction associated with 3,4-methylenedioxymethamphetamine ('Ecstasy') abuse.
    European neurology, 1995, Volume: 35, Issue:3

    Topics: Adult; Cerebral Infarction; Corpus Striatum; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; N

1995
[Hair analysis in the diagnosis of toxic hepatitis after Ecstasy abuse].
    Deutsche medizinische Wochenschrift (1946), 1995, Aug-25, Volume: 120, Issue:34-35

    Topics: Adolescent; Chemical and Drug Induced Liver Injury; Clinical Enzyme Tests; Hair; Humans; Male; N-Met

1995
Intracerebral haemorrhage due to amphetamine abuse: report of two cases with underlying arteriovenous malformations.
    British journal of neurosurgery, 1995, Volume: 9, Issue:1

    Topics: Adult; Amphetamine; Cerebral Cortex; Cerebral Hemorrhage; Female; Humans; Intracranial Arteriovenous

1995
Aplastic anaemia following exposure to 3,4-methylenedioxymethamphetamine ('Ecstasy').
    British journal of haematology, 1994, Volume: 88, Issue:2

    Topics: Adolescent; Adult; Anemia, Aplastic; Blood Cell Count; Bone Marrow; Cells, Cultured; Designer Drugs;

1994
MDMA ("ecstasy") abuse: psychopathological features and craving for chocolate: a case series.
    Biological psychiatry, 1994, Dec-01, Volume: 36, Issue:11

    Topics: Adult; Behavior, Addictive; Cacao; Female; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Ser

1994
Urinary retention with misuse of "ecstasy".
    BMJ (Clinical research ed.), 1995, Feb-25, Volume: 310, Issue:6978

    Topics: Adult; Designer Drugs; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related Disor

1995
A study of the precursors, intermediates and reaction by-products in the synthesis of 3,4-methylenedioxymethylamphetamine and its application to forensic drug analysis.
    Forensic science international, 1993, Volume: 60, Issue:3

    Topics: 3,4-Methylenedioxyamphetamine; Designer Drugs; Drug and Narcotic Control; England; Forensic Medicine

1993
Persistent effects of (+/- )3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") on human sleep.
    Sleep, 1993, Volume: 16, Issue:6

    Topics: 3,4-Methylenedioxyamphetamine; Adult; Amphetamines; Electroencephalography; Female; Humans; Male; Me

1993
Cerebral infarction in association with Ecstasy abuse.
    Postgraduate medical journal, 1993, Volume: 69, Issue:817

    Topics: 3,4-Methylenedioxyamphetamine; Adult; Cerebral Infarction; Designer Drugs; Humans; Male; N-Methyl-3,

1993
A fatal overdose with 3,4-methylenedioxyamphetamine derivatives.
    Forensic science international, 1994, Volume: 64, Issue:1

    Topics: 3,4-Methylenedioxyamphetamine; Adult; Amphetamines; Cannabinoids; Cannabis; Designer Drugs; Drug Ove

1994
In vitro release of [3H]5-hydroxytryptamine from fetal and maternal brain by drugs of abuse.
    Brain research. Developmental brain research, 1994, Mar-18, Volume: 78, Issue:1

    Topics: 3,4-Methylenedioxyamphetamine; Animals; Brain; Brain Chemistry; Cocaine; Designer Drugs; Female; Fen

1994
Increasing use of "Ecstasy" (MDMA) and other hallucinogens on a college campus.
    Journal of American college health : J of ACH, 1994, Volume: 42, Issue:6

    Topics: 3,4-Methylenedioxyamphetamine; Adult; Cross-Sectional Studies; Designer Drugs; Hallucinogens; Humans

1994
Reckless behaviour related to the use of 3,4-methylenedioxymethamphetamine (ecstasy): apropos of a fatal accident during car-surfing.
    International journal of legal medicine, 1994, Volume: 106, Issue:6

    Topics: Accidents, Traffic; Adult; Alcoholism; Brain Injuries; Dangerous Behavior; Fatal Outcome; Humans; Ma

1994
[Morbidity and mortality due to the use of ecstacy].
    Nederlands tijdschrift voor geneeskunde, 1994, Nov-19, Volume: 138, Issue:47

    Topics: Adolescent; Adult; Female; Humans; Male; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Nether

1994
[The dangers of "ecstasy"].
    Der Nervenarzt, 1994, Volume: 65, Issue:9

    Topics: Adolescent; Adult; Female; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Psychoses, Substanc

1994
A case of toxic psychosis induced by 'eve' (3,4-methylene-dioxyethylam-phetamine)
    Archives of general psychiatry, 1993, Volume: 50, Issue:1

    Topics: 3,4-Methylenedioxyamphetamine; Administration, Oral; Adult; Humans; Male; N-Methyl-3,4-methylenediox

1993
Simultaneous identification of amphetamine and its derivatives in urine using HPLC-UV.
    International journal of legal medicine, 1993, Volume: 105, Issue:5

    Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Chromatography, High Pressure Liquid; Gas Chromatography

1993
'Ecstasy' induced pneumomediastinum.
    Journal of the Royal Society of Medicine, 1993, Volume: 86, Issue:4

    Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Designer Drugs; Humans; Male; Mediastinal Emphysema; N-Me

1993
'Ecstasy' ingestion: a case report of severe complications.
    Journal of the Royal Society of Medicine, 1993, Volume: 86, Issue:4

    Topics: 3,4-Methylenedioxyamphetamine; Acute Kidney Injury; Adult; Amphetamine; Designer Drugs; Disseminated

1993
Ecstasy and Whizz at a rave resulting in a major burn plus complications.
    Burns : journal of the International Society for Burn Injuries, 1993, Volume: 19, Issue:3

    Topics: 3,4-Methylenedioxyamphetamine; Adult; Amphetamine; Burns; Designer Drugs; Drug Overdose; Humans; Mal

1993
Point-counterpoint. A reader writes: speed, ice, and ecstasy.
    Pediatrics in review, 1993, Volume: 14, Issue:3

    Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Adolescent Behavior; Designer Drugs; Humans; Male; N-Meth

1993
'Rave' to the grave.
    Forensic science international, 1993, Volume: 60, Issue:1-2

    Topics: 3,4-Methylenedioxyamphetamine; Adult; Designer Drugs; Humans; Male; N-Methyl-3,4-methylenedioxyamphe

1993
Reinforcing subjective effects of (+/-) 3,4-methylenedioxymethamphetamine ("ecstasy") may be separable from its neurotoxic actions: clinical evidence.
    Journal of clinical psychopharmacology, 1993, Volume: 13, Issue:3

    Topics: 3,4-Methylenedioxyamphetamine; Adult; Arousal; Designer Drugs; Dose-Response Relationship, Drug; Dru

1993
Amphetamine, not MDMA, is associated with intracranial hemorrhage.
    Journal of accident & emergency medicine, 1995, Volume: 12, Issue:3

    Topics: Amphetamine; Central Nervous System Stimulants; Cerebral Hemorrhage; Drug Overdose; Female; Hallucin

1995
Pathology of deaths associated with "ecstasy" and "eve" misuse.
    Journal of clinical pathology, 1996, Volume: 49, Issue:2

    Topics: 3,4-Methylenedioxyamphetamine; Adult; Brain; Humans; Liver; Male; Myocardium; N-Methyl-3,4-methylene

1996
Acute liver damage and ecstasy ingestion.
    Gut, 1996, Volume: 38, Issue:3

    Topics: Adolescent; Adult; Fatal Outcome; Female; Fever; Humans; Hypotension; Liver; Liver Failure, Acute; L

1996
Use of drugs at 'raves'.
    Scottish medical journal, 1995, Volume: 40, Issue:6

    Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Adult; Catha; Central Nervous System Stimulants; Dancing;

1995
A fatal trip with ecstasy: a case of 3,4-methylenedioxymethamphetamine/3,4- methylenedioxyamphetamine toxicity.
    Journal of the Royal Society of Medicine, 1996, Volume: 89, Issue:1

    Topics: Adolescent; Fatal Outcome; Female; Fever; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Physical E

1996
Adverse symptomatology and suicide associated with the use of methylenedioxymethamphetamine (MDMA; "Ecstasy").
    Biological psychiatry, 1996, May-01, Volume: 39, Issue:9

    Topics: Adolescent; Adult; Combined Modality Therapy; Depressive Disorder; Female; Hallucinogens; Humans; Ma

1996
[Ecstasy, the drug of the route of bakalao].
    Medicina clinica, 1996, May-11, Volume: 106, Issue:18

    Topics: Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Spain; Substance-Related Disorders

1996
Identification of N-methyl-1-(3,4-methylenedioxyphenyl)-2-butanamine (MBDB) in urine from drug users.
    Journal of analytical toxicology, 1996, Volume: 20, Issue:6

    Topics: 3,4-Methylenedioxyamphetamine; Adult; Calibration; Gas Chromatography-Mass Spectrometry; Humans; N-M

1996
Ecstasy induced retropharyngeal emphysema.
    Journal of accident & emergency medicine, 1996, Volume: 13, Issue:5

    Topics: Adult; Central Nervous System Stimulants; Emphysema; Hallucinogens; Humans; Male; Methamphetamine; N

1996
Drug-drug discrimination: stimulus properties of drugs of abuse upon a serotonergic-dopaminergic continuum.
    Pharmacology, biochemistry, and behavior, 1997, Volume: 56, Issue:1

    Topics: Amphetamine; Animals; Discrimination, Psychological; Dopamine; Dopamine Agonists; Dopamine Uptake In

1997
Hyponatraemia at a rave.
    Postgraduate medical journal, 1997, Volume: 73, Issue:855

    Topics: Adult; Drinking Behavior; Female; Hallucinogens; Humans; Hyponatremia; N-Methyl-3,4-methylenedioxyam

1997
Hair analysis for drug abuse. XV. Disposition of 3, 4-methylenedioxymethamphetamine (MDMA) and its related compounds into rat hair and application to hair analysis for MDMA abuse.
    Forensic science international, 1997, Jan-17, Volume: 84, Issue:1-3

    Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Gas Chromatography-Mass Spectrometry; Hair; Ha

1997
The agony of "ecstasy".
    The Medical journal of Australia, 1997, Feb-03, Volume: 166, Issue:3

    Topics: Amphetamines; Animals; Australia; Drug Overdose; Hallucinogens; Humans; Individuality; N-Methyl-3,4-

1997
[Epidemiology of designer drug use in Spain].
    Medicina clinica, 1997, Jan-18, Volume: 108, Issue:2

    Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Adult; Cocaine; Designer Drugs; Female; Heroin; Humans; M

1997
Adverse effects of stimulant drugs in a community sample of drug users.
    Drug and alcohol dependence, 1997, Mar-14, Volume: 44, Issue:2-3

    Topics: Adolescent; Adult; Amphetamines; Central Nervous System Depressants; Central Nervous System Stimulan

1997
The pathology of the ring-substituted amphetamine analogue 3,4-methylenedioxymethylamphetamine (MDMA, 'Ecstasy')
    The Journal of pathology, 1997, Volume: 181, Issue:3

    Topics: Brain Diseases; Dopamine; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Serotonin; Substance-Relat

1997
[Is the anxiety about Ecstasy justified?].
    Fortschritte der Medizin, 1997, Mar-10, Volume: 115, Issue:7

    Topics: Adolescent; Adult; Animals; Brain; Cause of Death; Hallucinogens; Humans; Malignant Hyperthermia; N-

1997
["Nice young people looking for fun". Interview by Dr. rer nat. Anita Schweiger].
    Fortschritte der Medizin, 1997, Mar-10, Volume: 115, Issue:7

    Topics: Adolescent; Adult; Female; Hallucinogens; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Risk

1997
[Attention deficit hyperactivity disorder, facilitating alcohol and drug abuse in an adult].
    Harefuah, 1997, May-01, Volume: 132, Issue:9

    Topics: Adult; Alcoholism; Attention Deficit Disorder with Hyperactivity; Cannabis; Central Nervous System S

1997
Biochemical implications of ecstasy toxicity.
    Annals of clinical biochemistry, 1997, Volume: 34 ( Pt 4)

    Topics: 3,4-Methylenedioxyamphetamine; Adult; Creatine Kinase; Creatinine; Hemoglobins; Humans; Isoenzymes;

1997
Designer drugs--the Ecstasy and the agony.
    Singapore medical journal, 1997, Volume: 38, Issue:1

    Topics: Designer Drugs; Humans; Indonesia; Malaysia; N-Methyl-3,4-methylenedioxyamphetamine; Public Health;

1997
Repeated administration of 3,4-methylenedioxymethamphetamine augments cocaine's action on dopamine in the nucleus accumbens: a microdialysis study.
    European journal of pharmacology, 1997, Jul-16, Volume: 331, Issue:1

    Topics: Animals; Cocaine; Dopamine; Dopamine Uptake Inhibitors; Drug Synergism; Male; Microdialysis; N-Methy

1997
Mood and cognitive effects of +/-3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'): week-end 'high' followed by mid-week low.
    Addiction (Abingdon, England), 1997, Volume: 92, Issue:7

    Topics: Adult; Affect; Alcohol Drinking; Cognition; Female; Follow-Up Studies; Hallucinogens; Humans; Male;

1997
Hair concentrations and self-reported abuse history of 20 amphetamine and ecstasy users.
    Forensic science international, 1997, Sep-19, Volume: 89, Issue:1-2

    Topics: Adolescent; Adult; Amphetamine; Baths; Chromatography, High Pressure Liquid; Female; Gas Chromatogra

1997
MDMA induced hyperthermia: a survivor with an initial body temperature of 42.9 degrees C.
    Journal of accident & emergency medicine, 1997, Volume: 14, Issue:5

    Topics: Adult; Blood Gas Analysis; Body Temperature; Dantrolene; Emergency Service, Hospital; Fever; Halluci

1997
Spontaneous pneumomediastinum and Ecstasy abuse.
    Journal of accident & emergency medicine, 1997, Volume: 14, Issue:5

    Topics: Adolescent; Chest Pain; Dancing; Emergency Service, Hospital; Female; Hallucinogens; Humans; Mediast

1997
Return to Ecstasy.
    Nursing standard (Royal College of Nursing (Great Britain) : 1987), 1997, Aug-06, Volume: 11, Issue:46

    Topics: Adolescent; Follow-Up Studies; Heroin Dependence; Humans; Mental Disorders; Mental Health; N-Methyl-

1997
Hair analysis for drugs of abuse. XVIII. 3,4-Methylenedioxymethamphetamine (MDMA) disposition in hair roots and use in identification of acute MDMA poisoning.
    Biological & pharmaceutical bulletin, 1997, Volume: 20, Issue:9

    Topics: Acute Disease; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Hair; Hallucinogen

1997
Bitter pill.
    Nursing standard (Royal College of Nursing (Great Britain) : 1987), 1997, Oct-08, Volume: 12, Issue:3

    Topics: Emergency Nursing; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Psychiatric Nursin

1997
[Drug abuse--explosion of Ecstasy in Oslo. Interview by Kari Anne Aase].
    Tidsskriftet sykepleien, 1997, Mar-11, Volume: 85, Issue:5

    Topics: Adolescent; Female; Hallucinogens; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Norway; Sub

1997
[Emergencies associated with the consumption of designer drugs, hallucinogens and amphetamines treated at 15 Spanish hospitals in 1994. Work Group on the Study of Emergencies due to Psychostimulants].
    Revista clinica espanola, 1997, Volume: 197, Issue:12

    Topics: Adolescent; Adult; Amphetamine-Related Disorders; Child; Cocaine-Related Disorders; Designer Drugs;

1997
[Ecstasy--adolescents and drugs].
    Kinderkrankenschwester : Organ der Sektion Kinderkrankenpflege, 1998, Volume: 17, Issue:2

    Topics: Adolescent; Adolescent Behavior; Designer Drugs; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxya

1998
[Effects and risks of substituted amphetamines (Ecstasy)].
    Der Internist, 1998, Volume: 39, Issue:3

    Topics: Animals; Brain; Dose-Response Relationship, Drug; Euphoria; Humans; N-Methyl-3,4-methylenedioxyamphe

1998
[Toxicity of ecstasy].
    Presse medicale (Paris, France : 1983), 1997, Dec-06, Volume: 26, Issue:38

    Topics: Adolescent; Adult; Female; Hallucinogens; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Subs

1997
[Ecstasy: a forgotten drug].
    Atencion primaria, 1998, Feb-28, Volume: 21, Issue:3

    Topics: Adolescent; Adult; Designer Drugs; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Su

1998
[The family physician and designer drugs].
    Atencion primaria, 1998, Feb-28, Volume: 21, Issue:3

    Topics: Designer Drugs; Health Education; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Physicians, Family

1998
[Hepatitis from ecstasy].
    Gastroenterologia y hepatologia, 1998, Volume: 21, Issue:3

    Topics: Adolescent; Chemical and Drug Induced Liver Injury; Female; Hallucinogens; Humans; N-Methyl-3,4-meth

1998
Hair analysis for abused drugs by capillary zone electrophoresis with field-amplified sample stacking.
    Forensic science international, 1998, Apr-05, Volume: 92, Issue:2-3

    Topics: Cocaine; Electrophoresis, Capillary; Follow-Up Studies; Hair; Hallucinogens; Humans; Morphine; N-Met

1998
Detection of designer drugs in human hair by ion mobility spectrometry (IMS).
    Forensic science international, 1998, Jun-08, Volume: 94, Issue:1-2

    Topics: 3,4-Methylenedioxyamphetamine; Designer Drugs; Forensic Medicine; Hair; Hallucinogens; Humans; N-Met

1998
An association between the regular use of 3,4 methylenedioxy-methamphetamine (ecstasy) and excessive wear of the teeth.
    Addiction (Abingdon, England), 1998, Volume: 93, Issue:5

    Topics: Drinking; Female; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related Disorders;

1998
Severe hyponatremia and inappropriate antidiuretic hormone secretion following ecstasy use.
    Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 1998, Volume: 5, Issue:8

    Topics: Adult; Emergencies; Female; Hallucinogens; Humans; Hyponatremia; Inappropriate ADH Syndrome; N-Methy

1998
Death by "ecstasy": the serotonin syndrome?
    Annals of emergency medicine, 1998, Volume: 32, Issue:3 Pt 1

    Topics: Adult; Arrhythmias, Cardiac; Autonomic Nervous System Diseases; Cognition Disorders; Epilepsy, Tonic

1998
Is the use of ecstasy and hallucinogens increasing? Results from a community study.
    European addiction research, 1998, Volume: 4, Issue:1-2

    Topics: Adolescent; Adult; Age Distribution; Age of Onset; Amphetamines; Comorbidity; Data Collection; Femal

1998
[Acute hepatitis due to ecstasy].
    Presse medicale (Paris, France : 1983), 1998, Mar-14, Volume: 27, Issue:10

    Topics: Acute Disease; Adult; Chemical and Drug Induced Liver Injury; Hallucinogens; Humans; Jaundice; Liver

1998
"Saturday night fever": ecstasy related problems in a London accident and emergency department.
    Journal of accident & emergency medicine, 1998, Volume: 15, Issue:5

    Topics: Adolescent; Adult; Emergency Service, Hospital; Hallucinogens; Humans; London; N-Methyl-3,4-methylen

1998
MDMA ('ecstasy') consumption in the context of polydrug abuse: a report on 150 patients.
    Drug and alcohol dependence, 1998, Sep-01, Volume: 52, Issue:1

    Topics: Adult; Dose-Response Relationship, Drug; Female; Hallucinogens; Humans; Illicit Drugs; Male; Mental

1998
[Mind Zone--prevention in the techno-scene].
    Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)), 1998, Volume: 60 Suppl 1

    Topics: Adolescent; Adult; Female; Germany; Health Education; Humans; Illicit Drugs; Male; N-Methyl-3,4-meth

1998
[Toxicity of ecstasy].
    Medicina clinica, 1998, Oct-24, Volume: 111, Issue:13

    Topics: Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related Disorders

1998
[Ecstasy: idiosyncrasy, overdosage or collateral effects].
    Medicina clinica, 1998, Oct-24, Volume: 111, Issue:13

    Topics: Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related Disorders

1998
[Clinical and toxicological aspects of the use of ecstasy].
    Nederlands tijdschrift voor geneeskunde, 1998, Oct-17, Volume: 142, Issue:42

    Topics: Adverse Drug Reaction Reporting Systems; Drug Contamination; Drug Interactions; Female; Humans; Illi

1998
Ecstasy (MDMA) dependence.
    Drug and alcohol dependence, 1999, Jan-07, Volume: 53, Issue:2

    Topics: Adult; Hallucinogens; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Seizures; Self Medicatio

1999
Toxic effect of MDMA on brain serotonin neurons.
    Lancet (London, England), 1999, Apr-10, Volume: 353, Issue:9160

    Topics: Brain; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Neurons; Sensitivity and Specificity; Seroton

1999
A concealed cause of recurrent renal failure in a patient with juvenile chronic arthritis.
    Annals of the rheumatic diseases, 1999, Volume: 58, Issue:7

    Topics: Adult; Amphetamines; Arthritis, Juvenile; Hallucinogens; Humans; Kidney Failure, Chronic; Male; N-Me

1999
Ecstasy use in Australia: patterns of use and associated harm.
    Drug and alcohol dependence, 1999, Jun-01, Volume: 55, Issue:1-2

    Topics: Adolescent; Adult; Australia; Female; Health Status; Humans; Interview, Psychological; Male; Middle

1999
The occurrence of toothwear in users of Ecstasy (3,4-methylenedioxymethamphetamine).
    Community dentistry and oral epidemiology, 1999, Volume: 27, Issue:4

    Topics: England; Hallucinogens; Humans; Incidence; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related

1999
5-HT receptor knockout mice: pharmacological tools or models of psychiatric disorders.
    Annals of the New York Academy of Sciences, 1999, Apr-30, Volume: 868

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aggression; Animals; Behavior, Animal; Cocaine; Disease Models, Anim

1999
Level of use of 3,4-methylenedioxymethamphetamine (MDMA or Ecstasy) in humans correlates with EEG power and coherence.
    Psychopharmacology, 1999, Volume: 145, Issue:1

    Topics: Adolescent; Adult; Affect; Alpha Rhythm; Cognition; Electroencephalography; Hallucinogens; Humans; I

1999
Effects of "Ecstasy" blocked by serotonin reuptake inhibitors.
    The Journal of clinical psychiatry, 1999, Volume: 60, Issue:7

    Topics: Adult; Citalopram; Female; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Paroxetine

1999
Plain abdominal radiography in the diagnosis of the "body packer".
    Journal of accident & emergency medicine, 1999, Volume: 16, Issue:5

    Topics: Adult; Drug Overdose; Emergency Treatment; Foreign Bodies; Hallucinogens; Humans; Male; N-Methyl-3,4

1999
Spontaneous pneumomediastinum and ecstasy abuse.
    Journal of accident & emergency medicine, 1999, Volume: 16, Issue:5

    Topics: Adult; Chest Pain; Dancing; Emergency Treatment; Hallucinogens; Humans; Male; Mediastinal Emphysema;

1999
Cerebral (1)H MRS alterations in recreational 3, 4-methylenedioxymethamphetamine (MDMA, "ecstasy") users.
    Journal of magnetic resonance imaging : JMRI, 1999, Volume: 10, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Aspartic Acid; Brain; Brain Chemistry; Choline; Creatine; Female; Ha

1999
Fatal uncertainty: death-rate from use of ecstasy or heroin.
    Lancet (London, England), 1999, Oct-09, Volume: 354, Issue:9186

    Topics: Accidents, Traffic; Adolescent; Adult; England; Hallucinogens; Heroin; Humans; Meta-Analysis as Topi

1999
[Poisoning with central nervous system stimulants. Amphetamine, ecstasy, cocaine and gamma-hydroxybutyrate].
    Ugeskrift for laeger, 1999, Dec-13, Volume: 161, Issue:50

    Topics: Amphetamine; Amphetamine-Related Disorders; Cocaine; Cocaine-Related Disorders; Denmark; Drug Overdo

1999
Neurochemical neutralization of methamphetamine with high-affinity nonselective inhibitors of biogenic amine transporters: a pharmacological strategy for treating stimulant abuse.
    Synapse (New York, N.Y.), 2000, Mar-01, Volume: 35, Issue:3

    Topics: Adrenergic Uptake Inhibitors; Animals; Dopamine; Dopamine Uptake Inhibitors; Indans; Methamphetamine

2000
Long-lasting effects of (+/-)3,4-methylenedioxymethamphetamine (ecstasy) on serotonin system function in humans.
    Biological psychiatry, 2000, Jan-15, Volume: 47, Issue:2

    Topics: Adolescent; Adult; Exploratory Behavior; Fenfluramine; Hallucinogens; Hostility; Humans; Hydrocortis

2000
[Comment on R. Thomasius, M. Schmolke, D. Kraus: MDMA ("Ecstasy") use--an overview of psychiatric and medical sequelae].
    Fortschritte der Neurologie-Psychiatrie, 1999, Volume: 67, Issue:12

    Topics: Drug Contamination; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related

1999
Hair analysis by using radioimmunoassay, high-performance liquid chromatography and capillary electrophoresis to investigate chronic exposure to heroin, cocaine and/or ecstasy in applicants for driving licences.
    Forensic science international, 2000, Jan-10, Volume: 107, Issue:1-3

    Topics: Automobile Driving; Chromatography, High Pressure Liquid; Cocaine-Related Disorders; Electrophoresis

2000
The use of supercritical fluid extraction for the determination of amphetamines in hair.
    Forensic science international, 2000, Jan-10, Volume: 107, Issue:1-3

    Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Designer Drugs; Gas Chromatography-Mass Spectrometry; H

2000
Bilateral sixth nerve palsy associated with MDMA ("ecstasy") abuse.
    American journal of ophthalmology, 2000, Volume: 129, Issue:3

    Topics: Abducens Nerve Diseases; Adolescent; Diplopia; Hallucinogens; Humans; Male; N-Methyl-3,4-methylenedi

2000
Hair analysis: self-reported use of "speed" and "ecstasy" compared with laboratory findings.
    Journal of forensic sciences, 2000, Volume: 45, Issue:2

    Topics: Adolescent; Adult; Central Nervous System Stimulants; False Negative Reactions; False Positive React

2000
Impaired cognitive performance in drug free users of recreational ecstasy (MDMA)
    Journal of neurology, neurosurgery, and psychiatry, 2000, Volume: 68, Issue:6

    Topics: Cognition Disorders; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Neuropsychological Tests; Subst

2000
Impaired cognitive performance in drug free users of recreational ecstasy (MDMA)
    Journal of neurology, neurosurgery, and psychiatry, 2000, Volume: 68, Issue:6

    Topics: Adolescent; Adult; Attention; Cognition Disorders; Female; Hallucinogens; Humans; Intelligence; Lear

2000
Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users.
    Drug and alcohol dependence, 2000, Jul-01, Volume: 60, Issue:1

    Topics: Adolescent; Adult; Analysis of Variance; Female; Hallucinogens; Humans; Male; N-Methyl-3,4-methylene

2000
MDMA ("Ecstasy") abuse and high-risk sexual behaviors among 169 gay and bisexual men.
    The American journal of psychiatry, 2000, Volume: 157, Issue:7

    Topics: Adolescent; Adult; Bisexuality; Comorbidity; Homosexuality, Male; Humans; Male; N-Methyl-3,4-methyle

2000
Bilateral gluteal compartment syndrome after 'ecstasy' hyperpyrexia.
    Journal of the Royal Society of Medicine, 2000, Volume: 93, Issue:5

    Topics: Adult; Buttocks; Compartment Syndromes; Fever; Hallucinogens; Humans; Male; N-Methyl-3,4-methylenedi

2000
Ecstasy and new patterns of drug use: a normal population study.
    Addiction (Abingdon, England), 1999, Volume: 94, Issue:11

    Topics: Adolescent; Alcoholism; Amphetamines; Cannabis; Cohort Studies; Female; Hallucinogens; Heroin; Human

1999
Some light from the heat: implications of rave parties for clinicians.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2000, Jun-27, Volume: 162, Issue:13

    Topics: Adolescent; Adult; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Poisoning; Sodium

2000
Raves: a review of the culture, the drugs and the prevention of harm.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2000, Jun-27, Volume: 162, Issue:13

    Topics: Adolescent; Adult; Hallucinogens; Humans; Ketamine; Male; N-Methyl-3,4-methylenedioxyamphetamine; Po

2000
Raves worry Edmonton MDs, police.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2000, Jun-27, Volume: 162, Issue:13

    Topics: Adolescent; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related Disorde

2000
Striatal serotonin is depleted in brain of a human MDMA (Ecstasy) user.
    Neurology, 2000, Jul-25, Volume: 55, Issue:2

    Topics: Adult; Brain Mapping; Corpus Striatum; Dopamine; Female; Humans; Hydroxyindoleacetic Acid; Male; N-M

2000
The lure of ecstasy.
    Time, 2000, Jun-05, Volume: 155, Issue:23

    Topics: Adolescent; Brain; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Serotonin Agents;

2000
Cognitive performance amongst recreational users of "ecstasy".
    Psychopharmacology, 2000, Volume: 151, Issue:1

    Topics: Adult; Attention; Cannabis; Cognition; Female; Hallucinogens; Humans; Illicit Drugs; Male; Memory; N

2000
[Ecstasy].
    Ugeskrift for laeger, 2000, Jul-31, Volume: 162, Issue:31

    Topics: Adolescent; Adult; Brain; Central Nervous System Stimulants; Denmark; Hallucinogens; History, 20th C

2000
Chemical analysis of ecstasy pills.
    JAMA, 2000, Nov-01, Volume: 284, Issue:17

    Topics: Dextromethorphan; Humans; Illicit Drugs; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related D

2000
Medical complications derived from lucid drug use.
    Revista clinica espanola, 2000, Volume: 200, Issue:8

    Topics: Cocaine; Hallucinogens; Heroin; Humans; Illicit Drugs; N-Methyl-3,4-methylenedioxyamphetamine; Spain

2000
Priapism: ecstasy related?
    Urology, 2000, Dec-20, Volume: 56, Issue:6

    Topics: Adult; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Penis; Priapism; Substance-Related Diso

2000
New drugs of abuse.
    Emergency medicine clinics of North America, 2000, Volume: 18, Issue:4

    Topics: Age Factors; Anesthetics; Emergencies; Hallucinogens; History, 20th Century; Humans; Ketamine; N-Met

2000
Intracerebral haemorrhage and drug abuse in young adults.
    British journal of neurosurgery, 2000, Volume: 14, Issue:5

    Topics: Adult; Amphetamine-Related Disorders; Arteriovenous Malformations; Cerebral Angiography; Cerebral He

2000
No difference in brain activation during cognitive performance between ecstasy (3,4-methylenedioxymethamphetamine) users and control subjects: a [H2(15)O]-positron emission tomography study.
    Journal of clinical psychopharmacology, 2001, Volume: 21, Issue:1

    Topics: Adult; Affect; Age Factors; Arousal; Brain; Cognition; Depression; Female; Hallucinogens; Humans; Ma

2001
Cracking down on ecstasy. Law enforcement is treating the 'hug drug' as if it were the next cocaine. Is it?
    U.S. news & world report, 2001, Feb-05, Volume: 130, Issue:5

    Topics: Brain; Criminal Law; Drug and Narcotic Control; Humans; Illicit Drugs; N-Methyl-3,4-methylenedioxyam

2001
Addressing the threats of MDMA (Ecstasy): implications for school health professionals, parents, and community members.
    The Journal of school health, 2001, Volume: 71, Issue:1

    Topics: Adolescent; Child; Community Health Planning; Drug Overdose; Hallucinogens; Humans; N-Methyl-3,4-met

2001
[Young woman dies of water intoxication after taking one tablet of ecstasy. Today's drug panorama calls for increased vigilance in health care].
    Lakartidningen, 2001, Feb-21, Volume: 98, Issue:8

    Topics: Adult; Brain Edema; Cause of Death; Fatal Outcome; Female; Heart Failure; Humans; Illicit Drugs; Ina

2001
Fact, fiction, and function: mythmaking and the social construction of ecstasy use.
    Substance use & misuse, 2001, Volume: 36, Issue:1-2

    Topics: Adolescent; Adult; Affect; Aggression; Culture; Female; Hallucinogens; Humans; Interpersonal Relatio

2001
Monitoring synthetic drug markets, trends, and public health.
    Substance use & misuse, 2001, Volume: 36, Issue:1-2

    Topics: Consumer Product Safety; Drug Information Services; Drug Labeling; Hallucinogens; Humans; Incidence;

2001
The use of drugs within the techno party scene in European metropolitan cities.
    European addiction research, 2001, Volume: 7, Issue:1

    Topics: Adolescent; Adult; Age Factors; Cities; Cocaine-Related Disorders; Data Collection; Europe; Female;

2001
Designer drugs. Assess & manage patients intoxicated with ecstasy, GHB or rohypnol--the three most commonly abused designer drugs.
    JEMS : a journal of emergency medical services, 2001, Volume: 26, Issue:6

    Topics: 4-Butyrolactone; Designer Drugs; Education, Continuing; Emergency Medical Services; Emergency Treatm

2001
Rave on. Ecstasy use continues to grow & present new problems for EMS.
    JEMS : a journal of emergency medical services, 2001, Volume: 26, Issue:6

    Topics: Adult; Emergency Medical Services; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Substance-R

2001
Changes in serotonin, dopamine and noradrenaline levels in striatum and nucleus accumbens after repeated administration of the abused drug MDMA in rats.
    Neuroscience letters, 2001, Aug-03, Volume: 308, Issue:2

    Topics: Animals; Axons; Dopamine; Drug Administration Schedule; Hallucinogens; Hydroxyindoleacetic Acid; Mal

2001
Analysis of 4-methylthioamphetamine in clinical specimens.
    Annals of clinical biochemistry, 2001, Volume: 38, Issue:Pt 4

    Topics: Amphetamines; Animals; Chromatography, High Pressure Liquid; Hallucinogens; Humans; Indicators and R

2001
Long-term effects of 'ecstasy' abuse on the human brain studied by FDG PET.
    Nuclear medicine communications, 2001, Volume: 22, Issue:8

    Topics: Adolescent; Adult; Biological Transport; Brain; Brain Neoplasms; Carbon Radioisotopes; Female; Fluor

2001
Ecstasy experts want realistic messages.
    JAMA, 2001, Aug-15, Volume: 286, Issue:7

    Topics: Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related Disorders; United S

2001
[Fatal brain edema after ingestion of ecstasy and benzylpiperazine].
    Deutsche medizinische Wochenschrift (1946), 2001, Jul-13, Volume: 126, Issue:28-29

    Topics: Adult; Brain Edema; Fatal Outcome; Female; Hallucinogens; Humans; Hyponatremia; Illicit Drugs; N-Met

2001
The road to rave.
    Newsweek, 2001, Aug-06, Volume: 138, Issue:6

    Topics: Adolescent; Adult; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Sexual Behavior; S

2001
Drug use and life style among college undergraduates: a 30-year longitudinal study.
    The American journal of psychiatry, 2001, Volume: 158, Issue:9

    Topics: Alcohol Drinking; Amphetamine-Related Disorders; Cocaine-Related Disorders; Homosexuality; Humans; L

2001
Former chronic methylenedioxymethamphetamine (MDMA or ecstasy) users report mild depressive symptoms.
    Journal of psychopharmacology (Oxford, England), 2001, Volume: 15, Issue:3

    Topics: Adult; Depression; Female; Humans; Internal-External Control; Life Change Events; Male; Motivation;

2001
Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy"): preliminary findings.
    Archives of general psychiatry, 2001, Volume: 58, Issue:10

    Topics: Adult; Brain Chemistry; Carrier Proteins; Cerebral Cortex; Cocaine; Female; Follow-Up Studies; Human

2001
"Ecstasy" and serotonin neurotoxicity: new findings raise more questions.
    Archives of general psychiatry, 2001, Volume: 58, Issue:10

    Topics: Brain Chemistry; Carrier Proteins; Cerebral Cortex; Cocaine; Follow-Up Studies; Humans; Membrane Gly

2001
Electrophysiological evidence of serotonergic impairment in long-term MDMA ("ecstasy") users.
    The American journal of psychiatry, 2001, Volume: 158, Issue:10

    Topics: Acoustic Stimulation; Adult; Auditory Perception; Dose-Response Relationship, Drug; Dronabinol; Elec

2001
Ecstasy: the key to understanding problem use lies in understanding the users'social networks.
    Addiction (Abingdon, England), 2001, Volume: 96, Issue:10

    Topics: Hallucinogens; Humans; Life Style; N-Methyl-3,4-methylenedioxyamphetamine; Social Environment; Subst

2001
[Clinical aspects of abuse drugs mainly used by adolescents].
    Minerva pediatrica, 2001, Volume: 53, Issue:5

    Topics: Adolescent; Adolescent Behavior; Age Factors; Amphetamine-Related Disorders; Amphetamines; Anti-Anxi

2001
[Hepatic and hematological complications following ecstasy usage].
    Harefuah, 2001, Volume: 140, Issue:10

    Topics: Adult; Chemical and Drug Induced Liver Injury; Hematologic Diseases; Humans; Liver Failure; Male; N-

2001
Hippocampal 1H-MRSI in ecstasy users.
    European archives of psychiatry and clinical neuroscience, 2001, Volume: 251, Issue:3

    Topics: Adult; Aspartic Acid; Brain Chemistry; Case-Control Studies; Choline; Creatine; Hippocampus; Humans;

2001
The subjective effects of MDMA and mCPP in moderate MDMA users.
    Drug and alcohol dependence, 2001, Dec-01, Volume: 65, Issue:1

    Topics: Adolescent; Adult; Affect; Analysis of Variance; Blood Pressure; Dose-Response Relationship, Drug; D

2001
Amnesic syndrome and severe ataxia following the recreational use of 3,4-methylene-dioxymethamphetamine (MDMA, 'ecstasy') and other substances.
    Neurocase, 2001, Volume: 7, Issue:5

    Topics: Adult; Amnesia; Brain Mapping; Cerebellar Ataxia; Disseminated Intravascular Coagulation; Drug Inter

2001
Increasing MDMA use among college students: results of a national survey.
    The Journal of adolescent health : official publication of the Society for Adolescent Medicine, 2002, Volume: 30, Issue:1

    Topics: Adolescent; Adolescent Behavior; Adult; Cross-Sectional Studies; Female; Hallucinogens; Humans; Illi

2002
Updates on students and their perceptions of risk associated with drug use.
    School nurse news, 2000, Volume: 17, Issue:3

    Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Attitude; Cannabis; Child; Female;

2000
Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems.
    Psychopharmacology, 2001, Volume: 159, Issue:1

    Topics: Adolescent; Adult; Analysis of Variance; Female; Humans; Illicit Drugs; Italy; Male; Mental Disorder

2001
Drug dependence studies and regulations: an overview of the past and present.
    Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology, 2001, Volume: 21, Issue:5

    Topics: Cannabis; Drug and Narcotic Control; Forecasting; History, 20th Century; Humans; Methamphetamine; N-

2001
Interactions in anesthesia: anesthetic management of the drug abusing parturient.
    Acta anaesthesiologica Belgica, 2001, Volume: 52, Issue:4

    Topics: Alcoholism; Amphetamine-Related Disorders; Anesthesia, Obstetrical; Cocaine-Related Disorders; Femal

2001
[The new drugs: ecstasy, GHB. Update for practitioners].
    Revue medicale de la Suisse romande, 2001, Volume: 121, Issue:12

    Topics: Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Sodium Oxybate; Substance-Related Dis

2001
Reduced N-acetylaspartate levels in the frontal cortex of 3,4-methylenedioxymethamphetamine (Ecstasy) users: preliminary results.
    AJNR. American journal of neuroradiology, 2002, Volume: 23, Issue:2

    Topics: Adult; Aspartic Acid; Choline; Creatine; Frontal Lobe; Hallucinogens; Humans; Magnetic Resonance Spe

2002
Ecstasy tablet testing: a case of guilty until proven innocent?
    Addiction (Abingdon, England), 2002, Volume: 97, Issue:2

    Topics: Drug Contamination; Health Knowledge, Attitudes, Practice; Humans; N-Methyl-3,4-methylenedioxyamphet

2002
The pediatric forum: ecstasy use among club rave attendees.
    Archives of pediatrics & adolescent medicine, 2002, Volume: 156, Issue:3

    Topics: Adolescent; Adult; Baltimore; Data Collection; District of Columbia; Female; Hallucinogens; Humans;

2002
Annual survey documents continued increases in use of ecstasy among U.S. teenagers.
    Psychiatric services (Washington, D.C.), 2002, Volume: 53, Issue:3

    Topics: Adolescent; Documentation; Female; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Substance-R

2002
MDMA ('ecstasy') use, and its association with high risk behaviors, mental health, and other factors among gay/bisexual men in New York City.
    Drug and alcohol dependence, 2002, Apr-01, Volume: 66, Issue:2

    Topics: Adolescent; Adult; Bisexuality; Confidence Intervals; Data Collection; Domestic Violence; Hallucinog

2002
Use, abuse and dependence of ecstasy and related drugs in adolescents and young adults-a transient phenomenon? Results from a longitudinal community study.
    Drug and alcohol dependence, 2002, Apr-01, Volume: 66, Issue:2

    Topics: Adolescent; Adult; Confidence Intervals; Data Collection; Female; Germany; Hallucinogens; Humans; Lo

2002
The BDI of the beholder.
    Journal of psychopharmacology (Oxford, England), 2002, Volume: 16, Issue:1

    Topics: Depression; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Psychiatric Status Rating

2002
Ecstasy in the brain: a model for neuroimaging.
    The Journal of neuropsychiatry and clinical neurosciences, 2002,Spring, Volume: 14, Issue:2

    Topics: Brain; Brain Diseases; Corpus Striatum; Frontal Lobe; Globus Pallidus; Hallucinogens; Magnetic Reson

2002
Morphological effects in the mouse myocardium after methylenedioxymethamphetamine administration combined with loud noise exposure.
    The Anatomical record, 2002, May-01, Volume: 267, Issue:1

    Topics: Animals; Drug Administration Schedule; Gas Chromatography-Mass Spectrometry; Hallucinogens; Heart; H

2002
Consumer & family information. Ecstasy.
    Psychiatric services (Washington, D.C.), 2002, Volume: 53, Issue:6

    Topics: Drug Interactions; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related

2002
Use of MDMA and other illicit drugs by young adult males in northern Spain. A five-year study.
    European addiction research, 2002, Volume: 8, Issue:3

    Topics: Adult; Hallucinogens; Humans; Longitudinal Studies; Male; Military Personnel; N-Methyl-3,4-methylene

2002
Street drug roulette continues.
    Emergency medical services, 2002, Volume: 31, Issue:6

    Topics: Amphetamine; Amphetamines; Central Nervous System Stimulants; Emergency Medical Technicians; Halluci

2002
What is a dose of ecstasy?
    Journal of psychopharmacology (Oxford, England), 2002, Volume: 16, Issue:2

    Topics: Cognition Disorders; Dose-Response Relationship, Drug; Hallucinogens; Humans; N-Methyl-3,4-methylene

2002
Possible interaction between an MAOI and "ecstasy".
    The American journal of psychiatry, 1992, Volume: 149, Issue:3

    Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Coma; Delirium; Designer Drugs; Drug Interactions; Female

1992
Flashbacks following MDMA.
    The British journal of psychiatry : the journal of mental science, 1992, Volume: 160

    Topics: 3,4-Methylenedioxyamphetamine; Designer Drugs; Hallucinations; Humans; N-Methyl-3,4-methylenedioxyam

1992
Another death from Ecstacy.
    Journal of the Royal Society of Medicine, 1992, Volume: 85, Issue:1

    Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Death, Sudden; Designer Drugs; Humans; Male; N-Methyl-3,4

1992
Phenomenology and sequelae of 3,4-methylenedioxymethamphetamine use.
    The Journal of nervous and mental disease, 1992, Volume: 180, Issue:6

    Topics: 3,4-Methylenedioxyamphetamine; Adult; Combined Modality Therapy; Designer Drugs; Emotions; Female; H

1992
The MDMA-neurotoxicity controversy: implications for clinical research with novel psychoactive drugs.
    The Journal of nervous and mental disease, 1992, Volume: 180, Issue:6

    Topics: 3,4-Methylenedioxyamphetamine; Animals; Combined Modality Therapy; Designer Drugs; Humans; Mental Di

1992
Acute renal failure after ecstasy.
    BMJ (Clinical research ed.), 1992, Jul-04, Volume: 305, Issue:6844

    Topics: 3,4-Methylenedioxyamphetamine; Acute Kidney Injury; Adult; Designer Drugs; Humans; Male; N-Methyl-3,

1992
Ecstasy and the dance of death.
    BMJ (Clinical research ed.), 1992, Jul-04, Volume: 305, Issue:6844

    Topics: 3,4-Methylenedioxyamphetamine; Designer Drugs; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Subst

1992
Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy")
    Lancet (London, England), 1992, Aug-15, Volume: 340, Issue:8816

    Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Adult; Female; Humans; Infant; Male; Morbidity; N-Methyl-

1992
Recreational MDMA use in Sydney: a profile of 'Ecstacy' users and their experiences with the drug.
    British journal of addiction, 1992, Volume: 87, Issue:8

    Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Adult; Arousal; Australia; Designer Drugs; Euphoria; Fema

1992
An overdose of ecstasy. A role for dantrolene.
    Anaesthesia, 1992, Volume: 47, Issue:8

    Topics: 3,4-Methylenedioxyamphetamine; Adult; Dantrolene; Humans; Intensive Care Units; Intermittent Positiv

1992
Complications of "ecstasy" misuse.
    Lancet (London, England), 1992, Sep-19, Volume: 340, Issue:8821

    Topics: 3,4-Methylenedioxyamphetamine; Anesthesia; Emergencies; Humans; N-Methyl-3,4-methylenedioxyamphetami

1992
Complications of "ecstasy" misuse.
    Lancet (London, England), 1992, Sep-19, Volume: 340, Issue:8821

    Topics: 3,4-Methylenedioxyamphetamine; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related Dis

1992
Complications of "ecstasy" misuse.
    Lancet (London, England), 1992, Sep-19, Volume: 340, Issue:8821

    Topics: 3,4-Methylenedioxyamphetamine; Dantrolene; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Substance

1992
Misuse of ecstasy.
    BMJ (Clinical research ed.), 1992, Aug-01, Volume: 305, Issue:6848

    Topics: 3,4-Methylenedioxyamphetamine; Acute Disease; Adult; Chemical and Drug Induced Liver Injury; Designe

1992
Misuse of ecstasy.
    BMJ (Clinical research ed.), 1992, Aug-01, Volume: 305, Issue:6848

    Topics: 3,4-Methylenedioxyamphetamine; Acute Disease; Adult; Chemical and Drug Induced Liver Injury; Designe

1992
Misuse of ecstasy.
    BMJ (Clinical research ed.), 1992, Aug-01, Volume: 305, Issue:6848

    Topics: 3,4-Methylenedioxyamphetamine; Acute Disease; Adolescent; Chest Pain; Designer Drugs; Female; Humans

1992
Misuse of ecstasy.
    BMJ (Clinical research ed.), 1992, Aug-01, Volume: 305, Issue:6848

    Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Adult; Cerebrovascular Disorders; Designer Drugs; Humans;

1992
Misuse of ecstasy.
    BMJ (Clinical research ed.), 1992, Aug-01, Volume: 305, Issue:6848

    Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Designer Drugs; Humans; Male; N-Methyl-3,4-methylenedioxy

1992
Drugs, music, and ideology: a social pharmacological interpretation of the Acid House Movement.
    The International journal of the addictions, 1992, Volume: 27, Issue:10

    Topics: 3,4-Methylenedioxyamphetamine; Humans; Leisure Activities; Lysergic Acid Diethylamide; Mass Media; M

1992
Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: effects on mood and neuropsychological function?
    The American journal of drug and alcohol abuse, 1992, Volume: 18, Issue:3

    Topics: 3,4-Methylenedioxyamphetamine; Adult; Cognition Disorders; Depressive Disorder; Female; Humans; Male

1992
Chronic paranoid psychosis after misuse of MDMA ("ecstasy")
    BMJ (Clinical research ed.), 1991, Mar-23, Volume: 302, Issue:6778

    Topics: 3,4-Methylenedioxyamphetamine; Adult; Designer Drugs; Humans; Male; N-Methyl-3,4-methylenedioxyamphe

1991
Chronic paranoid psychosis after misuse of MDMA.
    BMJ (Clinical research ed.), 1991, May-11, Volume: 302, Issue:6785

    Topics: 3,4-Methylenedioxyamphetamine; Adult; Designer Drugs; Female; Humans; Male; N-Methyl-3,4-methylenedi

1991
Ecstasy, 3-4 methylenedioxymethamphetamine (MDMA), a fatality associated with coagulopathy and hyperthermia.
    Journal of the Royal Society of Medicine, 1991, Volume: 84, Issue:6

    Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Designer Drugs; Disseminated Intravascular Coagulation; F

1991
Chronic atypical psychosis associated with MDMA ("ecstasy") abuse.
    Lancet (London, England), 1991, Nov-23, Volume: 338, Issue:8778

    Topics: 3,4-Methylenedioxyamphetamine; Adult; Chronic Disease; Humans; Male; N-Methyl-3,4-methylenedioxyamph

1991
Lasting neuropsychiatric sequelae of (+-)methylenedioxymethamphetamine ('ecstasy') in recreational users.
    Journal of clinical psychopharmacology, 1991, Volume: 11, Issue:5

    Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Adult; Anxiety Disorders; Depressive Disorder; Female; Fo

1991
Aminergic metabolites in cerebrospinal fluid of humans previously exposed to MDMA: preliminary observations.
    Annals of the New York Academy of Sciences, 1990, Volume: 600

    Topics: 3,4-Methylenedioxyamphetamine; Adult; Biogenic Amines; Designer Drugs; Female; Homovanillic Acid; Hu

1990
Neuroendocrine and mood responses to intravenous L-tryptophan in 3,4-methylenedioxymethamphetamine (MDMA) users. Preliminary observations.
    Archives of general psychiatry, 1989, Volume: 46, Issue:1

    Topics: 3,4-Methylenedioxyamphetamine; Adult; Affect; Amphetamines; Designer Drugs; Female; Humans; Infusion

1989
'Ecstasy': a human neurotoxin?
    Archives of general psychiatry, 1989, Volume: 46, Issue:2

    Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Nervous

1989
Blasted with ennui.
    BMJ (Clinical research ed.), 1989, Jan-21, Volume: 298, Issue:6667

    Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Designer Drugs; Humans; N-Methyl-3,4-methylenedioxyamph

1989
Ecstasy abuse.
    The New Zealand medical journal, 1989, Aug-23, Volume: 102, Issue:874

    Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Designer Drugs; Humans; N-Methyl-3,4-methylenedioxyamph

1989
Responses to i.v. L-tryptophan in MDMA users.
    NIDA research monograph, 1989, Volume: 95

    Topics: 3,4-Methylenedioxyamphetamine; Adult; Affect; Amphetamines; Designer Drugs; Female; Humans; Male; N-

1989
A bit on the Wilde side: MDMA abuse.
    North Carolina medical journal, 1985, Volume: 46, Issue:12

    Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Drama; Famous Persons; Hallucinogens; Humans; Literatur

1985
Toxicity of methylenedioxymethamphetamine (MDMA) in the dog and the rat.
    Fundamental and applied toxicology : official journal of the Society of Toxicology, 1987, Volume: 9, Issue:1

    Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Body Weight; Brain; Dogs; Eating; Female; Male

1987
Incidence of recreational use of 3,4-methylenedimethoxymethamphetamine (MDMA, "ecstasy") on an undergraduate campus.
    The New England journal of medicine, 1987, Dec-10, Volume: 317, Issue:24

    Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; California; Humans; N-Methyl-3,4-methylenedioxyamphetam

1987
New data intensify the agony over ecstasy.
    Science (New York, N.Y.), 1988, Feb-19, Volume: 239, Issue:4842

    Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Brain; Haplorhini; Humans; Legislation, Drug;

1988
Legal limbo for ecstasy.
    Science (New York, N.Y.), 1988, Feb-19, Volume: 239, Issue:4842

    Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Humans; Legislation, Drug; N-Methyl-3,4-methyl

1988
Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 1988, Volume: 1, Issue:4

    Topics: 3,4-Methylenedioxyamphetamine; Adult; Amphetamines; Behavior; Designer Drugs; Humans; Interviews as

1988